|
|
||||||||
Physiological Reviews, Vol. 81, No. 2, April 2001, pp. 495-537
Copyright ©2001 by the American Physiological Society
Division of Biochemistry and Molecular Biology, Faculty of Science, Australian National University, Canberra, Australian Capital Territory, Australia
I. INTRODUCTION
II. THE INTRAERYTHROCYTIC PHASE OF THE MALARIA PARASITE LIFE CYCLE
III. METHODS
A. Cell Preparations
B. Radioisotope Fluxes
C. Isosmotic Hemolysis
D. Fluorescence
E. Ion Analysis
F. Electrophysiological Techniques
G. Genetic Techniques
IV. SOLUTE TRAFFICKING ROUTES IN THE PARASITIZED CELL
A. Windows, Tubes, Vesicles, and Ducts
B. Does the Intracellular Parasite Have Direct Access to the Extracellular Medium?
C. Does the Parasitized Erythrocyte Take Up Macromolecules and Other High-Molecular-Weight Solutes?
D. Summary
V. THE RED BLOOD CELL MEMBRANE
A. General Considerations
B. Increased Transport Via Pathways Having the Characteristics of Endogenous Host Cell Transporters
C. New Permeation Pathways
VI. THE PARASITOPHOROUS VACUOLE MEMBRANE
A. Origin and Composition of the PVM
B. Permeability Properties of the PVM
VII. THE PARASITE PLASMA MEMBRANE
VIII. INTRACELLULAR ORGANELLAR MEMBRANES
IX. TRANSPORT OF SPECIFIC SOLUTES IN THE PARASITIZED ERYTHROCYTE
A. Sugars
B. Amino Acids
C. Peptides
D. Nucleosides
E. Vitamins
F. Choline
G. Lactate
H. ATP/ADP
I. Chloride
J. Sodium, Potassium, and Protons
K. Calcium
L. Magnesium
M. Drugs
X. CONCLUSIONS
| |
ABSTRACT |
|---|
|
|
|---|
Kirk, Kiaran
Membrane Transport in the Malaria-Infected
Erythrocyte. Physiol. Rev. 81: 495-537, 2001.
The malaria
parasite is a unicellular eukaryotic organism which, during the course
of its complex life cycle, invades the red blood cells of its
vertebrate host. As it grows and multiplies within its host blood cell,
the parasite modifies the membrane permeability and cytosolic
composition of the host cell. The intracellular parasite is enclosed
within a so-called parasitophorous vacuolar membrane, tubular
extensions of which radiate out into the host cell compartment. Like
all eukaryote cells, the parasite has at its surface a plasma membrane,
as well as having a variety of internal membrane-bound organelles
that perform a range of functions. This review focuses on the transport
properties of the different membranes of the malaria-infected
erythrocyte, as well as on the role played by the various membrane
transport systems in the uptake of solutes from the extracellular
medium, the disposal of metabolic wastes, and the origin and
maintenance of electrochemical ion gradients. Such systems are of
considerable interest from the point of view of antimalarial
chemotherapy, both as drug targets in their own right and as routes for
targeting cytotoxic agents into the intracellular parasite.
| |
I. INTRODUCTION |
|---|
|
|
|---|
Malaria is an infectious disease, caused by unicellular, protozoan parasites of the genus Plasmodium. There are an estimated 300-500 million cases of the disease, world-wide, each year, giving rise to an estimated 1.5-2.7 million deaths (323). Four species of plasmodia are infectious to humans: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale. It is the first of these, P. falciparum, that is responsible for the vast majority of deaths from malaria.
During the course of its complex life cycle, the malaria parasite invades the red blood cells of its vertebrate host, resulting in the unusual situation of one eukaryotic cell (the metabolically voracious and biosynthetically active parasite) living inside another (the comparatively inert erythrocyte). It is this phase of the parasite's life cycle that gives rise to all of the clinical symptoms of malaria. The strategy of living inside the cells of its host helps the parasite evade the host's immune system. However, it does pose significant challenges to the invading organism. The interior of the host erythrocyte represents a highly unusual extracellular environment (231). The intracellular parasite is confronted with an extracellular milieu that has, at least initially, high concentrations of K+ and proteins, low levels of Na+, and only trace levels of Ca2+. The invading parasite must have mechanisms for maintaining its chemical composition and for obtaining from the host cell cytosol all of the nutrients that it requires for its survival, doing so in competition with the metabolic and biosynthetic machinery of the host. Furthermore, there must be mechanisms for eliminating metabolic wastes, both from within the parasite and from the host cell. As in other cells, these processes involve membrane transport mechanisms that control the flux of solutes across the membranes of the host cell and the intracellular parasite. It is these mechanisms that are the major focus of this review.
It has long been recognized that after malaria infection the parasitized erythrocyte undergoes marked alterations in its basic membrane transport properties (reviewed in Refs 39, 40, 80, 109, 116, 120, 125, 130, 183, 276, 288). The activity of a number of the endogenous transport systems is altered. Furthermore, there appear in the infected cell new permeation pathways (NPP) with properties quite unlike those of any of the endogenous red cell systems. These pathways are yet to be identified at a molecular level; however, their functional characteristics have been described in some detail. The transport properties of the "parasitophorous vacuole" membrane (PVM) in which the intracellular parasite is enclosed, the parasite plasma membrane (PPM), and the membranes of the various organelles within the parasite are less well characterized. Functional studies, both of intact infected erythrocytes and of parasites isolated from their host cells using a variety of techniques, have provided some information about the transport properties of the PPM and PVM. The application of genetic techniques has yielded sequences of malaria parasite proteins that are homologous to membrane transport proteins from other organisms. Many more such sequences are emerging from the systematic sequencing of the P. falciparum genome (28, 58, 104, 306). P. falciparum has 14 chromosomes. The recently published sequence of chromosomes 2 and 3 of P. falciparum include four and three sequences, respectively, of putative membrane transporters (28, 104). One of these (on chromosome 2) has been shown to transport hexose sugars (190a, 349a, 350). Another gene (on chromosome 14) has been shown to encode a nucleoside transporter (44, 241b). At the time of writing, however, these are the only examples of Plasmodium-encoded transporters for which both the protein sequence and detailed functional characteristics (e.g., substrate specificity, kinetics etc.) have been established.
The aim of this article is to review what is currently known about the membrane transport systems that mediate the flux of solutes between the intraerythrocytic malaria parasite and the plasma. The major focus is on the most virulent of the malaria parasites infectious to humans, P. falciparum, but with reference made to other parasite and host species where appropriate. Most of the work discussed has been carried out since 1976 when a culture system that enabled the in vitro cultivation of P. falciparum in human erythrocytes first became available (320). Earlier studies of membrane transport phenomena in parasitized erythrocytes from malaria-infected animals have been reviewed elsewhere (288).
Section II gives a brief (and far from comprehensive) outline of the intraerythrocytic phase of the parasite life cycle, concentrating on those features that are relevant to the subject of this review. Section III deals with methodological issues and discusses the advantages and shortcomings of the various techniques that have been applied to the study of membrane transport in the malaria-infected cell. Section IV deals with general aspects of membrane transport in the malaria-infected erythrocyte, focusing in particular on the important (and contentious) issue of compartmentalization in the parasitized cell, and its implications for the interpretation of transport data. In sections V-VIII, the general transport properties of the different membrane systems in the malaria-infected erythrocyte are discussed, while section IX focuses in more detail on the various classes of solute for which there is information available regarding their transport in the parasitized cell.
| |
II. THE INTRAERYTHROCYTIC PHASE OF THE MALARIA PARASITE LIFE CYCLE |
|---|
|
|
|---|
Malaria parasites enter their vertebrate host via the bite of an infected female Anopheles mosquito. They make their way first, via the bloodstream, to the liver where a single parasite (or "sporozoite" as it is then called) invades a liver cell. Once inside, it multiplies to produce thousands of "merozoites." The liver cell swells and, eventually, bursts, releasing the merozoites into the circulation, where they set about invading the red blood cells of their host.
The different stages of the asexual intraerythrocytic phase of the parasite life cycle are represented schematically in Figure 1. The malaria parasite gains entry into its prospective host erythrocyte by a process that leaves the intracellular parasite enclosed within a PVM (discussed in more detail in sect. VI). In the hours immediately after invasion (the so-called "ring" stage), the intracellular parasite seemingly lies dormant. However, from ~15 h postinvasion there is a progressive increase in metabolic and biosynthetic activity within the infected cell as the parasite enters the "trophozoite" stage. The malaria parasite has a single mitochondrion but lacks a functional citric acid cycle and is thought to be wholly reliant on glycolysis for its energy supply. As the parasite matures, the rate of glucose utilization and lactic acid production by the parasitized cell increases to up to 100 times the rate in the uninfected erythrocyte (248, 267, 333). The parasite endocytoses portions of the erythrocyte cytoplasm into "cytostomal vesicles" that fuse with the internal digestive or food vacuole membrane. Here the proteins of the host cell cytosol (predominantly hemoglobin) are digested to small peptides (165, 186, 266) that serve as a source of amino acids for the parasite. There is extensive synthesis of proteins, RNA, and DNA, a situation that contrasts markedly with that in normal erythrocytes which lack the ability to synthesize macromolecules. Parasite-derived proteins are expressed not only within the parasite but are exported to the parasitophorous vacuole, to the PVM, to the cytosol, cytoskeleton, and plasma membrane of the host cell, and perhaps beyond, into the extracellular medium.
|
Concomitant with this dramatic increase in metabolic and biosynthetic activity, the parasite grows in size until, by 36 h postinvasion, it occupies approximately one-third of the total volume of the host cell (273). It remains enclosed within the PVM, which increases in size accordingly. At the same time, there appears in the erythrocyte cytosol a variety of tubular and vesicular membrane structures, thought to extend out from the PVM and variously referred to as the "tubovesicular membrane" (TVM; Ref. 87) or "tubovacuolar" (80) network. There are pronounced changes in the morphology of the infected cell, which is transformed from the smooth biconcave disk of the normal erythrocyte to an irregularly shaped cell, the surface of which becomes covered with a plethora of small electron-dense protrusions known as "knobs." The knobs are the site of localization of a number of parasite-derived proteins, including the products of the so-called var gene family (60). These proteins, known collectively as Pfemp1 (for Plasmodium falciparum erythrocyte membrane protein 1), are integral membrane proteins that play a central role in the dual phenomena of cytoadherence (i.e., binding of infected cells to the endothelial cells lining the capillaries of the brain and other organs, as well as to uninfected erythrocytes) and antigenic variation (16, 264, 268, 298, 307).
In addition to the insertion of new proteins into the red blood cell membrane (RBCM), there is a marked alteration of the composition and organization of the lipid phase of this membrane (159, 211, 281, 294, 353), as well as some rearrangement and modification of the endogenous red cell membrane proteins. The band 3 anion exchanger, which is the most abundant of the host cell integral membrane proteins, undergoes a decrease in mobility (317), and a proportion of the band 3 proteins are also truncated by proteolytic cleavage (54, 55, 290).
Approximately 40 h after the initial invasion, the late-stage trophozoite enters the "schizont" stage at which point it subdivides to produce 20-30 daughter merozoites. These are released at "schizogony" when the host cell finally ruptures, some 48 h after invasion. Each of the new generation of merozoites is capable of invading another erythrocyte, thereby continuing the cycle.
| |
III. METHODS |
|---|
|
|
|---|
A number of different experimental techniques have been applied to the study of membrane transport mechanisms in the malaria-infected erythrocyte. In this section these techniques are considered in detail and their advantages and limitations are discussed.
A. Cell Preparations
1. Malaria-infected erythrocytes
Until the late 1970s, the majority of investigations into the
physiology and biochemistry of the malaria-infected erythrocyte were carried out using blood taken from animals (mice, rats, birds, monkeys) infected with one of the various different species of plasmodia that infect animals of different species. Laboratory studies
of malaria were revolutionized in 1976 with the development of a method
for the in vitro culture of P. falciparum (320,
321). This method, in combination with techniques to
synchronize the parasites in culture to within a few hours
(198), and to separate parasitized from nonparasitized
cells, either by centrifugation on a Percoll density gradient or using
a simple gelatin flotation technique (244), enables the
production of synchronized suspensions of P. falciparum-infected human erythrocytes in the quantities necessary
for physiological and biochemical studies. 2. "Isolated" malaria parasites
Studies of the transport properties of the membranes at the
surface of the intracellular malaria parasite have entailed the use of
a range of techniques to either free the parasite from its host
erythrocyte or to permeabilize the host cell membrane. The following
approaches have been used for this purpose. A) DETERGENTS. The plant-derived detergents saponin and
digitonin interact with cholesterol in cell membranes, thereby causing a fundamental disruption of the barrier properties of
cholesterol-containing membranes (84,
284, 285, 297). Treatment of
parasitized erythrocytes with either saponin (e.g., Refs. 8, 9, 273,
327) or digitonin (e.g., Ref. 63) renders the RBCM freely permeable to
solutes as large as soluble proteins (e.g., hemoglobin), while leaving the intracellular parasite intact. There is evidence that, in addition
to its effect on the RBCM, saponin also permeabilizes the PVM in which
the intracellular parasite is enclosed (9). B) OTHER BIOLOGICAL AGENTS. Complement, in conjunction with
an appropriate antiserum, has been used to permeabilize the erythrocyte membranes of parasitized cells (322). Ginsburg and
colleagues (124, 166, 167) have
made effective use of Sendai virus for the same purpose. The Sendai
virions induce the fusion of erythrocytes, causing, in the process, the
permeabilization of the erythrocyte membrane to small solutes. As a
result, the host cell undergoes colloid osmotic hemolysis, leaving the
parasite intact within freely permeable erythrocyte ghosts. Streptolysin O is a bacterial protein that forms pores of >30 nm in
diameter (22). It has been used previously to study the
transport of peptides across the endoplasmic reticulum membrane of
mammalian cells (233) and has been shown recently by
Lingelbach and colleagues to provide an effective means of
permeabilizing the RBCM of malaria-infected erythrocytes
(8, 9). The same group has also provided
evidence that whereas the detergent saponin permeabilizes both the RBCM
and the PVM, streptolysin O permeabilizes only the former, leaving the
latter intact (9). In a very recent study, Lauer et al. (199a) have reported
that treatment of trophozoite-stage parasitized erythrocytes with the
cholesterol-depleting agent methyl- C) OSMOTIC LYSIS. The appearance in the membrane of
malaria-infected erythrocytes of NPP some hours after invasion (see
sect. VC) forms the basis of a number of
methods for the selective disruption of the host erythrocyte membrane.
Suspension of trophozoite-infected cells in an isosmotic solution
of compounds that permeate the NPP freely, but to which the normal
erythrocyte has a limited permeability, leads to the selective lysis of
infected cells (see sect. IIIC). If the
PPM and/or PVM has a lower permeability to the permeating solute than
the RBCM, or if the parasite is able to actively regulate its volume
and thereby counteract any osmotic swelling, it emerges from this
procedure unscathed. A variation on this approach involves suspending
trophozoite-infected erythrocytes in culture medium made
hyperosmotic by the addition of a solute able to permeate the NPP in
the erythrocyte membrane. On exposure to the hyperosmotic medium, the
infected cell shrinks (in response to the increased extracellular
osmolality), then recovers its volume as the permeant solute enters the
cell. On return of the cells to an isosmotic saline, the osmolality of
the host cell compartment is higher than that of the external medium,
and it therefore swells and bursts. Providing that the intracellular
parasite is less permeable to the added solute than the host red cell
membrane and/or it is able to withstand a greater hyposmotic shock than
its host cell, it remains intact. Hoppe et al. (158) have used this approach, with sorbitol
as the permeant solute, to isolate P. falciparum
trophozoites from their host cells. Elford (79) has
described a similar approach using di- and tripeptides. In the latter
protocol, cells are exposed to a (slightly) hyperosmotic solution of
di- and tripeptides then transferred back to an isosmotic saline,
whereupon the parasitized cells lyse, releasing the intracellular
parasite. Although the mechanism underlying the peptide-induced
hemolysis has not been elucidated in detail, the likely explanation is,
as above, an initial shrinkage then gradual volume recovery for the
cells in the hyperosmotic peptide medium, followed by the osmotic lysis of the host cell compartment on return of the cells to isosmotic conditions. The use of peptides as the permeant solute in this procedure has the additional advantage that hydrolysis of the peptides
(to their component amino acids) by peptidases within the host
erythrocyte compartment (173) may increase the
intracellular osmolality and thereby add to the magnitude of the
osmotic shock to which the infected cells are exposed on return to
isosmotic media. D) PHYSICAL DISRUPTION. Nitrogen decompression of a
malaria-infected cell suspension, involving exposure of the cells
to a high pressure N2 atmosphere (typically for 15 min),
followed by their return to atmospheric conditions, results in the
disintegration of the RBCM of parasitized erythrocytes into vesicles,
leaving the majority of the parasites (as well as the majority of
uninfected cells present) intact (237). Haldar et al.
(142) have described the use of a stainless steel ball
homogenizer to release intact parasites from their host erythrocytes.
However, the yield of parasites from this method is relatively low
(10-30%). E) MEROZOITES AND AXENIC CULTURE OF PARASITES. An
alternative approach to obtaining malaria parasites free of
erythrocytes is to rely on the natural release of the parasites
(merozoites) from their host erythrocyte at the end of each
intraerythrocytic cycle (23). The merozoites would
normally spend as short a time as possible in the extracellular medium
before invading another erythrocyte (Fig. 1). They can, however, be
harvested in sufficient quantity to allow biochemical and physiological
measurements to be made (23, 327). In a
recent study it was demonstrated that treatment of schizont stage
parasites with a cysteine-protease inhibitor causes the accumulation in
the medium of extraerythrocytic merozoites, trapped within the PVM
(276a). These merozoites are viable and capable of normal
erythrocyte invasion and development. They are readily purified from
the medium and may therefore be used in the types of studies described
in the following sections. Attempts to culture the erythrocytic stages
of the malaria parasite extracellularly have shown that supplementation
of the medium with erythrocyte extract permits the development of some
of the parasites to the ring stage, although the yields are low
(321). B. Radioisotope Fluxes
Quantitative estimates of membrane transport rates, as well as the
investigation of the kinetic and pharmacological characteristics of
membrane transport mechanisms in both intact malaria-infected erythrocytes and isolated malaria parasites, have usually involved measuring the influx (and, less often, the efflux) of radiolabeled forms of the solutes of interest. The general approach in influx experiments is to combine cells and radiolabeled substrate, incubate them for an appropriate time, separate the cells from the suspending medium (either by centrifuging the cells through an oil layer of
density intermediate between the cells and the aqueous solution or by
repeated washing of the cells by centrifugation and resuspension in a
"stopping solution"), then analyze the radioactivity in the cell
pellet. A common strategy in such studies is to carry out initial time
course experiments to establish the period for which the uptake of
solute remains approximately linear with time, then, in subsequent
experiments, to estimate influx rates from the amount of radiolabel
taken up during a fixed-length incubation that falls within this period. The intention in such experiments is usually to estimate the initial
rate of influx of radiolabeled substrate into the cells. The major
underlying difficulty with this approach is that it is not always a
straightforward matter to know with certainty what and where is the
rate-limiting step for the measured uptake of radiolabel. This
question is of central importance in flux studies with any cell type,
but it is of particular concern in malaria-infected erythrocytes,
for reasons relating to both the complex compartmentalization and
active metabolism of the parasitized cell. The conventional assumption in interpreting influx data derived from
intact malaria-infected erythrocytes is that the first membrane
encountered by a solute added to the extracellular solution is the
RBCM, and that the transport across this membrane, into the erythrocyte
cytosol, therefore provides the rate-limiting step for the initial
phase of solute uptake. However, this assumption is challenged by the
suggestion that there may be pathways that allow extracellular solution
to come into direct contact with the surface of the intracellular
parasite and/or that allow extracellular solutes to enter the parasite
without actually entering the erythrocyte cytosol (see sect.
IVB). If such pathways do exist, then the uptake of labeled solute from the external medium as measured in initial rate
experiments may occur across the host erythrocyte membrane, the
parasite membrane, or both. Even if there are no such "parallel routes," and the traffic of all
solutes between the parasite and the external medium is via the
erythrocyte cytosol, the issues of intracellular compartmentalization and metabolism still raise significant difficulties. If a solute, on
entering the erythrocyte cytosol, is transported into the parasite and/or metabolized, the question immediately arises of the extent to
which these processes determine the uptake of the solute of interest
over the time period over which the experiments are carried out. This point is illustrated in Figure 2.
Figure 2B shows an idealized time course for the uptake of a
solute (denoted by S) that equilibrates rapidly between the erythrocyte
cytosol compartment and the extracellular medium (Phase I) and is then
either sequestered into the parasite, metabolized (to an impermeant
form, denoted by S'), or both, at a much slower rate (Phase II). Under
these conditions, uptake of radiolabel will provide a true measure of the transport of the solute across the RBCM only if it is measured over
the very early portion of Phase I of the time course. The use of longer
time periods that fall outside this initial linear phase will lead to
an underestimate of the transport rate, as well as an overestimate of
IC50 values for inhibitors and of Michaelis constant
(Km) values for saturable transport processes.
-cyclodextrin causes the release
of parasites, free of the PVM. The parasites may be obtained in high
yield (50-70% of parasites are released) and remain viable for up to
24 h. Parasites obtained in this way may offer the opportunity to study
the physiological properties of the PPM without interference from the PVM.

View larger version (27K):
[in a new window]
Fig. 2.
Idealized time courses for the uptake of solute (denoted by S) into
a multicompartmental system such as a malaria-infected erythrocyte,
represented schematically in A. B: an idealized
time course for the uptake of a solute that equilibrates rapidly across
the erythrocyte membrane via a passive (i.e., nonconcentrative) process
(Phase I) and that is then either metabolized (to an impermeant form;
S'), sequestered into the parasite, or both, at a much slower rate
(Phase II). C: an idealized time course for solute uptake
under conditions in which the initial equilibration step (Phase I) is
significantly slower than the subsequent step(s) (Phase II) so that the
solute is sequestered and/or metabolized immediately on entering the
parasitized cell. The "distribution ratio" is the total
concentration of the solute (S + S') inside the cell, relative to that
in the extracellular solution.
Figure 2C shows an idealized time course for solute uptake under conditions in which the initial transport step (Phase I) is significantly slower than the subsequent step(s) (Phase II), so that in practice, no sooner has a solute entered the host cell cytosol then it finds itself sequestered and/or metabolized. Under these conditions, the uptake of radiolabel may be rate-limited by the transport of solute across the RBCM for an extended period, during which the total concentration of radiolabel inside the cell may reach a much higher level than in the extracellular solution. This does offer significant advantages to the experimenter who, apart from anything else, will be able to use less radiolabeled substrate to make a quantitative estimate of the influx rate. However, it also holds significant dangers.
First, as discussed in general terms by Wohlhueter and Plagemann (349), if the concentration of metabolized or sequestered radiolabel is very large relative to the concentration of unaltered solute in the erythrocyte cytosol, then the uptake time course might appear to extrapolate through the origin, while not truly doing so (i.e., the time course may appear to take the form of Fig. 2C, whereas the real situation is actually that of Fig. 2B). This leads to an underestimate of the influx rate.
Second, even if under one set of conditions the rate of metabolism or sequestration (i.e., Phase II) is truly much greater than the rate of influx (Phase I), so that the rate of accumulation of radiolabel provides an accurate measure of the initial transport rate, this will not necessarily be the case under all conditions. If, in investigating the effects of different experimental conditions (e.g., increasing substrate concentration, addition of competitive substrates or of potential inhibitors), a particular maneuver reduces the rate of the metabolic or intracellular compartmentalization step (Phase II) while having a lesser effect on the initial transport step (Phase I), there is a risk that the compartmentalization process will become the rate-limiting process. In this case, the situation will revert to that represented in Figure 2B. If, under these conditions, the length of the uptake incubation falls outside the initial part of the time course, then the amount of radiolabel taken up will be affected by both the rate of transport and by the subsequent conversion or compartmentalization rate. In this case, the characteristics that emerge from such an analysis (kinetic constants, pharmacological properties) may be a combination of those of the transport step and those of the intracellular process(es).
C. Isosmotic Hemolysis
An alternative method that has been used extensively to study the altered permeability of the malaria-infected erythrocyte, as well as various other induced-permeability phenomena in erythrocytes, involves suspending the cells in an isosmotic solution of the solute of interest. The principle behind this method is illustrated in Figure 3. On suspension of the cell in the isosmotic solution, there is a large inward concentration gradient, and hence a large driving force for the influx of the extracellular solute (represented by solid circles). If the permeability of the RBCM to this compound is higher than that to the solutes comprising the cell cytosol (represented by open circles), the rate of influx of material into the cell exceeds the rate of efflux, resulting in a net uptake of solute and water. This causes cell swelling and eventual hemolysis, the rate of which provides a semi-quantitative estimate of the (net) rate of influx of solute. Hemolysis is readily monitored by measuring the release of hemoglobin (spectrophotometrically, using absorbance at 540 nm), or that of other intracellular solutes (e.g., ATP; Refs. 40, 166).
|
The isosmotic hemolysis technique has been used to investigate the
permeability of the malaria-infected erythrocyte to a wide range of
nonelectrolytes (127, 128, 179)
and to a number of cations (178, 179,
303). It may be adapted for use with anions, although this
requires that the permeability of the cell membrane to cations be
higher than its permeability to the anions of interest. It is only
under this condition that the net influx of the anion of interest is
limited by the permeability of the anion itself, and not by the
permeability of the accompanying cation (as would normally be the
case). In practice, this can be achieved by the use of
NH


The isosmotic hemolysis technique offers the major advantages of requiring relatively small amounts of material (the spectrophotometric determination of hemoglobin concentration is highly sensitive and allows the detection of the hemolysis of relatively few cells), of being applicable to infected cell suspensions at low parasitemia (uninfected cells are stable for long periods in isosmotic solutions of many of the solutes of interest and therefore do not contribute to measured hemoglobin release) and of not requiring the use of expensive radioisotopes.
However, it also has the following significant limitations.
1) Its application is restricted to solutes that are sufficiently hydrophilic to be soluble at the concentrations needed to make an isosmotic solution (i.e., ~300 mM for nonelectrolytes and ~150 mM for monovalent salts) and which are not hemolytic to normal erythrocytes at these high concentrations.
2) It requires that the cells be exposed to conditions that are far from physiological. This may affect the operation of the pathways of interest.
3) The technique provides information about the net influx of a particular solute under conditions in which the cell is exposed to a single, high concentration of that solute. If the influx pathway is saturated by high concentrations of the solute of interest, the rate of hemolysis will not be indicative of the true permeability of the pathway to the solute.
4) The rate of hemolysis is influenced not only by the net influx rate of extracellular solute but by the fate of the solute once it has entered the infected cell. In Figure 3, the solute is shown as being excluded from the intracellular parasite and remaining unaltered and in free solution within the erythrocyte cytosol. However, if the solute enters the parasite and is either metabolized or bound, in such a way as to change its osmotic contribution, then the amount of solute that will have to enter the cell to produce a given amount of cell swelling (and, ultimately, hemolysis) may be either more or less than if this does not occur. Under such circumstances, estimates of the relative permeation rates of different solutes from relative rates of hemolysis are, at best, semi-quantitative.
5) The technique is of limited use in comparing the permeation of different solutes (or the effects of inhibitors on the influx of different solutes) as the different isosmotic solutions provide quite different extracellular environments and the properties (e.g., inhibitor sensitivity; see Ref. 179) of the pathways of interest may well vary between these different conditions.
In summary, the isosmotic hemolysis technique provides a semi-quantitative measure of net solute permeation rates under limited (nonphysiological) conditions. It offers a convenient means for testing relative potencies of different inhibitors on the transport of any given substrate (albeit under extremely nonphysiological conditions). However, as noted in point 5 (above), caution must be exercised in using this approach to compare the effect of one or more given inhibitors on the transport of different substrates.
D. Fluorescence
1. Fluorescent transport solutes
Cabantchik, Ginsburg, and colleagues have used both the efflux
(193, 195) and influx (34) of
the fluorescent anion NBD-taurine to probe the altered permeability
properties of the parasitized erythrocyte. In the efflux experiments,
cells were preloaded with the fluorescent solute, washed, then
suspended at low hematocrit in saline. The fluorescence of the
suspension increased as the compound effluxed from the cells. This
approach offers an advantage over analogous radiotracer experiments in
allowing "on-line" measurements. However, it is restricted to
fluorescent (and hence relatively large nonphysiological) substrates.
It is also difficult to know with certainty which membrane in the
infected cell constitutes the rate-limiting step for the efflux of the
fluorescent probe that remains in the cell after the initial wash procedure. More recently, larger fluorescent molecules such as Lucifer yellow
(141, 199) and various fluorescent
macromolecule conjugates (138, 153,
253) have been used in conjunction with fluorescence microscopy to study the uptake of such solutes into individual parasitized erythrocytes. The data are qualitative and, as discussed in
section IVC, may, in some cases, be compromised
by the dissociation of the fluorophore from the molecules of interest
(153, 291). 2. Fluorescent ion indicators
Over the last decade, the study of ion transport in animal and
plant cells has been revolutionized by the use of ion-sensitive fluorescent indicators that can be loaded into cells and thereby used
to monitor the intracellular concentrations of a range of different
ions. Ions for which fluorescent indicators are available include
H+, Na+, K+, Ca2+,
Mg2+, and Cl Although fluorescent ion indicators have not, as yet, been widely
applied to the study of the intracellular malaria parasite, there have
been a number of recent studies demonstrating the applicability of this
approach. Mikkelsen et al. (225) used the
pH-sensitive fluorescent dye
2',7'-bis(2-carboxyethyl)-5,6-carboxyfluorescein (BCECF) to
measure the intracellular pH (pHi) of parasites
(P. chabaudi) freed from their host cells using
N2 cavitation (see sect.
IIIA2D), whereas Bosia et al.
(27) used 6-carboxyfluoroescein to measure the
pHi of parasites (P. falciparum) within
erythrocytes permeabilized using Sendai virus (see sect.
IIIA2B). More recently, Wunsch and
colleagues have described the use of BCECF in conjunction with a
digital imaging system, to monitor the cytosolic pH of the parasite
[both within intact erythrocytes and in parasites released from their
host erythrocytes using the peptide hemolysis technique described in
sect. IIIA2C; (355,
356)] and the pH in the cytoplasm of the host erythrocyte
(see sect. IXJ). The same group
has used the Na+-sensitive dye benzofuran isophthalate
acetoxymethyl ester (SBFI) to monitor the concentration of
Na+ within the intracellular parasite (see sect.
IXJ) (354,
356). Several other groups have reported the use of the fluorescent
Ca2+ indicators indo 1, fluo 3 (1), and fura 2 (102) to estimate cytosolic Ca2+
concentrations in intact and/or permeabilized malaria-infected erythrocytes, as well as the use of the colourimetric Ca2+
indicator arsenazo III (242), in isolated parasites. The
transport and homeostasis of Ca2+ in the
malaria-infected erythrocyte is discussed in detail in section
IXK. E. Ion Analysis
Early estimates of the Na+/K+
composition of malaria-infected erythrocytes were made using flame
photometry of extracts of erythrocytes from malaria-infected
animals (74). These measurements did indicate a
perturbation of the normal Na+/K+ balance in
infected erythrocytes; however, the conclusions that could be drawn
were limited by the multi-compartmental nature of the parasitized
cell. Ginsburg et al. (124) used flame photometry, in
combination with Sendai virus permeabilization of the host cell
membrane (see sect. IIIA2B), to
estimate the Na+/K+ concentration ratio in the
host cell and parasite compartments of malaria-infected cells,
showing it to be increased to well above normal levels in the red cell
cytosol but maintained at a low level within the parasite. Similar
results were obtained by Lee et al. (200) who used
X-ray microanalysis in conjunction with electron microscopy to
obtain estimates of the Na+, K+,
Cl F. Electrophysiological Techniques
The patch-clamp technique involves the formation of a
high-resistance (giga-ohm) seal between a cell membrane and a glass micropipette, then monitoring the currents arising from the flux of
ions either across the enclosed patch of membrane or across the whole
cell membrane (see Ref. 155). This technique has proven invaluable in
elucidating the characteristics of ion channels in many animal and
plant cells, but it has not, as yet, been widely applied to parasitic protozoa. Patch-clamping malaria-infected erythrocytes is not
straightforward. The infected cells are, compared with the cell types with which most electrophysiologists are familiar, both small and
fragile, with a tendency to either burst or to disappear up into the
patch pipette on application of suction. The earliest mention in the
literature of patch-clamp data from intact, malaria-infected erythrocytes of which I am aware is in a review by Cabantchik (39) which refers to unpublished data (from Stutzin and
Cabantchik) suggesting the presence of a voltage-dependent,
phloridzin-sensitive ion channel in the infected cell membrane.
However, the data were not presented. In a study of Ca2+ transport in the malaria-infected
erythrocyte, Desai et al. (64) reported a series of
cell-attached patch-clamp measurements on intact parasitized
erythrocytes. In these experiments they observed (in 2 of 26 parasitized cells tested) a seemingly novel channel activity. In each
case, however, the cell lysed before the channel could be characterized
in any detail (see sect. IXK). Very recently,
Desai and colleagues (62a, 67) have reported obtaining
both whole cell and cell-attached recordings of intact, trophozoite-stage parasitized erythrocytes and obtained evidence for a novel, voltage-dependent anion channel (see sect.
VC3). Desai et al. (63) have also described single-channel
recordings from the PVM enclosing parasites freed from their host
erythrocytes using two different techniques (digitonin and an
electrical pulse applied to the host cell membrane). Similar recordings
were obtained in a study in which the membrane fraction of homogenized
intact parasitized erythrocytes were reconstituted into a planar lipid bilayer (65). The characteristics of this channel are
discussed in section VIB. G. Genetic Techniques
The techniques of modern molecular biology have, over the past
decade, yielded sequences of a number of putative plasmodial membrane
transport proteins. In all cases, this has involved cloning homologs of
transporters from other organisms. These include a number of P-type
ATPases (75, 172, 188,
189, 324, 325), two V-type
ATPase subunits (170, 171), several members
of the ABC transporter family (29, 96,
347), and homologs of the mitochondrial ATP/ADP exchanger
(76, 149, 150) and phosphate transporter (20). The malaria genome sequencing project is now nearing completion
(58, 104, 306). The recently
published sequence of chromosomes 2 and 3 of P. falciparum
include a total of seven putative transporter sequences
(28, 104) and, as the genome sequencing
project progresses, a wealth of other such sequences are becoming
available. This poses a major challenge to those in the field.
Functional expression of malaria-encoded membrane proteins is
difficult, particularly if they are large (as is likely to be the case
for many transporters and channels). The recent reports of increased
transport of several solutes into Xenopus oocytes injected
with P. falciparum mRNA (247) and the
successful expression of cloned P. falciparum hexose (190, 190a, 349a, 350) and nucleoside
(44, 241b) transporters indicate that the
Xenopus oocyte is likely to be an extremely useful tool for
the characterization of plasmodial transport proteins, as well as,
perhaps, for the identification of novel transport proteins by
expression cloning (247). However, the Xenopus
oocyte system does have limitations, not least of which is the presence in these cells of an array of endogenous transporters and channels, some of which are activated in response to the expression of
"foreign" proteins (e.g., Refs. 38, 292, 326). The ability of at least one plasmodial ABC protein to complement a
transport-deficient yeast strain (340) indicates that yeast might be a suitable system in which to clone (by complementation) and/or characterize plasmodial transporters and channels. This approach
has proven highly successful in the identification and characterization
of a range of transporters and channels from plants (98)
but has not, as yet, been widely used in other organisms. Other approaches still in their infancy in this field but which will,
in the longer term, yield vital information regarding the function and
physiological role(s) of the proteins of interest within the parasite
include the use of antisense oligonucleotides (14,
15, 59, 257), ribozymes
(93), gene knockout (53, 344),
and gene transfection (334, 344,
352).
. Those for H+ and
Ca2+ are in routine use in a wide range of cell types and
have provided a wealth of information on the regulation of these two
ions. The use of indicators for the other ions is less straightforward
and has been much more limited.
, and phosphorous content of the different compartments
of the malaria-infected erythrocyte. The transport of monovalent
inorganic cations in the parasitized erythrocyte is discussed in detail in section IXJ.
| |
IV. SOLUTE TRAFFICKING ROUTES IN THE PARASITIZED CELL |
|---|
|
|
|---|
A. Windows, Tubes, Vesicles, and Ducts
According to the traditional view of the malaria-infected erythrocyte, represented in Figure 4A, the movement of solutes between the intracellular parasite and the external milieu occurs via the erythrocyte cytoplasm. Solutes taken up into the intracellular parasite have first to gain entry to the erythrocyte, across the RBCM. From here they can move into the parasite either by being transported sequentially across the PVM and PPM or by endocytosis (see sect. VII).
|
In recent years there has been considerable interest in the possibility that there is, in addition to the "sequential route" (in which solutes cross each of the three membranes in sequence) outlined above, one or more additional "parallel routes" that allow solutes to move between the parasite and the external medium, without their actually entering the erythrocyte cytosol. There is evidence that the plasma membrane of the parasitized erythrocyte is incapable of endocytosis (143, 251), as is thought to be the case for the normal, mature erythrocyte. It remains controversial, however, whether there might be some means by which the parasite accesses the external medium other than via transport across the host erythrocyte membrane, into the red cell cytoplasm.
As long ago as 1973, Bodammer and Bahr (24) proposed, on the basis of scanning and transmission electron micrographs of P. berghei-infected mouse erythrocytes, that a localized region of apposition of the intracellular parasite to the red blood cell surface might serve as "a specialized entry and exit site for metabolites" and coined the phrase metabolic window (Fig. 4Ba). Lauer et al. (199) have recently proposed a variation of this model in which specialized regions of membrane formed at points of contact between the TVM and the RBCM serve as a route of entry for low-molecular-weight solutes into the TVM network, from where they are taken up by the parasite (Fig. 4Bb). However, much of the recent attention has focused on the proposal from Taraschi and colleagues (253) that the parasite has direct access to the extracellular solution via a so-called "parasitophorous duct," a tubular membranous structure that extends between the parasitophorous vacuole membrane and the erythrocyte membrane. The duct, as originally proposed, would allow the parasite plasma membrane to come into direct contact with the extracellular solution (Fig. 4C) and would provide a means for the intracellular parasite to take up macromolecules from the external medium, across the PPM, by a process of endocytosis. This proposal has been the subject of considerable controversy and in the heated debate surrounding the question of whether the duct exists, there has been a tendency for a number of related but separate issues to become intertwined. Here, two issues are considered separately. The first is the question of whether there is some form of parallel route that allows solutes to move between the intracellular parasite and the external solution, without actually entering the erythrocyte cytosol. The second is the question of whether the malaria-infected erythrocyte has the capacity to take up at least some macromolecules from the extracellular medium.
B. Does the Intracellular Parasite Have Direct Access to the Extracellular Medium?
A number of experimental observations have been interpreted in terms of the existence of a mechanism that allows solutes to pass between the intracellular parasite and the external medium, without entering the host cell cytosol.
In two intriguing studies, Cabantchik and colleagues (209) showed that two different Fe3+ chelators (desferrioxamine and a fluorescent derivative thereof) and the bioflavonoid glycoside phloridzin (208) were toxic to the parasite when added to the extracellular solution, but had little effect on the parasite when they were encapsulated (at much higher concentrations) within red blood cells that were subsequently infected by the parasite. In interpreting these results, the authors proposed that these reagents cannot enter the parasite from the red cell cytosol but are able to do so only from the external solution (via some form of parallel route). This interpretation is consistent with the data; however, alternative explanations cannot be ruled out.
One possibility is that one or more of the agents tested exert their cytotoxic effects at the external surface of the infected cell, perhaps by blocking the uptake of nutrients and/or the release of metabolic wastes (80). Phloridzin does block the induced transport of small solutes into parasitized cells (194, 293). However, the same is not known to be true of the Fe3+ chelators, and there is evidence that desferrioxamine exerts its antiplasmodial effect from within the parasite (283).
Another possibility is that in the experiments with cells preloaded with the different antiplasmodial agents then invaded by the parasite, leakage of the compounds from the cytosol of the infected erythocytes into the extracellular medium reduced their concentration (both inside and outside the cell) to below that required to exert an antiplasmodial effect. Parasitized erythrocytes do have a substantially increased permeability to a wide range of solutes (sect. V), and Loyevsky and Cabantchik (208) demonstrated that erythrocytes preloaded with the different reagents did lose the majority to the external medium, particularly once the parasites reached the mature trophozoite-schizont stage (which is when the different drugs of interest exert their major antiplasmodial effect). It was argued that the concentration remaining within the infected cell should have been more than enough to retard parasite growth. However, it was not demonstrated that the drug retained by trophozoite-infected cells was actually in the erythrocyte cytosol. At least some may have been taken up into the parasite's food vacuole in the endocytotic feeding process (138, 319), before the induction of NPP in the RBCM and before the parasites become sensitive to the drug. Once there it may have been trapped, unable to gain access to potential targets elsewhere in the parasite.
A separate line of evidence for the existence of parallel routes comes from confocal microscopy studies of parasitized erythrocytes incubated with various fluorescent solutes, including several fluorescently labeled macromolecules and the smaller, widely used endocytosis marker Lucifer yellow. Papers describing a number of such studies report that fluorescence was localized to the intracellular parasite, and associated tubular structures in the host cell compartment, while apparently remaining excluded from the bulk host cell cytosol (138, 199, 252, 253). In the case of the fluorescently labeled macromolecules, concerns have been raised about dissociation of the fluorescent label (see sect. IVC). However, this issue notwithstanding, the question still arises of why in such experiments the fluorescence appears in the parasite and associated tubular structures, but not in the erythrocyte cytosol. The data have been interpreted as indicating that the fluorescent solutes are taken up directly into the parasite from the external medium (138, 252, 253). There are, however, a number of technical considerations, some or all of which may be relevant.
The composition of the red cell cytosol is quite different from that of the interior of the parasite and the TVM system, and it is possible that there is significant interference by components of the erythrocyte cytosol (in particular the hemoglobin) with fluorescent signal arising from this compartment. It is also possible that the fluorescent compounds are somehow accumulated within the parasite and the compartment(s) enclosed by the TVM, to levels substantially higher than those reached in the erythrocyte cytosol. Both situations would tend to give the appearance of there being negligible fluorescent compound in the host cell compartment, while not actually being the case.
Another possibility is that the lack of fluorescence associated with the host cell cytosol is due simply to the compounds leaking out of this compartment before (and perhaps during) the confocal microscopy measurements. In the majority of experiments of this sort, parasitized erythrocytes were preincubated for prolonged periods (typically 30-120 min) in the presence of fluorescent solute, then the "loading solution" was removed by washing the cells repeatedly before confocal measurements were made. It is conceivable that during the wash procedure, and subsequently, the fluorescent compound was lost from the host cell compartment, perhaps via NPP induced by the parasite in the host cell membrane (see sect. VC).
In summary, although there are several independent lines of evidence in support of the existence of parallel routes in the malaria-infected erythrocyte, none is entirely conclusive, and the issue awaits further clarification.
C. Does the Parasitized Erythrocyte Take Up Macromolecules and Other High-Molecular-Weight Solutes?
The existence of tubular structures traversing the cytosol of malaria-infected erythrocytes was described by Grellier et al. (139). However, it was Taraschi and colleagues (138, 253, 313) who first proposed that these tubes mediate the trafficking of macromolecules with diameters of up to 50-70 nm between the external medium and the parasite, and who coined the term parasitophorous duct (see Fig. 4C). This hypothesis was first proposed on the basis of experiments in which it was shown using confocal microscopy that macromolecules (e.g., fluorescent dextrans, biotinylated protein A, IgG antibody) and fluorescent latex beads, added to the extracellular medium, gained access to the aqueous space surrounding the parasite. In cells incubated with the fluorescent beads, fluorescence was shown to be associated with tubular structures that were proposed to connect the parasitophorous vacuole and host erythrocyte membranes.
The experiments of Pouvelle et al. (253) have been questioned on a number of technical grounds. Fujioka and Aikawa (99, 100) demonstrated that parasitized erythrocytes that had been maltreated in various ways took up colloidal gold and fluorescent dextrans, whereas parasitized cells maintained under normal conditions did not. This prompted the suggestion that the uptake of macromolecules described by Pouvelle et al. (253) was due to the parasitized erythrocytes used in this earlier study having been exposed to adverse conditions (99, 100), a contention strongly rejected by Taraschi and Pouvelle (313, 314).
Several others have emphasized potential problems arising from the dissociation of low-molecular-weight fluorophores from the fluorescently labeled probes used in the original study (143, 153, 291). In particular, Hibbs et al. (153), using a combination of confocal and electron microscopy, demonstrated that although incubation of malaria-infected erythrocytes with the fluorescent beads used in the original study by Taraschi and colleagues resulted in fluorescent labeling of the parasite and, in some cases, of associated tubular structures, the beads themselves (which had diameters down to 14 nm, well below that of the putative duct) remained excluded from the parasitized erythrocyte. The labeling of the parasite in this study was attributed to the release of membrane-permeant fluorescent dye from the beads during the incubation period, and it was suggested that the same phenomenon was responsible for the original results reported by Pouvelle et al. (253).
Using thin-layer chromatography, Goodyer et al. (138) demonstrated that the fluorescent dextrans used in the initial work of Pouvelle et al. (253) did undergo significant degradation during a 4-h incubation period. However, <0.0001% of the fluorophore molecules were released. It was argued that this could not account for the observed uptake of fluorescence by parasitized erythrocytes; however, it was not actually demonstrated that the fluorescence taken up into the intracellular parasite was in the form of the macromolecular dextran conjugate, and the data presented do not exclude the possibility that the fluorescence associated with the parasite is in the form of low-molecular-weight fluorophore molecules taken up from the external medium and perhaps concentrated from the extremely low levels in the extracellular solution to relatively high levels within the intracellular parasite.
Goodyer et al. (138) have also presented electron microscopic evidence for the uptake of ruthenium red, an electron-dense marker into ductlike structures that appeared to interconnect the erythrocyte membrane and the PVM. These findings would appear to be directly at odds with those of Elford and colleagues (80, 89), who have presented evidence that in parasitized erythrocytes exposed to ruthenium red, the compound remains entirely excluded from the infected cell. This is difficult to reconcile with the existence of a duct, as is the earlier finding by a number of groups (including that of Taraschi and colleagues) that parasitized erythrocytes fail to take up fluorescent molecules that have dimensions well below the diameter of the proposed duct (143, 251).
In addition to the various papers claiming to demonstrate directly the uptake of high-molecular-weight solutes into the malaria-infected erythrocyte (138, 252, 253), there are a number of studies that have been cited as providing independent evidence for the uptake by parasitized erythrocytes of at least some such solutes. These include a number of demonstrations that antisense oligodeoxynucleotides and ribozymes (i.e., oligonucleotides incorporating a sequence able to mediate the cleavage of complementary mRNA), targeted against parasite-encoded enzymes, inhibit the growth of the malaria parasite. Following on from the original reports of antisense oligonucleotides inhibiting parasite proliferation (59, 257), it was suggested that this was a nonspecific effect arising from the polyanionic oligonucleotides interfering with the invasion of the erythrocyte by the parasite (49, 256). It was shown subsequently, however, that although these reagents show sequence-independent effects when used at concentrations >1 µM, at lower concentrations their effects are sequence specific (14, 15). The same has also been shown to be true of ribozymes (93). The conclusion to be drawn from this work is that the oligonucleotides are somehow gaining access to the interior of the parasite.
In the original paper describing the antiplasmodial activity of antisense oligonucleotides, it was reported that radiolabeled antisense oligonucleotides were taken up by infected, but not normal, erythrocytes (257). However, the data were not presented, and it is not clear whether other explanations (e.g., uptake of radiolabeled products of oligonucleotide degradation) might account for the results described.
In a number of the studies of the antiplasmodial effect of antisense oligonucleotides, parasite growth was measured using asynchronous cultures and/or measured over a period that encompassed one or more schizogony and reinvasion steps. The data from these papers do not exclude the possibilities that the reagent(s): 1) targeted the merozoites during the brief period in between their release from one cell and invasion of another, 2) inhibited parasite invasion, or 3) entered the parasitophorous vacuole in sufficient quantity during the endocytotic invasion process to cause the subsequent retardation of parasite growth. However, in at least one study, oligonucleotides (ribozymes) were shown to exert a significant sequence-specific antiplasmodial effect within a single intraerythrocytic cycle (measured over 24 h after their addition to early ring-stage parasites; Ref. 93). In this case at least, there is therefore reason to believe that the oligonucleotides entered the parasitized erythrocyte at some time subsequent to the initial invasion step.
Oligonucleotides are not the only high-molecular-weight solutes reported to inhibit the growth of the intracellular malaria parasite. Gelonin, a single peptide chain protein inhibitor of protein synthesis, has been shown to inhibit parasite proliferation when exposed to parasitized erythrocytes for a fixed period within a single erythrocytic cycle (235). Dermaseptins, linear polycationic peptides composed of 28-34 amino acids, have also been shown to gain access to the intracellular malaria parasite within seconds of their addition to P. falciparum-infected human erythrocytes and to inhibit the growth of the parasite (114). The dermaseptins are amphipathic and do interact with lipid bilayers. Although it was argued that they do not translocate across the plasma membrane of normal uninfected erythrocytes, the data do not exclude the possibility that these compounds enter parasitized cells via the lipid phase of the RBCM.
Very recently it has been reported that addition to the culture medium
of a 93-amino acid fragment of the enzyme
-aminolevulinate dehydratase inhibits parasite growth (25a). It was shown
using both immunofluorescence and a radiolabeled form of the
polypeptide that the molecule (termed ALAD-
NC) was taken up by
infected but not uninfected cells. The radiolabel experiments provided
evidence that the polypeptide was present within the parasite
(including the food vacuole) but not in the erythrocyte cytosol,
although the mechanism of uptake was not investigated.
There have also been reports that antibodies directed against antigens localized within the parasitized erythrocyte inhibit parasite growth (169). However, the mechanism by which they do so is unclear, and it has not been demonstrated that these antibodies are actually taken up into intact parasitized cells.
Table 1 provides a summary of the results of those studies that provide evidence in support of the view that the malaria-infected erythrocyte is able to take up macromolecules and other high-molecular-weight solutes from the external medium, as well as listing those which would argue against there being a nonspecific uptake of such solutes.
|
D. Summary
The two related questions of 1) whether there is a mechanism by which solutes can pass between the extracellular medium and the intracellular parasite without actually entering the erythrocyte cytosol, and 2) whether there is a mechanism by which the parasite is able to take up macromolecules and other high-molecular-weight solutes from the extracellular solution, have been, and remain, contentious. There is substantial evidence against the existence of a parasitophorous duct in the form originally proposed (253). Nevertheless, there is sufficient evidence in support of both hypotheses to warrant further investigation.
| |
V. THE RED BLOOD CELL MEMBRANE |
|---|
|
|
|---|
A. General Considerations
The mature human erythrocyte membrane is endowed with a plethora of membrane transport systems. In at least some cases these serve no known purpose in the mature erythrocyte but are thought to be the vestiges of those required for the much higher metabolic and biosynthetic requirements of the cells from which the erythrocyte is derived. Many of these endogenous transport pathways have been characterized at a functional level, with their kinetic and pharmacological properties described in detail. Some have been identified at a molecular level and are homologous to transport proteins in other tissues.
For some solutes there are a number of alternative transport pathways across the erythrocyte membrane, all of which may contribute to the measured influx or efflux. For example, the erythrocyte has at least four discrete and well-characterized K+ transport mechanisms (the Na+/K+ pump, the NaKCl2 cotransporter, the KCl cotransporter, and the Ca2+-activated K+ channel) as well as others that are less well understood (e.g., Ref. 19). Amino acids are transported across the erythrocyte membrane via a number of different systems with overlapping specificity, e.g., at least five different pathways contribute to the flux of glycine across the erythrocyte membrane under physiological conditions (86). Similarly, the monovalent anion lactate permeates the membrane via at least three distinct pathways: a monocarboxylate carrier, the band 3 anion exchanger, and simple diffusion of the protonated acid across the bilayer (68, 250). In many cases, these alternative pathways can be distinguished on the basis of their different pharmacological and kinetic properties.
For any perturbation that causes an increase in the rate of transport across the erythrocyte membrane, the question arises of whether the increase is due to a change in the activity of endogenous systems or to the induction of new pathways. In the case of malaria infection (in which the parasite invades only a fraction of the erythrocytes available to it either in the bloodstream or in culture), the further question arises of whether an apparent increase in the flux via an endogenous pathway is due to a genuine change in the activity of that pathway in parasitized cells, or to the parasite invading preferentially a subpopulation of cells that have transport activity different from that of the population as a whole. Reticulocytes and young erythrocytes have higher activity of many transport systems than do mature erythrocytes (e.g., Refs. 145, 182). Thus, if the parasites have a significant preference for younger over older cells, the infected cells might be expected to show higher activity of many transporters than do uninfected cells in a suspension with a normal cell age distribution. Some strains of malaria (e.g., P. vivax) do show a very strong "reticulocyte preference" (226). P. falciparum shows a weak (2- to 3-fold) preference for reticulocytes over mature erythrocytes (226), although its relative preference for erythrocytes of different ages is not known.
Distinguishing membrane transport changes associated with altered flux via constitutively active endogenous systems from those arising from the insertion or activation of new pathways is not straightforward. In most cases the use of transport inhibitors, kinetic analyses, and (in some cases) different stereoisomers of relevant solutes enables the flux into or out of an infected cell to be dissected into functionally discrete components. The characteristics of these different components can be compared with those of the endogenous systems. However, the imperfect specificity of most inhibitors, as well as the possibility that the basic properties of the endogenous systems (e.g., pharmacology, substrate affinity) are fundamentally altered in the parasitized cell means that such analyses are rarely definitive. There is also the possibility (as yet neither proven nor excluded) that the parasite inserts into the erythrocyte membrane transport proteins having characteristics similar to those of the host cell.
B. Increased Transport Via Pathways Having the Characteristics of Endogenous Host Cell Transporters
Concerns such as those outlined above notwithstanding, there have been a number of studies showing enhanced transport in malaria-infected erythrocytes via pathways showing characteristics very similar to those endogenous to the host cell membrane. In human erythrocytes infected in vitro with P. falciparum, the activity of the Na+-K+ pump is increased by up to twofold (175, 300, 301a), probably due primarily to the raised Na+ concentration in the infected cell cytosol (see sect. IXJ). Ginsburg and Krugliak (126) found that in human erythrocytes infected in vitro with P. falciparum there was a significant increase in the maximum velocity (Vmax) for the saturable component of tryptophan influx. The most striking examples of this phenomenon, however, come from experiments with erythrocytes taken from malaria-infected animals.
Parasitized erythrocytes from monkeys infected with P. knowlesi (4) and from mice infected with P. vinckei vinckei (302) both show increased uptake of choline via a pathway that has the same Michaelis constant (Km) and pharmacological characteristics as the endogenous choline transporter, but a Vmax some 10- to 20-fold higher than that in uninfected erythrocytes (see sect. IXF). By contrast, in human erythrocytes infected in vitro with P. falciparum, there is no evidence for an increase in flux via the endogenous choline transporter (82, 184).
Parasitized erythrocytes from P. knowlesi-infected monkeys also show an increased influx of the polyamine putrescine, via a saturable pathway with a Km similar to that of the putrescine transporter of normal erythrocytes but a Vmax some threefold higher than that seen in uninfected cells (295). It is possible that choline and putrescine share the same carrier (both are cations at physiological pH) and that the increase in the rate of transport of both substrates can be attributed to the increased activity of a single class of carrier. However, this has not been tested directly.
The mechanism underlying the increased rate of transport of substrates via pathways having the characteristics of endogenous host cell transporters remains to be clarified. After malaria infection, an erythrocyte undergoes many modifications of its physical/chemical properties, any of which might be expected to alter the activity of endogenous transport systems. The lipid composition of the erythrocyte membrane is altered (336), as are the cytoplasmic ion and, perhaps, protein concentrations. All of these are known to influence the activity of endogenous transporters and channels. Furthermore, the rate of influx and efflux of solutes via constitutive systems is affected by the cytoplasmic concentrations of the solutes themselves (via trans- as well as cis-effects). Alterations of these concentrations in the parasitized cell will therefore result in altered fluxes via the relevant transport systems.
C. New Permeation Pathways
In addition to causing an increased flux via pathways with the characteristics of endogenous host cell transporters, the intracellular malaria parasite induces in the host cell NPPs that have properties quite different from those of the endogenous transporters and which confer on the host cell an increased permeability to a wide range of solutes. The question of how many different types of NPP there are present in the parasitized erythrocyte has been addressed using a pharmacological approach. Various different classes of reagent have been shown to inhibit the NPP (see below). In experiments comparing the relative abilities of several of these reagents to inhibit the hemolysis of parasitized erythrocytes suspended in isosmotic solutions of different solutes (40, 41, 179), there was evidence that these reagents blocked the influx of some solutes with higher potency than that of others, prompting the suggestion that there are several different classes of parasite-induced pathway, each differing somewhat in its inhibitor sensitivity (40, 41). As discussed in section IIIC, however, the isosmotic hemolysis technique does have significant shortcomings and is not well-suited to comparisons of this type. More quantitative pharmacological studies, carried out by comparing the flux of radiolabeled solutes into cells suspended under identical conditions (which is not the case in the hemolysis experiments), have yielded data consistent with the view that the transport of a wide range of solutes occurs via common pathways. For each of a number of different inhibitors, the dose-response curves for the inhibition of the transport of several different structurally unrelated solutes are superimposable (177, 179, 327), consistent with (although not proof of) the hypothesis that much of the parasite-induced transport of small solutes into (and out of) the malaria-infected erythrocyte is mediated by NPP of a single type.
1. Properties of the NPP
The NPP responsible for the increased permeability of the infected erythrocyte membrane to low-molecular-weight solutes show the following general characteristics.
1) They are induced in the parasitized cell between 10 and 20 h postinvasion (301a).
2) They have a broad specificity and are permeable to a wide range of inorganic and organic monovalent ions (both cations and anions), zwitterions, and nonelectrolytes. It is unclear whether the NPP have a fixed size cut-off for permeating solutes. Although they have a low (it remains to be demonstrated whether negligible) permeability to sucrose (Mr = 342; Refs. 128, 179), there is evidence that they accommodate compounds as large as oxidized glutathione (GSSG; Mr = 613; Ref. 10) and the protease inhibitor pepstatin A, a peptidomimetic compound (Mr = 686; Ref. 274) (see sect. IXC).
3) Flux via the NPP is blocked by a variety of reagents, including a number of compounds known to inhibit anion transport mechanisms in a range of other cell types. These are listed in Table 2. The most potent blockers [compounds such as furosemide and 5-nitro-2-(3-phenylpropylamino)benzoic acid and its various derivatives] are monovalent anions, each having a carboxylate "head group" and a sizeable hydrophobic "tail" (177).
|
4) The NPP have been found to be nonsaturable (at least within the physiologically relevant concentration range) for all solutes for which kinetic measurements have been made. These include the organic cation choline (82, 184), the nucleosides adenosine and thymidine (179, 327), and the monovalent anion pantothenate (273).
5) The activation energy for the transport of solutes via the NPP has been estimated to be 10-11 kcal/mol (127, 195, 301a). This value is lower than that typical of carrier-mediated transport but is typical of that for a diffusive process (85).
6) The NPP do not discriminate between enantiomeric forms of permeating solutes [e.g., L- and D-alanine (82, 179); D- and L- glucose (128); D- and L-adenosine (327)]. They do, however, show differential sensitivity to the R- and S-enantiomers of several optically active arylaminobenzoates (177).
7) They are, in general, anion selective, showing a general
preference for anions and electroneutral solutes over cations. As is
represented in Figure 5, the inorganic
anion Cl
permeates the NPP at a rate several orders of
magnitude higher than the inorganic cations Na+,
K+, and Rb+, with a wide range of both charged
and uncharged solutes permeating at a rate between the two extremes
(179).
|
8) The rate of permeation is influenced by both the size and hydrophobicity of the solute, with the pathways showing an apparent preference for smaller and more hydrophobic solutes. Among the neutral amino acids, the presence of a (hydrophilic) hydroxyl group decreases the permeation rate (e.g., threonine < valine; serine < alanine; Ref. 179), whereas the presence of (more hydrophobic) methyl groups increases the permeation rate (e.g., alanine < valine; serine < threonine; Ref. 179). This is consistent with the NPP having a preference for hydrophobic amino acids over similarly sized hydrophilic amino acids. A comparison of the rates of permeation of a series of monovalent organic cations likewise reveals a preference for more hydrophobic over less hydrophobic solutes, and for smaller over larger solutes (e.g., the phenyltrimethylammonium ion permeates much more rapidly than either the similarly sized but less hydrophobic tetramethylammonium ion, or the similarly hydrophobic but substantially larger, tetrapropylammonium ion; Ref. 303).
9) Despite their very broad specificity, the NPP show some ability to discriminate between alkali metal cations, with the permeability increasing in the order Na+ < K+ < Rb+ < Cs+ (178, 300, 301a). This series corresponds to Eisenman series I for monovalent inorganic cations and is characteristic of a pathway with a low electrical field strength (155).
10) The rate of cation permeation shows a marked dependence
on the nature of the anion present in the suspending medium, increasing in the order Cl
< Br
< I
< NO3
,
SCN
(178, 300, 301a,
302, 303). This sequence corresponds to Eisenman
series I for monovalent inorganic anions (351). In
contrast to cations, the rates of permeation of the uncharged polyol,
sorbitol, and the monovalent lactate anion decrease slightly on
replacement of Cl
with NO
2. Could the NPP be somewhere other than the RBCM?
The pathways that mediate the increased flux of small solutes into parasitized erythrocytes and which thereby cause the infected cells to hemolyse when suspended in isosmotic solutions of these solutes have traditionally been assumed to be in the host erythrocyte membrane. The hypothesis that there are, in the parasitized erythrocyte, parallel routes by which solutes can pass between the intracellular parasite and the extracellular medium (see Fig. 4) does, however, raise the theoretical possibility that the NPP may actually be located at the surface of the parasite, with access occurring via the putative duct (Fig. 4C). In this situation the hemolysis of parasitized erythrocytes suspended in isosmotic solutions of permeant solutes (see sect. IIIC) might be a secondary consequence of the osmotic swelling of the intracellular parasite (and/or the parasitophorous vacuole). However, experiments with permeabilized erythrocytes in which the uptake of solutes (nucleosides) into the intracellular parasite was measured directly have failed to detect a pathway with the pharmacological characteristics of the NPP in the parasite membrane (146). Furthermore, recent patch-clamp studies of the infected erythrocyte membrane (sect. VC3) have provided independent evidence that the NPP are on the surface of the parasitized erythrocyte (62a). It therefore seems likely that the NPP are, as has been assumed, in the RBCM, although whether they are distributed over the surface of the parasitized cell or limited to specialized regions formed at points of contact between the RBCM and the TVM, as has been postulated (199; Fig. 4Bb), remains to be clarified.
3. The nature and origin of the NPP
Induction of the NPP in the malaria-infected erythrocyte is prevented by inhibition of protein synthesis (34), consistent with the involvement of parasite-derived proteins in the formation of the NPP. The observation that the NPP are blocked with different affinities by enantiomeric inhibitors (177) is consistent with the permeation pathway having protein components, although alternative explanations cannot be excluded.
The very broad specificity of the pathways, their failure to saturate, their inability to distinguish between enantiomeric substrates, and their relatively low activation energy all point to the passage of solutes via the NPP being by a diffusive process, rather than carrier mediated. These characteristics are those expected of a pore or channel.
Figure 6A shows a proposed schematic representation of the NPP. The anion selectivity is derived from a positive charge or dipole located somewhere within the pathway, and the pore contains a hydrophobic region that confers upon the pathway the selectivity for hydrophobic over similarly sized hydrophilic solutes. Figure 6, B and C, illustrates two alternative mechanisms by which cations might permeate a pathway of this type, either of which would account for the observed anion dependence of cation permeation (178). In one (Fig. 6B), the anion interacts with a positively charged site on the pathway, thereby shielding permeant cations from exposure to the positive charge as they move through the pathway. In the other (Fig. 6C), cations permeate the pathway in the form of cation-anion pairs. Figure 6D shows how the lipophilic anions that inhibit the flux of solutes via the NPP (Table 2) might interact with the pathway, with the anionic headgroup binding to the cationic site and the hydrophobic tail interacting with the hydrophobic region of the pathway.
|
Many of the characteristics of the NPP are similar to those of
anion-selective channels in the plasma membrane of other cell types
(179, 181), and in a recent study, Desai et al.
(62a) have provided the first direct
(electrophysiological) evidence for the presence of a novel anion
channel on the RBCM of parasitized erythrocytes. In this study, whole
cell recordings of trophozoite-infected cells revealed a novel,
voltage-dependent current showing an ion selectivity that was:
1) similar to that shown by the NPP [Cl
(1) > lactate (0.43) > glutamate (0.11) >> Na+; Ref. 62a,
cf. Fig. 5], and 2) the same as that for the observed anion
dependence of cation transport through the NPP (Cl
< Br
< I
< SCN
; cf. sect.
VC1). The current was blocked by a range of NPP
inhibitors, with comparable potencies to those reported previously
(Table 2). Single-channel recordings revealed the presence in the
infected cell membrane of a novel, small-conductance,
furosemide-sensitive channel that displayed complex gating properties
and which was present at an estimated 1,000 copies per cell
(62a).
As has been noted previously (179), there is a significant resemblance between the properties of the NPP and those of the swelling-activated osmolyte channels that are present in a wide range of cell types and which play a central role in the volume-regulatory response of cells to osmotic swelling (reviewed in Refs. 174, 236, 304). The properties of swelling-activated osmolyte channels vary somewhat between cell types. One of the better characterized channels of this type is that of fish erythrocytes (91, 103, 134-136, 151, 176, 203, 229), and as summarized in Table 3, this pathway does have many features in common with the NPP. A similar pathway has been described in K562 (human erythroleukemic) cells (160). However, the mature human erythrocyte does not have a swelling-activated osmolyte channel (91). Whether, during the maturation process, the human erythrocyte loses the channel itself or simply the ability to activate the channel in response to cell swelling is unclear. If it is the latter, then it would seem possible that the NPP induced by the malaria parasite in the host cell membrane is simply the endogenous erythrocyte osmolyte channel, activated by the intracellular parasite, via an unknown mechanism.
|
The molecular identity of the swelling-activated osmolyte channel of fish erythrocytes is, as yet, unknown, although a variety of proteins have been proposed to be involved. These include the erythrocyte band 3 anion transport protein (90, 134, 228, 232). Whether or not band 3 does mediate the swelling-activated transport of osmolytes, it is a plausible candidate for the NPP. A fraction of the erythrocyte band 3 proteins undergo cleavage in the parasitized cell (54, 55, 290), and it may be these modified proteins that comprise the NPP. Other normal erythrocyte membrane proteins may also be modified in such a way as to generate the NPP.
Another endogenous channel that might be involved in the formation of the NPP is the so-called cystic fibrosis transmembrane regulator (CFTR), a cAMP-regulated anion channel which, when defective, gives rise to the severe inherited disorder cystic fibrosis. This channel is blocked by compounds known to inhibit the NPP (e.g., glibenclamide; Ref. 286), is permeable to a range of organic solutes (42, 205-207, 254, 262, 282), and is expressed in human erythrocytes (299). Whether it might play a role in the NPP remains to be investigated.
An alternative explanation for the appearance of NPP in malaria-infected erythrocytes is that the pathways are formed by proteins inserted into the erythrocyte membrane by the parasite. The parasite is thought to insert a number of different proteins into the host cell membrane. Members of the Pfemp1 family (encoded by the highly polymorphic multigene family var) are high-molecular-weight proteins expressed at the surface of the parasitized erythrocyte where they mediate adhesion of the parasitized erythrocytes to endothelial cells as well as to uninfected erythrocytes (16, 298, 307). The substantially smaller (27-45 kDa) "rifins," which may be related to the similarly small "rosettins" described previously (152), are again encoded by a highly polymorphic multigene family, rif, and there is evidence that these too are inserted into the RBCM (196). The rif genes are similar in size and structure to the stevor genes, which form another, lower copy number, gene family (45, 196). The proteins encoded by the rif and stevor genes are predicted to have at least one (and perhaps as many as three) transmembrane domains. In both the rifin and stevor proteins, there is a concentration of positively charged residues in a region proposed to be located on the cytsosolic side of the membrane (45). It is possible that these proteins may be involved in formation of the NPP, with the positively charged domain playing a role in their selectivity properties (see Fig. 6).
Ginsburg and Stein (130) have proposed that the NPP are formed at the interface between parasite-derived membrane proteins and the erythrocyte membrane lipid bilayer, and this model does provide a plausible explanation for much of the data. However, there is little direct evidence in support of either this or any other model, and it is not, at this stage, possible to state with certainty that the NPP are actually comprised of protein(s), let alone whether the putative proteins involved are derived from the parasite or host.
4. Physiological roles of the NPP
Inhibitors of the NPP have been shown to inhibit the in vitro growth of the malaria parasite (177, 181, 194, 274), consistent with (although not proof of) the NPP playing an important role in the malaria-infected erythrocyte. The inhibitors used are known to affect a range of physiological and biochemical pathways, and it remains to be established whether their antiplasmodial effect is a consequence of their effect on the NPP or of action(s) elsewhere in the parasitized cell. Nevertheless, there is evidence for the NPP serving a number of functions.
A) NUTRIENT UPTAKE. Perhaps the most obvious role for the NPP is in the delivery of nutrients to the intracellular parasite. It has been argued that the normal erythrocyte membrane has a limited transport capacity for metabolic and biosynthetic substrates required by the intracellular parasite, and that the induction of the NPP ensures that the intracellular parasite is adequately supplied with these compounds (81, 128). However, details as to precisely which nutrients rely on the NPP to gain access to the parasite are scarce. In vitro growth experiments indicate that the intracellular parasite requires relatively few nutrients from the extracellular medium (69). Those that are required include the following: glucose; a source of purines; the amino acids isoleucine, methionine, glutamine, glutamate, cystine, proline, and tyrosine; and the water-soluble vitamin pantothenic acid (69). There is also evidence for the parasite having an extracellular requirement for choline (6).
With the exception of glutamate (81, 183, 199) and pantothenic acid (273), the compounds required by the intracellular parasite from the extracellular medium are transported across the normal erythrocyte membrane, by one or more endogenous transporters, and the question of the relative contributions of endogenous and parasite-induced pathways to the supply of the relevant compounds to the intracellular parasite has not been explicitly addressed. For at least some of these compounds the transport rate of the endogenous erythrocyte transport systems is probably more than adequate to meet the parasites requirements, assuming that the parasite does have unrestricted access to nutrients entering the host cell cytosol via these routes. However, in the cases of glutamate and pantothenate, there is little if any flux via the endogenous transporters of the host cell membrane, and both rely on the NPP to gain entry into the parasitized erythrocyte (183, 273). The transport of these two solutes is discussed in more detail in section IX, B and E, respectively.
B) WASTE DISPOSAL. In addition to its role as a nutrient supply route, the NPP probably play an important role in the excretion of metabolic wastes from the malaria-infected cell. Compounds known to be lost from the parasitized erythrocyte via the NPP include lactate (produced in large quantities as a product of the parasite's, and to a much lesser extent the host cell's, anaerobic metabolism, Refs. 56, 168) and oxidized glutathione (10). These are discussed in more detail in section IX, G and C, respectively.
C) VOLUME REGULATION. During its occupancy of the erythrocyte, the malaria parasite internalizes and digests host cell hemoglobin, initially to small peptides (165, 186) and subsequently to their component amino acids (363). This constitutes a significant osmotic challenge to the parasitized cell. A proportion of the amino acids generated is utilized by the parasite for protein synthesis. However, many are not, and unless these are removed from the infected cell, they will give rise to a substantial increase in the osmotic contents of the parasitized erythrocyte, with the result that water will move into the cell, causing swelling and, ultimately, hemolysis. The NPP, by providing a (nonsaturable) route for the efflux of the large quantities of amino acids generated by the proteolytic activity of the parasite, may therefore play an important role in host cell volume control.
Another property of the NPP that is relevant to the issue of host cell
volume homeostasis is their selectivity for K+ over
Na+ (178, 301a), together with their very high
Cl
permeability (56, 179,
181). The induction in the erythrocyte plasma membrane of
pathways with these characteristics will result in a net efflux of
inorganic ions from the cell, with the efflux of KCl exceeding the
influx of NaCl, down their respective electrochemical gradients. The
net loss of inorganic solutes will be accompanied by a loss of water
and hence a decrease in volume of the host cell compartment during the
initial period of parasite growth (301a).
There have been a number of estimates made of the volume of P. falciparum-infected human erythrocytes. One study reported the volume of late-trophozoite-infected cells to be significantly less than that of uninfected cells (362), whereas another reported it to be significantly greater (113). More recently, several studies have found the volume of late-trophozoite-infected cells to be not significantly different from that of normal cells (180, 273), consistent with the operation of mechanisms preventing the growth of the intracellular parasite from causing swelling of the host cell.
D) ION BALANCE. As the intracellular parasite proceeds from ring to trophozoite stage, the inorganic ion composition of the host cell cytosol changes dramatically, with the Na+ concentration increasing and the K+ concentration decreasing to levels approaching those in the plasma (124, 200). The NPP play a central role in this process by providing a substantial K+, and to a lesser extent Na+, leak pathway (178, 300, 301a). The physiological significance of the altered Na+ and K+ concentrations is not well understood, but may relate to a requirement for a substantial inward Na+ gradient across the parasite plasma membrane to facilitate the secondary-active transport of solutes and/or an effect of K+ on the parasite membrane potential (see sect. IXJ).
| |
VI. THE PARASITOPHOROUS VACUOLE MEMBRANE |
|---|
|
|
|---|
A. Origin and Composition of the PVM
The PVM enclosing the intracellular malaria parasite is formed at the time of invasion and expands to accommodate the growth of the parasite as it proceeds from the ring stage to the much larger trophozoite and schizont stages. There is evidence for the insertion of parasite-derived lipids into the erythrocyte membrane during invasion (71), as well as for the incorporation of lipid from the erythrocyte membrane into the newly formed PVM (251, 342). It therefore seems likely that the PVM, at least initially, contains a combination of lipids from the two sources (204). A number of erythrocyte membrane proteins have been shown to be excluded from the PVM (11, 70, 342), although there is recent evidence that glycophosphatidylinositol-anchored proteins and at least one membrance spanning protein (Duffy) from the host cell membrane are incorporated into the PVM (199a).
The growth of the intracellular parasite is accompanied by the expansion of the PVM which, at the late trophozoite stage, appears to form protrusions extending into the erythrocyte cytosol, forming the TVM network. The lipid composition of the PVM and TVM is unknown. The host erythrocyte lacks the ability to synthesize lipids, and although there is some evidence for the parasite taking up lipids from the inner leaflet of the host erythrocyte membrane bilayer (204), it is likely that the bulk of the lipid incorporated into the expanding PVM and TVM is synthesized by the parasite. The finding that the TVM is permeabilized by saponin (9; see sect. IIIA2A) is consistent with it having a significant cholesterol content, and Lauer et al. (199a) have presented direct evidence that this is the case. There is evidence that the parasite has two discrete sphingomyelin synthase activities and that at least one of these is essential for the expansion of the PVM/TVM (88, 199), although it remains unclear whether sphingomyelin is a major component of the PVM/TVM.
B. Permeability Properties of the PVM
The little information that we have about the permeability properties of the PVM of malaria-infected erythrocytes comes from the electrophysiological studies of Desai and colleagues (63, 65). Using the "cell-attached" patch-clamp technique, applied to parasites freed from their host erythrocyte using either digitonin (see sect. IIIA2A), or a brief electrical pulse administered to the host cell membrane via the patch pipette, Desai et al. (63) obtained single-channel recordings of a high-conductance (140-pS) channel. Electron micrographs of the "freed" parasites indicated that they remained enclosed within the PVM, and the observed channel activity was therefore attributed to this membrane. The channel is permeable to a range of unrelated anions and cations (lysine, Tris, Ca2+, Mg2+, and glucuronate), with little selectivity between them. It is present at high density and is open >98% of the time at the resting potential of the PVM, thus rendering this membrane highly permeable to small solutes.
More recently, Desai and Rosenberg (65) have reconstituted vesicles prepared from digitonin-freed parasites into planar lipid bilayers and obtained single-channel recordings of a channel having electrophysiological characteristics similar to those obtained in the original patch-clamp study. The channel observed in the bilayer experiments showed negligible cation/anion selectivity and had an open probability of 96% at near-zero membrane potentials. The size-exclusion limit of the reconstituted channel was estimated (on the basis of the ability of the channel to admit or exclude spherical polyethylene glycol molecules of varying size) as 1,400 Da, equivalent to a pore diameter of ~23 Å. This is similar to the estimated size-exclusion limit of a channel in the PVM of another intracellular protozoan parasite, Toxoplasma gondii (280).
Although the properties of the channel observed in the lipid bilayer system do show marked similarities to those of the channel observed in the whole cell patch-clamp study of PVM-enclosed parasites, it should be noted than the vesicles used in the bilayer study were derived from lysate of whole digitonin-permeabilized parasitized erythrocytes. The possibility that the reconstituted channel originated from somewhere other than the PVM can therefore not be excluded. The properties of the channel described do show some similarities to those of the voltage-dependent anion channel (VDAC), a high-conductance porinlike channel that is present in the outer membrane of mitochondria (50, 156) and chloroplasts (249). Whether the mitochondrion, as well as perhaps the recently described plastid organelle of the malaria parasite (185, 219, 220, 341), has such a channel has not been tested. However, the possibility remains that the channel described in the bilayer study is organellar in origin, rather than being from the PVM.
This caveat notwithstanding, the available evidence is consistent with the PVM of the malaria-infected erythrocyte (and that of at least some other intracellular protozoan parasites) serving as a molecular sieve, allowing the free exchange of nutrients and metabolic wastes while preventing the proteins of the red cell cytosol from contacting the parasite surface, as well as, perhaps, confining parasite-derived proteins to the parasitophorous vacuole (17, 125, 204).
As has been discussed elsewhere (63,
119, 125), the hypothesis that the PVM is
riddled with high-capacity, nonselective channels that render it
sievelike is difficult to reconcile with aspects of the parallel route
models discussed in section IV. A duct of the form
illustrated in Figure 4C would bring the extracellular solution into direct contact with the PVM and the channels postulated to be present in this membrane would thereby render the host
erythrocyte compartment freely permeable to all low-molecular-weight
solutes, making it impossible to maintain gradients of such solutes
between the erythrocyte compartment and the extracellular solution.
This is demonstrably not the case. Although there is a decline in the normal Na+/K+ gradients across the erythrocyte
membrane as the parasite matures (124, 200,
301a), this is a gradual process, and it is not until the
parasite approaches a late stage, if at all, that these gradients are
eliminated. In the case of Ca2+, the gradient is even more
pronounced, with the erythrocyte compartment maintaining a
Ca2+ concentration of
1-2 µM (1,
187) in the face of an extracellular Ca2+
concentration of 1-2 mM (see sect. IXK).
There are also difficulties in reconciling the presence of the PVM channels with the proposal by Lauer et al. (199) that low-molecular-weight solutes enter the TVM via the NPP (located at specialized regions of membrane where the TVM and RBCM come into contact) and are delivered, via the TVM, to the parasite surface (Fig. 4Bb). If, as is thought to be the case, the TVM is continuous with the PVM, then the PVM channels should allow solutes entering the TVM to equilibrate throughout the host erythrocyte compartment.
| |
VII. THE PARASITE PLASMA MEMBRANE |
|---|
|
|
|---|
In 1962 Moulder (230) suggested "that in the course of evolutionary adaptation to life inside the red blood cell, the malarial parasite may have lost many of the active transport systems regulating the passage of molecules ... across its cell membrane and has become freely permeable to all sorts of molecules which it derives directly from its host." In an insightful review, published in 1988, Sherman (288) argued that there was, at that time, insufficient evidence to either refute or confirm Moulder's suggestion. In recent years there has emerged evidence that the parasite does actively maintain its cytoplasmic composition, independently of that of the host erythrocyte. The combined PVM/PPM at the parasite surface supports transmembrane gradients of Na+ and K+ (124, 200), H+ (27, 275, 356), and Mg2+ (10) and are therefore not "freely permeable," to these solutes at least. Biochemical and molecular evidence is gradually accumulating for the presence at the parasite surface of a range of transporters and channels, which serve to regulate the flux of solutes into and out of the intracellular parasite. These pathways are not well understood, nor is it clear what are the respective roles played by membrane transport and by the endocytotic feeding process in controlling the uptake of solutes by the parasite from the host cell compartment. As emphasized by Trager (319), the endocytotic route provides a means for solutes in the red blood cell to gain entry into the parasite, without necessarily having to traverse the PPM/PVM complex. However, its possible contribution to the uptake of anything other than hemoglobin from the host cell cytosol remains largely unexplored and undefined. The proposal by Taraschi and colleagues (138, 253, 312) that the intracellular parasite is also capable of taking up solutes from the parasitophorous vacuole via endocytosis adds further to the uncertainty in this regard.
Figure 7 provides a schematic illustration of the different routes by which the intracellular parasite may take up solutes from the erythrocyte cytosol. The specific characteristics of the various transporters either demonstrated or postulated to be present on the PPM are discussed in more detail in section IX.
|
| |
VIII. INTRACELLULAR ORGANELLAR MEMBRANES |
|---|
|
|
|---|
The malaria parasite has a number of prominent intracellular organelles, the membrane transport properties of which are largely unknown.
The food vacuole, to which the hemoglobin-filled vesicles derived from the endocytotic feeding process are directed, is thought to have at its surface a multisubunit V-type H+-ATPase that pumps H+ into the vacuole, thereby maintaining an estimated intravacuolar pH of 5.0-5.2 (192, 214, 357, 358). Homologs of the A and B subunits of V-type H+-ATPases of other organisms have been cloned from P. falciparum (170, 171), although immunofluorescence experiments indicate that their distribution is not restricted to the food vacuole (see sect. IXJ). One protein that is localized primarily, although not exclusively, to the vacuolar membrane is P-glycoprotein homolog 1 (Pgh-1), the product of the pfmdr1 gene and a homolog of the mammalian "drug pump," P-glycoprotein (52). The function of this protein remains unclear, although it has been variously proposed to act as a peptide transporter (sect. IXC), a drug pump (sect. IXM), and/or a chloride channel/channel regulator (sect. IXM). Expression of the pfmdr1 gene in yeast was reported to confer resistance to antimalarial drugs (271), although this was later retracted. It has also been reported to restore the normal wild-type phenotype to a yeast mutant that lacks a peptide pheromone-exporting protein (340). The implications of this observation for the normal function of Pgh-1 in the vacuolar membrane are, as yet, unclear.
Each intraerythrocytic malaria parasite contains a single acristate mitochondrion (329). The P. falciparum mitochondrion is thought to lack a functional tricarboxylic acid cycle and ATP synthase and is thought not to contribute to the production of ATP. However, there is increasing evidence that this organelle does play a significant role in the physiology of the parasite and that it may serve as a suitable drug target (329). Genes for two putative mitochondrial transport proteins, an ATP/ADP exchanger (76, 149, 150) and a phosphate transporter (20), have been cloned and sequenced, and the latter has been shown to be imported into rat liver mitochondria in heterologous in vitro experiments (21).
In many eukaryote cell types, the mitochondria serve as important intracellular Ca2+ stores. Whether the plasmodial mitochondrion serves a similar role is unclear. However, there is evidence for at least two other (i.e., nonmitochondrial) intracellular Ca2+ stores, one of which has been attributed to the parasite's endoplasmic reticulum and the other to an "acidic compartment" (Ref. 101, see sect. IXK).
The recently described "apicoplast," a plastidlike organelle, is, like the mitochondrion, thought to serve an important function in the malaria parasite, although it remains to be established what this might be (185, 219, 220, 265).
| |
IX. TRANSPORT OF SPECIFIC SOLUTES IN THE PARASITIZED ERYTHROCYTE |
|---|
|
|
|---|
This section of the review focuses in more detail on those solutes or classes of solutes for which the transport in the malaria-infected erythrocyte (across some or all of the membranes discussed in the preceding sections) has been studied in some detail.
A. Sugars
The malaria parasite, like its host erythrocyte, uses glucose as its primary fuel, metabolizing it via glycolysis to lactic acid. Compared with the relatively meager requirements of an uninfected erythrocyte, the glucose consumption (and lactate production) of a malaria-infected cell is enormous: parasitized cells utilize glucose at 40-100 times the rate of normal human erythrocytes (248, 267, 333).
Glucose transport across the human erythrocyte membrane is mediated by an equilibrative (and well-characterized) transporter (GLUT-1). The high density of this protein in the human erythrocyte membrane results in a very rapid rate of transport for glucose which, under physiological conditions, equilibrates between the intra- and extracellular compartments within a few seconds. The glucose transport capacity of the normal human red cell membrane exceeds, by orders of magnitude, the rate of glucose consumption by uninfected cells and is also more than sufficient to ensure that the metabolism of glucose in the malaria-infected erythrocyte is not rate limited by the entry of glucose into the erythrocyte cytosol. However, the same may not be true in erythrocytes from other species (e.g., mice, birds) in which the rate of glucose transport across the erythrocyte membrane is very much slower than in humans.
Both D-glucose and its nonphysiological stereoisomer, L-glucose, permeate the NPP (128, 180). In human erythrocytes infected with P. falciparum, the rate at which they do so is negligible compared with the rate at which D-glucose (but not L-glucose) is transported via the endogenous glucose transporter, and there is no evidence that the flux of D-glucose via the NPP is of any physiological significance. However, in parasitized erythrocytes from species with much lower constitutive glucose transport rates, the flux of glucose via the NPP may play a significant role in the supply of the sugar to the parasite.
The mechanism of entry of glucose into the intracellular parasite has been somewhat controversial. In early studies of the transport of the nonmetabolizable D-glucose analog 3-O-methylglucose (3-O-MG), P. lophurae-infected duck erythrocytes were shown to take up the sugar, with the intracellular concentration equilibrating at a level slightly below the extracellular concentration (289). This is consistent with the sugar being transported into the intracellular parasite via a nonconcentrative process. In contrast, Izumo et al. (161) showed that another glucose analog, 2-deoxy-D-glucose (2-DOG), was concentrated to high levels within the intracellular parasite compartment of P. yoelii-infected mouse erythrocytes. This prompted the hypothesis that glucose was driven into the parasite, across the PPM, via a H+-glucose cotransport mechanism (161, 308). However, this conclusion was called into question by the demonstration that although P. falciparum-infected human erythrocytes accumulated radiolabeled 2-DOG in a similar manner to P. yoelii-infected mouse erythrocytes, they did so as a result of the phosphorylation (and hence intracellular trapping) of 2-DOG; the concentration of (nonphosphorylated) 2-DOG within the cell remained at a level similar to that in the external medium (180). The same was also shown to be true of both 3-O-MG (180) and, in a separate study, 6-deoxy-D-glucose (137), neither of which are phosphorylated. The available evidence is therefore consistent with the view that the transport of glucose across the parasite plasma membrane is an equilibrative (passive) rather than a concentrative (active) process.
The recently published sequence of chromosome 2 of P. falciparum includes a putative monosaccharide transporter (104). The sequence shows a high degree of homology with those of glucose transporters in other organisms, and in a recent and seminal study, Krishna and colleagues (190, 350) have expressed the protein in Xenopus oocytes, yielding evidence that it is a saturable, Na+-independent, stereospecific hexose sugar transporter (PfHT1). The protein was shown to be expressed during the intraerythrocytic phase of the parasite life cycle and was immunolocalized to the region of the parasite plasma membrane (350).
In a subsequent study, the same group demonstrated that PfHT1 also transports fructose (349a) which can replace glucose as an energy source for the parasite (190a, 349a).
B. Amino Acids
The intracellular malaria parasite is thought to have limited ability to synthesize amino acids, and most of the amino acids used by the parasite for protein synthesis are therefore derived from alternative sources. The digestion of hemoglobin within the food vacuole of the parasite yields large quantities of amino acids. Although much of these are released from the infected cell, into the external medium (363), the parasite is able to draw on this pool of amino acids for protein synthesis. However, the parasite is not able to derive all of its amino acid requirements from within its host erythrocyte. Adult human hemoglobin does not contain any isoleucine and has only low levels of a number of the other amino acids required by the parasite (287). Careful studies of the nutritional requirements of P. falciparum growing in vitro have shown that the short-term survival of the parasite is dependent on a supply of exogenous isoleucine and methionine and that maintenance of normal growth over a longer period also requires extracellular supplies of glutamine, glutamate, cysteine, proline, and tyrosine (69, 97). However, even those amino acids for which the parasite does not have an extracellular requirement are taken up by the parasite and incorporated into proteins (69). The parasite therefore has the means (if not an absolute requirement) to take up a wide range of amino acids from the external medium.
The plasma membrane of the mature human erythrocyte is endowed with a variety of different amino acid transport systems, each varying in their substrate specificity. The majority of amino acids are transported across the normal erythrocyte membrane via one or more of these transporters, although glutamate, one of the amino acids required to support the growth of the intracellular parasite, is not. In the malaria-infected erythrocyte, the majority of amino acids also enter the cell via the NPP induced by the parasite, the exception being the cationic amino acids lysine and arginine (128). In the case of glutamate, the NPP provides the major route of entry of this essential nutrient into the parasitized erythrocyte (81, 183, 199). For most of the amino acids, however, the relative contributions of endogenous and parasite-induced pathways to the uptake of these compounds into the malaria-infected erythrocyte is unclear.
There are few details known of the mechanism(s) by which amino acids are taken up across the parasite plasma membrane. It is likely that the parasite has, at its surface, one or more types of amino acid transporter, although this remains to be established.
C. Peptides
A number of recent studies have focused on aspects of peptide transport within the malaria-infected erythrocyte. It is clear from the work of Elford and others (10, 79, 80, 142) that di- and tripeptides permeate the NPP of parasitized erythrocytes, and a recent study provided evidence that the antiplasmodial peptidomimetic protease inhibitor pepstatin A (which has a structure similar to that of a pentapeptide) enters the parasitized cell via the NPP (274).
Reduced glutathione (GSH), a tripeptide which serves to protect cells against oxidative stress, is produced by the intracellular parasite and is maintained at high levels within the parasite cytosol (10, 12). The oxidized form of the compound (GSSG), two tripeptides linked by a disulfide bond, is exported to the host cell, thereby maintaining a high GSH/GSSG ratio within the parasite. It has been proposed that the export of GSSG across the PPM occurs against a GSSG concentration gradient and that this may be mediated by an ATP-driven pump at the parasite surface (10). In the host cell compartment, the ability to synthesize GSH de novo is impaired, and the host cell reduces some of the GSSG extruded by the parasite to GSH for its own purposes (10). However, there is also a substantial loss of GSSG (and GSH) from the parasitized cell, via the NPP, into the external medium. GSH was shown not to be taken up across the PPM (10); there is therefore a one-way traffic of glutathione from the parasite to the host (Fig. 8).
|
In another study relevant to the issue of peptide transport, Kolakovich et al. (186) presented evidence that contrary to what had previously been assumed, the products of the digestion of hemoglobin within the parasite's food vacuole are not individual amino acids, but small peptides. These are exported from the food vacuole into the parasite cytosol (Fig. 8). The export mechanism was not characterized, although it was speculated that the product of the pfmdr1 gene, Pgh-1, may be involved in the process. Pgh-1 is a member of the ABC family, at least some members of which do function as ATP-driven peptide transporters (e.g., Ref 233), and the finding that expression of Pgh-1 in a yeast mutant lacking a peptide pheromone-exporting protein restores normal yeast wild-type phenotype (340) is consistent with Pgh-1 having the capacity to transport peptides. Whether it is involved in the export of peptides from the parasite food vacuole remains to be established.
D. Nucleosides
The intracellular malaria parasite has the ability to synthesize
pyrimidines de novo (106), but lacks the enzymes involved in purine synthesis (110). It therefore requires an
extracellular source of compounds of this class, as well as a mechanism
for their uptake. Both purine and pyrimidine nucleosides are
transported rapidly across the normal erythrocyte membrane via a
broad-specificity nucleoside transporter that is nonconcentrative,
Na+-independent, stereoselective [e.g., it transports the
physiological purine and pyrimidine nucleosides,
D-adenosine and D-thymidine, but not the
nonphysiological enantiomers, L-adenosine and
L-thymidine; (105, 108,
112, 327)] and inhibited with high affinity
by 6-[(nitrobenzyl)thio]9-
-D-ribofuranosylpurine (NBMPR).
In erythrocytes infected with trophozoite-stage parasites and exposed to D-adenosine at a concentration of 1 µM, the rate of uptake of adenosine is similar to that in uninfected cells. However, whereas in uninfected cells NBMPR reduces adenosine influx to a negligible level, there is, in parasitized erythrocytes, a substantial NBMPR-insensitive influx component, comprising 30-50% of the measured uptake (105, 107, 111, 112). A large part of this is via the parasite-induced NPP (179), which transports both D- and L-nucleosides at comparable rates (327). There is also evidence for an additional NBMPR-insensitive, saturable transport component for D-adenosine (but not L-adenosine) (105, 327), although this may reflect a contribution of the intracellular metabolism and/or transport of D-adenosine to the measured uptake, rather than saturable transport across the RBCM. Uptake of D-adenosine into both infected and uninfected erythrocytes is extremely rapid, and even though most recent measurements of the uptake of D-adenosine have been carried out using incubation periods of only a few seconds, this is sufficient time for the intracellular concentration of radiolabeled nucleoside to reach levels comparable to or exceeding the extracellular concentration (111). Under these conditions, the measured uptake may reflect a combination of transport and metabolism of the radiolabeled solute, in which case a decrease in the rate of either will give rise to a decrease in the amount of radiolabel accumulated within the cell (see sect. IIIB).
Upston and Gero (327) have used a number of different approaches to investigate the transport of nucleosides across the PPM. P. falciparum merozoites were shown to take up both D- and L-adenosine at comparable rates (327). P. falciparum trophozoites within Sendai virus-permeabilized erythrocytes were also shown to take up both L-adenosine and L-thymidine via an NBMPR-insensitive mechanism (108), whereas those within saponin-permeabilized erythrocytes were reportedly unable to take up L-adenosine (327). The reason for this discrepancy is unclear.
The first evidence for the existence of parasite-encoded nucleoside and nucleobase transporters encoded by P. falciparum (247) came from experiments in which Xenopus oocytes injected with P. falciparum mRNA then incubated for 3 days to allow for protein expression showed increased uptake of both D-adenosine and the purine base hypoxanthine. The observation that 2'-deoxy-D-adenosine inhibited the uptake of D-adenosine, whereas L-adenosine did not is consistent with the increased uptake being via a stereoselective transporter, although it is possible that the enhanced uptake was due, at least in part, to increased activity of endogenous nucleoside/nucleobase transporters and/or activation/expression of broad-specificity permeation pathways such as the volume-sensitive osmolyte channel (174) that is known to be present in Xenopus oocytes (147, 339) and which is blocked by nucleoside analogs (140).
More recently, the Xenopus oocyte system has been used for the expression and characterization of a P. falciparum-encoded nucleoside transporter, designated PfNT1 in one study (44) and PfENT1 in another (241b). This protein is homologous to other members of the equilibrative nucleoside transporter family and mediates the transport of a range of nucleosides, including both D- and L-adenosine (the latter with much lower affinity than the former, Ref. 44). There are significant discrepancies between the results of the two studies with regard to the reported substrate affinities [the Km for adenosine was estimated as 13 µM in one study (44) and 320 µM in the other (241b)], substrate specificity [one study demonstrated uptake of nucleobases, including hypoxanthine (241b), whereas the other reported no effect of nucleobases on nucleoside transport and no uptake of hypoxanthine (44)], and inhibitor susceptibility [one study reported that the transporter was inhibited by 10 µM dipyridamole (44), whereas the other reported that it was not (241b)]. The reasons for these discrepancies are unclear.
The nucleoside transporter is expressed throughout the intraerythrocytic phase of the parasite's life cycle but is upregulated in the early trophozoite stage, before the onset of nuclear division (44). Its location within the parasitized cell is yet to be established.
E. Vitamins
Of all the water-soluble vitamins that are present in blood plasma and in culture media, the only one for which the intracellular parasite has an absolute extracellular requirement (and for which the parasitized cell must therefore have an appropriate uptake system) is pantothenic acid (vitamin B5), the precursor of the important enzyme cofactor coenzyme A (69). The normal human erythrocyte membrane is largely impermeable to pantothenic acid. However, pantothenic acid is taken up readily by P. falciparum-infected erythrocytes via the NPP (273). In the presence of an inhibitor of the NPP, the transport of pantothenate into the infected cell becomes rate limiting for the phosphorylation of pantothenate, the first step in its conversion to coenzyme A (273).
Earlier studies with avian malarias had led to the proposal that the conversion of pantothenic acid to coenzyme A occurs in the host cell cytosol, with the parasite taking up the fully formed coenzyme (35). In P. falciparum-infected human erythrocytes, however, the bulk of the phosphorylation of pantothenic acid occurs within the parasite (273). There must therefore be a mechanism for the uptake of pantothenic acid across the PPM, although this is yet to be characterized.
p-Aminobenzoic acid (p-ABA) is another vitamin that the parasite is able to utilize from the extracellular medium (364), although in the case of P. falciparum, omission of p-ABA from the medium does not retard parasite growth (69). In contrast to pantothenic acid, p-ABA has been shown to enter infected and uninfected cells rapidly, at a similar rate in both cases (364).
F. Choline
The growth and asexual reproduction of the intracellular malaria parasite within the red blood cells of its vertebrate host entails the synthesis of new membranes. The phospholipid content of the malaria-infected erythrocyte reportedly increases by up to fivefold during the course of parasite development, with the bulk (85%) of the new lipid being either phosphatidylcholine or phosphatidylethanolamine (157). The de novo synthesis of phosphatidylcholine within the intracellular parasite is reliant upon the uptake of choline from the external medium, and it has been demonstrated that in monkey erythrocytes infected with the malaria parasite Plasmodium knowlesi the transport of choline into the parasitized erythrocyte is a rate-limiting step for phosphatidylcholine biosynthesis (4, 337).
Choline is transported into normal mammalian erythrocytes via a well-characterized saturable carrier that has a Km of ~10 µM. Several studies have investigated the transport of choline into malaria-infected erythrocytes. Parasitized erythrocytes from malaria-infected monkeys (4) and mice (302) take up choline via a pathway with a Km similar to that of the endogenous host cell transporter but with a Vmax 10- to 20-fold higher than that seen in normal cells (see sect. VB). In parasitized cells from the malaria-infected mice, there is, in addition to the enhanced saturable transport component, a substantial nonsaturable flux of choline via the NPP, with the result that in cells exposed to a physiological extracellular choline concentration (20 µM), approximately two-thirds of the uptake is via the saturable transporter and one-third via the NPP (302).
In human erythrocytes infected in vitro with P. falciparum, there is little if any increase in the Vmax of the endogenous choline transporter, and the increased rate of choline transport into these cells is due predominantly to the flux of choline via the NPP (82, 184). Whether the differences between these results and those obtained with cells from malaria-infected animals are due to species differences or to differences between the in vitro and in vivo systems (182) is unclear.
The synthesis of phosphatidylcholine from choline occurs within the intracellular parasite (6). There must therefore be some means by which choline traverses the PPM, although this has not been characterized.
The dependence of the growing malaria parasite on an extracellular choline supply has prompted the proposal that choline transport inhibitors may be effective antimalarial agents (5, 7).
G. Lactate
Lactic acid crosses the plasma membrane of normal erythrocytes via
three major pathways (68, 250): a specific
H+-monocarboxylate transporter (designated MCT1), the band
3 anion exchanger, and diffusion of the protonated form of the compound via the lipid bilayer. It has been calculated, however, that even with
all three pathways operating, the total transport capacity is less than
that required to match the rate of production of lactate by the
parasite (56, 168, 250). A
number of studies have demonstrated the rapid flux of lactate across
the parasitized erythrocyte membrane under conditions where the
endogenous transporters are inhibited (56,
168, 179). The available evidence is
consistent with most of the enhanced transport of lactate being via the
broad specificity NPP. Cranmer et al. (56) have argued
that significant differences in the susceptibility of the transport of
lactate and Cl
into the parasitized erythrocyte to
various anion transport inhibitors may point to these two solutes
traversing the erythrocyte membrane via different pathways. However,
the differences are relatively small, and the data are consistent with
the bulk of the parasite-induced transport of lactate (and
Cl
) being via a common route (i.e., the NPP), with a
minor component of the flux of one or both of these solutes being via
an alternative pathway (e.g., the endogenous monocarboxylate
transporter). In the same paper it was argued that a correlation
between the equilibrium distribution of lactate (i.e.,
[lactate]i/[lactate]o, where
subscripts i and o denote the intra- and extracellular compartments,
respectively) in the parasitized erythrocyte and the transmembrane pH
gradient was indicative of the transport into the parasitized
erythrocyte being via a parasite-induced lactate-proton
cotransporter. However, it should be recognized that in the human
erythrocyte, permeant monovalent anions and protons are both at, or
close to, electrochemical equilibrium (245). The finding
that [lactate]i/[lactate]o = [H+]o/[H+]i
is therefore equally consistent with the equilibration of lactate via
an anion-selective diffusion pathway (such as the NPP).
In this context it is worth noting that all the studies of the transport of lactate across the membrane of the malaria-infected erythrocytes have entailed measuring the influx of radiolabeled lactate. The proposal that the parasite-induced NPP serves an important physiological role in providing a route for the efflux of lactate from the parasitized cell has not been tested directly.
The bulk of the lactic acid produced by the parasitized erythrocyte originates within the intracellular parasite (117). Kanaani and Ginsburg (168) have demonstrated the flux of radiolabeled lactate into parasites within Sendai virus-permeabilized erythrocytes. In this system lactate transport was found to be nonsaturable and insensitive to compounds known to inhibit lactate transport in other cell types. There was some evidence for the involvement of the proton electrochemical gradient in the transport process, consistent with H+-lactate cotransport. In many cells the transport of lactate is via H+-lactate cotransporters that are members of the "monocarboxylate transporter" (MCT) family (reviewed in Ref. 144), and a recent study has presented evidence for a transporter of this type operating in the intraerythrocytic parasite (84a).
H. ATP/ADP
Two studies with P. falciparum trophozoites isolated from their host erythrocytes describe the presence at the parasite surface of an ATP/ADP exchange system (47, 167). This transporter is inhibited by atractyloside, an inhibitor of the ATP/ADP exchanger of mitochondria (47, 167), and operates with a stoichiometry of 1:1 (47). It is able to carry ATP in either direction and seemingly functions to maintain similar ATP concentrations in the parasite and host cell cytosols (167). The observation that in parasitized erythrocytes preincubated with atractyloside the ATP content of the parasite compartment increases whereas that of the host cell compartment decreases is consistent with the view that the exchanger mediates a net flux of ATP, from the parasite to the host (167).
A homolog of the ATP/ADP exchanger of other eukaryote species has been cloned from P. falciparum (76, 149, 150). Low-stringency hybridization yielded only a single gene (76, 150). Western blots using polyclonal antibody directed against a bovine mitochondrial ATP/ADP exchanger gave a single band (31-32 kDa) on SDS-PAGE gels, and immunogold labeling showed labeling of the inner mitochondrial membrane, but not of the membranes at the parasite surface (149). There is, however, a recent report of a confocal microscopy study in which a polyclonal antibody raised against a recombinant form of the P. falciparum mitochondrial ATP/ADP exchanger recognized a homolog of this protein at the parasite surface (260), and Ginsburg (121) has reported similar results with another antibody.
I. Chloride
The monovalent chloride ion is the physiological solute to which
the NPP show the highest measured permeability (56,
179, 181). In normal, uninfected
erythrocytes, Cl
is distributed passively across the
plasma membrane. The conductive permeability of the normal erythrocyte
membrane to Cl
is several orders of magnitude higher than
that to Na+ or K+, and the membrane potential
is approximately equivalent to the Cl
equilibrium
potential {ECl = (RT/F)
ln([Cl
]i/[Cl
]o)},
where R, T, and F have their usual
meanings. The induction in the erythrocyte plasma membrane of NPP
having a Cl
permeability orders of magnitude higher than
their Na+ or K+ permeability will therefore
have negligible effect on either the Cl
distribution or
the membrane potential, but will serve to stabilize the membrane
potential at a value very close to ECl.
The Cl
content of the intracellular parasite is
intermediate between the Na+ and K+ content
(200), although the mechanisms by which this is regulated are unknown.
J. Sodium, Potassium, and Protons
1. General strategies
Eukaryotic cells use a number of different strategies for
controlling their cytosolic ion composition and for utilizing
transmembrane ion gradients to energize the flux of solutes either into
or out of the cells. As illustrated in Figure
9A, the cells of higher eukaryotes (e.g., vertebrates) have in their plasma membrane a (P-type)
Na+-K+-ATPase that pumps Na+ out of
and K+ into the cell. The large inward Na+
concentration gradient, together with the (inwardly negative) membrane
potential, constitutes the Na+ electrochemical gradient,
and animal cells make use of the concentration and/or electrical
components of this gradient to energize the movement of solutes across
the membrane via secondary active transporters (i.e., symporters and
antiporters). The Na+/H+ exchanger is an
example of one such transporter. In most animal cells, this protein
plays a key role in the regulation of intracellular pH, using the
energy in the Na+ gradient to extrude H+.

View larger version (25K):
[in a new window]
Fig. 9.
Schematic representations of the strategies used by higher eukaryote
(e.g., vertebrate) cells (A) and lower eukaryote (e.g.,
plant, yeast, and at least some protozoan) cells (B) to
energize the transport of solutes. The former rely primarily on the
Na+ electrochemical gradient (generated by a
Na+/K+ pump), whereas the latter rely primarily
on the H+ electrochemical gradient (generated by a
H+ pump), to drive the secondary active transport of other
solutes (denoted by S). Solid circles denote primary active
transporters (pumps); open circles denote "secondary active
transporters" that couple the movement of ions (Na+ or
H+) down their electrochemical gradient to the transport of
a second solute, either into or out of the cell.
In contrast to the cells of higher eukaryotes, the major "primary active transporter" in the cells of lower eukaryotes (e.g., plants, yeast) is usually an H+-ATPase that pumps H+ out of the cell, thereby establishing an inward H+ electrochemical gradient (Fig. 9B). In such cells, the secondary active transport of solutes is driven principally by the H+ gradient, again via symporters and antiporters. Plants (3) and yeast (162) both have Na+/H+ exchangers (of undefined stoichiometry), and in these organisms, their primary role is thought to relate to Na+ homeostasis, using the energy in the H+ gradient to extrude Na+ (i.e., the reverse of the situation in cells of higher eukaryotes; cf Fig. 9, A and B).
2. Na+ and K+
The normal human erythrocyte maintains a high intracellular K+ and low intracellular Na+ concentration through a well-characterized pump-leak mechanism (318). Na+ is pumped out and K+ pumped into the cell by the ouabain-sensitive Na+-K+-ATPase, which thereby generates substantial opposing concentration gradients for both ions (as in Fig. 9A). The pumping counterbalances the "leak" of the two ions, down their respective concentration gradients via various cotransporters, exchangers, and channels. The net result, in normal human erythrocytes, is a steady-state cytoplasmic [Na+]/[K+] of ~0.12 (200).
It has long been recognized that in mammalian erythrocytes infected with malaria parasites (Plasmodium spp.) there is a marked perturbation of the normal Na+/K+ levels (74, 124, 200, 241). The low [Na+]/[K+] is maintained within the erythrocyte cytosol in the hours after invasion by the parasite (the ring stage; Refs. 124, 200). As the parasite matures, however, the [Na+]/[K+] in the host cell cytosol increases. Using Sendai virus to permeabilize the plasma membrane of human erythrocytes infected with mature (trophozoite) stage forms of P. falciparum and thereby release the ions in the host cell compartment for analysis, Ginsburg et al. (124) estimated the [Na+]/[K+] in the erythrocyte cytosol to have increased 10-fold, to ~1.25. Using X-ray microanalysis, Lee et al. (200) obtained evidence for an even greater perturbation, estimating the [Na+]/[K+] in the cytosol of P. falciparum trophozoite-infected human erythrocytes to be ~11.6. This value implies an almost complete loss of the normal transmembrane Na+ and K+ gradients across the RBCM.
Any such perturbation of the [Na+]/[K+] ratio is indicative of a disruption of the pump-leak balance by which normal Na+/K+ levels are maintained. The induction of cation-permeable NPP in the RBCM causes an increased leak of both Na+ and K+ (301a). Direct measurements of K+(86Rb+) transport via the Na+/K+ pump in trophozoite-stage P. falciparum-infected erythrocytes indicate that in the period 24-36 h postinvasion, the pump activity is increased (to up to twice its normal value) in response to the increased leakage of ions via the NPP (175, 300, 301a). However, the increase is not sufficient to maintain the normal transmembrane Na+ and K+ gradients. In the latter 12 h of the parasite's occupancy of the erythrocyte (36-48 h postinvasion), the flux of ions via the NPP increases, whereas the activity of the Na+/K+ pump undergoes a progressive decrease (300, 301a).
In contrast to its host erythrocyte, the intracellular parasite maintains a low cytosolic [Na+]/[K+] (estimated using different techniques to be between 0.06 and 0.17) throughout the intraerythrocytic cycle (128, 200). The mechanisms by which this is achieved have not been elucidated.
3. H+
Work carried out in recent years on a number of different parasitic protozoa has led to the view that these organisms conform, to at least some extent, to the model represented in Figure 9B (i.e., they extrude H+ via a plasma membrane H+ pump and use H+ in preference to Na+ to drive the secondary active transport of solutes). In the case of Trypanasoma spp. (62, 61, 331, 365) and Leishmania spp. (133, 163, 338, 365), it has been proposed that there is a "P-type" H+-ATPase in the plasma membrane. Entamoeba histolytica (13), Trypanosoma cruzi (18), and Toxoplasma gondii (227) (which, like Plasmodium, belongs to the phylum Apicomplexa) have all been proposed to have a "V-type" H+-ATPase in their plasma membrane.
In early studies of the physiology of the murine malaria parasite
P. chabaudi, Mikkelsen and colleagues (224,
225) showed that both the membrane potential (estimated to
be approximately
90 mV under normal conditions) and the intracellular
pH of the parasite decreased in the presence of the H+ pump
inhibitors dicyclohexylcarbodiimide and orthovanadate. This led them to
postulate the presence on the PPM of an electrogenic H+
pump, similar to that which operates in other lower eukaryote cells.
In the case of P. falciparum, the intracellular pH within the parasite has been estimated to be within the range 7.2-7.4 (27, 31, 275, 356), compared with a pH in the host cell cytosol of ~7.1 (27, 355, 356). In a recent study it was reported that the region of the erythrocyte cytoplasm immediately adjacent to the intracellular parasite was more acidic than the bulk cytosol, having a pH of ~6.9 (150a). There is therefore a significant inward H+ concentration gradient across the PPM/PVM. Bosia et al. (27) have proposed that this gradient arises from the operation of a Na+/H+ exchanger coupled to the operation of a Na+ pump (i.e., as in the model of Fig. 9A rather than that of Fig. 9B). In this study it was reported that in parasites within Sendai virus-permeabilized erythrocytes, intracellular pH decreased on removal of Na+ from outside the cell or on addition of the Na+/H+ exchanger inhibitors amiloride and ethylisopropylamiloride (EIPA). Similarly, both maneuvers inhibited the recovery of intracellular pH after an imposed intracellular acidification (27).
These data are consistent with a Na+/H+ exchanger playing a key role in the extrusion of H+ from the parasite. However, they are at odds with those obtained in a recent study (275) in which it was shown that in parasites within saponin-permeabilized erythrocytes the maintenance of a normal resting intracellular pH and the recovery from an imposed intracellular acidification occurred via a Na+-independent but ATP-dependent process that was inhibited by a number of H+ pump inhibitors, including the potent and perhaps specific V-type H+-ATPase inhibitor bafilomycin A1. It was proposed in this study that the major pathway for the extrusion of H+ from the P. falciparum trophozoite is, as in at least some other parasitic protozoa (13, 18, 227), a V-type H+-ATPase at the cell surface. This proposal has gained further support from the finding that in intact parasitized cells V-type H+-ATPase inhibitors cause an acidification of the parasite cytosol and an alkalinization of the host cell cytosol, as well as from immunolocalization experiments indicating the presence of V-type H+-ATPase subunits at the parasite surface (171, 150a).
In the study with saponin-permeabilized erythrocytes (275) it was confirmed that amiloride and EIPA caused a substantial reduction in the resting intracellular pH of the parasite. However, EMD-96785, a potent inhibitor of Na+/H+ exchange in mammalian cells, had relatively little effect. These data were interpreted in terms of amiloride and EIPA (but not EMD-96785) inhibiting the operation of the V-type H+-ATPase, a hypothesis consistent with a previous observation of amiloride inhibiting the generation of a H+ gradient by a V-type H+-ATPase in the plasma membrane of insect cells (346).
The intracellular food vacuole maintains an internal pH substantially lower than that of the parasite cytosol through the operation of a V-type H+-ATPase (46) which pumps H+ into the organelle. V-type H+-ATPases are multisubunit complexes (234), and homologs of the A and B subunits of V-type ATPases of other species have been cloned from P. falciparum (170, 171).
The net influx of protons into the food vacuole requires that
there be an ion transport pathway, operating in parallel with the
H+-ATPase, to allow a flux of ions that counterbalances the
electrogenic H+ movement. It has been postulated that
Pgh-1, a P. falciparum homolog of the mammalian
P-glycoprotein, may be involved in this process, serving either as
a Cl
channel or as a Cl
channel regulator
(335). The proposal that Pgh-1 may itself be a
Cl
channel was based largely on the proposal that
mammalian P-glycoprotein serves as a Cl
channel
(115, 330). However, there is now substantial
evidence that the mammalian P-glycoprotein is unlikely to be a
Cl
channel (see Refs. 174, 236, 239, 304 for recent
reviews), although it may exert a regulatory influence on ion channels
in certain cell types (25, 148,
154). The observation that mammalian Chinese hamster ovary
cells expressing Pgh-1 show decreased intralysosomal pH
(335) is consistent with Pgh-1 exerting a modulatory
effect on vacuolar pH, although whether it does so via an effect on
Cl
transport remains to be established.
Table 4 lists the various putative ion-motive ATPases (or subunits thereof) for which genes have been identified in P. falciparum.
|
In addition to the various ATPases known to be present in Plasmodium, there is recent biochemical, immunological, and molecular evidence for the presence in the intraerythrocytric parasite of a H+-translocating pyrophosphatase (H+-PPase) of the type found on the membrane ("tonoplast") enclosing the large intracellular vacuole of plant cells (210, 221). The H+-PPase of plants utilizes the energy liberated by the hydrolysis of pyrophosphate to pump H+ into the vacuole. Immunolocalization experiments indicate that the P. falciparum homolog of the plant H+-PPase is present both on intracellular vesicles and at the parasite surface (210, 221). Its physiological role(s) is yet to be elucidated fully; however, it has been proposed to play a role (perhaps together with a V-type H+-ATPase) in the acidification of "acidocalcisomes" (novel, acidic Ca2+ storage organelles; see sect. IXK) within the parasite (212).
K. Calcium
Ca2+ plays a central role in the biology of eukaryote cells, serving a wide range of regulatory and signaling functions. Extracellular Ca2+ is essential for the invasion of the erythrocyte by the malaria merozoite, as well as for the maturation of the intracellular trophozoite (258, 343). Parasite growth is inhibited by a range of Ca2+ ionophores, Ca2+ channel blockers, and calmodulin (218, 279, 309), although the mode of action of these reagents and, more generally, the role of Ca2+ in the development of the intracellular parasite is unclear.
Normal mammalian erythrocytes lack intracellular Ca2+
stores and maintain a low cytosolic [Ca2+] (20-30 nM;
Ref. 202) through the action of a plasma membrane Ca2+ pump
(a P-type ATPase) which extrudes Ca2+
(43). The extracellular Ca2+ concentration is
typically 1-2 mM. There is therefore a large inward electrochemical
gradient for Ca2+ with the pumping of Ca2+ from
the cell counterbalancing the leak of Ca2+ into the cell,
down its electrochemical gradient, via a pathway showing the
characteristics of a saturable carrier with a Km
of ~1.3 mM (66, 222, 315). The
pump-leak Ca2+ turnover for erythrocytes suspended in
autologous plasma is 30-50 µmol · l
cells
1 · h
1 (202), well
below the maximum capacity of the pump (4-25 mmol · l
cells
1 · h
1) (57).
In the malaria-infected erythrocyte, the function of the erythrocyte Ca2+ pump is largely unimpaired (at least under Vmax conditions) (316). However, the total Ca2+ content is increased by 10- to 20-fold (26, 187, 201). It is important to recognize that this does not necessarily indicate a change in the Ca2+ permeability properties of the host cell membrane. Although the concentration of Ca2+ in the host cell cytosol is low, this is not a static pool. The pump-leak balance is a dynamic one, involving a continual cycling of Ca2+ between the erythrocyte cytosol and the extracellular medium, and the parasite may gain sufficient Ca2+ by "siphoning" it off from the small but continually replenished pool in the erythrocyte cytosol.
There have been a number of studies of the influx of 45Ca2+ into P. falciparum trophozoite-infected erythrocytes, with somewhat varying results. Kramer and Ginsburg (187) reported that the initial rate of 45Ca2+ influx into parasitized erythrocytes was higher than that into uninfected cells. In the same study it was also shown that uptake of 45Ca2+ by P. falciparum trophozoite-infected erythrocytes did not saturate with increasing Ca2+ concentration in the range 0-500 µM, although this is also true of the uptake of Ca2+ into (ATP-depleted, vanadate-treated) uninfected cells measured over the same concentration range (66). Kramer and Ginsburg (187) suggested that the basal permeability of the RBCM to Ca2+ is increased, and the same conclusion was drawn by Desai et al. (64). The latter workers reported that high concentrations of divalent cations inhibit the uptake of 45Ca2+ into parasitized erythrocytes, with a somewhat different order of potency than that seen in uninfected cells, and that the efflux of Ca2+ from preloaded parasitized erythrocytes differs from that from uninfected cells in not undergoing "trans-stimulation" in response to an increase in the extracellular Ca2+ concentration. In the same study (64), cell-attached patch-clamp recordings provided some evidence for the presence in the infected cell of a novel channel activity seen in 2 of 26 successful cell-attached patches on parasitized erythrocytes, compared with none of 18 patches on uninfected cells. The instability of the patched parasitized erythrocyte precluded the characterization of this channel in any detail. It was postulated that this channel may be permeable to, but not highly selective for, Ca2+ (64). However, there is little evidence in support of this, and the observation that the apparent reversal potential (estimated by extrapolation of the few data obtained) was close to zero under conditions where there was 80 mM Ca2+ in the microelectrode (compared with no more than a 1-2 µM concentration in the red cell cystosol; Refs. 1, 187) would argue against this channel having any particular preference for Ca2+.
In contrast to the two earlier studies, Staines et al. (301) have reported recently that in metabolically active parasitized erythrocytes, the passive Ca2+ permeability of the parasitized erythrocyte membrane is similar to that of nonparasitized cells and that only on depletion of intracellular ATP does the Ca2+ permeability increase. The nature of the ATP depletion-induced Ca2+ permeability (termed DICAP; Ref. 301) is unclear; however, its activation may well account for the increase in Ca2+ permeability reported in the earlier studies.
The bulk of the increased Ca2+ content of the malaria-infected erythrocyte is localized in the intracellular parasite (1, 26, 201, 310). However, the concentration of free Ca2+ within the parasite cytosol is only two to four times higher than that in the host erythrocyte cytosol. In early trophozoite-stage parasites, the [Ca2+] in the parasite cytosol is reportedly 40-44 nM, increasing to 110-125 nM in the late trophozoite/schizont stage (1, 102). 45Ca2+ is transported readily into P. falciparum parasites freed from their host erythrocytes (187). However, in freed parasites exposed to an increased extracellular Ca2+ concentration of 5 mM, there was reported to be no significant increase in the cytosolic Ca2+ concentration, consistent with the intracellular Ca2+ levels being tightly controlled (102).
The pathways involved in the regulation of Ca2+ in the intracellular parasite are not well characterized. It has been suggested that a plasma membrane Ca2+-H+ antiporter (187, 310) and/or a P-type Ca2+ pump (Ref. 102; see Table 4) might be involved, although this remains to be clarified. A series of recent studies on a range of different plasmodial species has provided evidence for the presence of a number of discrete intracellular Ca2+ pools within the intracellular parasite (reviewed in Ref. 101). One, presumed to be localized to the parasite's endoplasmic reticulum, is reportedly discharged by inhibitors of the endoplasmic reticulum Ca2+ pump [e.g., thapsigargin, 2,5-di-(tert-butyl)-1,4-hydroquinone, vanadate] (102, 242). Another, which is reportedly discharged by the alkalinizing agent NH4Cl, by the H+ ionophores nigericin and monensin (which operate as K+/H+ and Na+/H+ exchangers, respectively), by V-type ATPase inhibitors, and by the H+-PPase inhibitor aminomethylenediphosphonate (242, 243) has been attributed to an acidic compartment within the parasite. This compartment is postulated to be comprised of a population of acidocalcisomes (101, 212), acidic Ca2+ storage organelles which are found in trypanosomatids and other apicomplexans (reviewed in Ref. 72) and which are acidified by the combined action of a V-type H+-ATPase and a H+-PPase (72, 212).
Both the endoplasmic reticulum and acidic intracellular Ca2+ pools within the parasite are reported to be mobilized in response to inositol 1,4,5-trisphosphate (IP3), and this is inhibited by heparin, an IP3 receptor antagonist (242). It has been reported that the hormone melatonin triggers the IP3 cascade within the parasite, and this has been implicated as playing a role in the maintenance of synchrony of Plasmodium infections in vivo (158a).
A recent study with P. berghei has demonstrated the uptake of Ca2+ into the parasite mitochondria (328). The significance of this for intracellular Ca2+ regulation is unclear.
L. Magnesium
Mg2+, another divalent cation that plays an important (although less well characterized) regulatory role in eukaryotic cells, is also present at elevated levels in P. falciparum-infected erythrocytes (10, 216). Mice fed on a Mg2+-deficient diet showed a twofold reduction in erythrocyte Mg2+ content and, on infection with P. chabaudi, showed reduced parasitemia and mortality, compared with mice on a normal diet (216). Similarly, in P. falciparum in in vitro culture, removal of Mg2+ from the extracellular medium caused a marked inhibition of growth (217), consistent with Mg2+ playing an important role in the parasite life cycle.
The bulk of the Mg2+ within P. falciparum trophozoite-infected erythrocytes is present within the intracellular parasite, and the total concentration of Mg2+ in the host cell cytosol is actually significantly less than that in normal, uninfected erythrocytes under the same conditions (10). Increasing the extracellular Mg2+ concentration to which P. falciparum-infected erythrocytes are exposed gives rise to an increase in the Mg2+ levels in the host cell cytosol. This contrasts with the situation in normal, uninfected erythrocytes in which the intracellular Mg2+ concentration remains invariant with changing extracellular Mg2+ concentrations (92), and is consistent with the RBCM having an increased permeability to Mg2+. In contrast, the Mg2+ content of the intracellular parasite remains unaltered over a range of extracellular Mg2+ concentrations, consistent with the parasite having mechanisms through which it exerts a tight control over its intracellular Mg2+ level (10, 121).
M. Drugs
There is a substantial literature on the membrane transport of antimalarial drugs in the malaria-infected erythrocyte, and in particular, on the role of drug transport in drug resistance. A number of recent articles provide comprehensive reviews of this subject (32, 94, 95, 126a, 277a), and for this reason, it is covered here only briefly.
The majority of studies have focused on chloroquine, a 4-aminoquinoline diprotic weak base (pKa1 = 8.1, pKa2 = 10.2). Since its identification as an effective antimalarial agent in the 1940s, chloroquine has been the mainstay of antimalarial chemotherapy. However, the emergence in the 1950s, and the progressive spread since then, of P. falciparum strains showing high levels of resistance to chloroquine has led to the situation in which this cheap, and previously highly effective, drug is now of limited use in treating malaria in many parts of the world.
The antimalarial effect of chloroquine is restricted to the blood stage of the malaria parasite. There is substantial evidence that its primary site of action is in the food vacuole of the parasite, although additional sites of action have also been postulated (122, 132). The degradation of hemoglobin within the food vacuole produces heme as a by-product. Free heme is potentially toxic to both the parasite and host cell, inhibiting important enzymes and causing membrane damage (48, 223, 240, 332). However, problems associated with heme toxicity are circumvented, at least in part (132), by the incorporation of the heme molecules into nontoxic "hemozoin" crystals (241a) that remain trapped within the food vacuole. It has been postulated that hemozoin formation is catalyzed by a parasite-encoded "heme polymerase" (296). However, subsequent studies have led to the view that it is a purely physicochemical (as opposed to enzyme-mediated) process (73, 77, 259, 263).
Irrespective of the mechanism involved, it is clear that chloroquine interferes with hemozoin formation (296), prompting the proposal that the antimalarial activity of chloroquine is due to the accumulation of cytotoxic heme monomers and/or heme-chloroquine complexes, within the parasitized erythrocyte. Chloroquine accumulates to high levels within the acidic food vacuole, driven to at least some extent, although not exclusively (31, 32), by the low vacuolar pH and the weak base nature of the drug. In malaria-infected erythrocytes exposed to cytotoxic concentrations of chloroquine, the concentration of the drug within the vacuole is sufficient to inhibit hemozoin formation (123, 129, 359).
The hypothesis that chloroquine exerts its antimalarial effect, at least in part, within the parasite's food vacuole is consistent with the observation that that chloroquine resistance is associated with decreased accumulation of chloroquine within the vacuole (95, 272). A range of different models have been put forward as to how this decreased accumulation might arise, and a number of these are represented schematically in Figure 10.
|
In the model represented in Figure 10A, a transporter on the vacuolar membrane mediates the active export of chloroquine from the food vacuole. This model was postulated on the basis of early reports that the half-life for the release of preloaded chloroquine from erythrocytes infected with chloroquine-resistant parasites is shorter than that measured in erythrocytes infected with chloroquine-sensitive parasites (191). The combined findings that 1) chloroquine efflux from cells infected with chloroquine-resistant parasites is inhibited (and chloroquine resistance reversed) by compounds such as verapamil which are known to block the P-glycoprotein-mediated efflux of anticancer drugs from multidrug resistant cancer cells (191, 213) and 2) P. falciparum expresses Pgh-1, a homolog of the mammalian P-glycoprotein, localized primarily to the food vacuole membrane (52, 96, 347), led to the proposal that chloroquine resistance is a result of the active export of chloroquine from the food vacuole by Pgh-1. This hypothesis has been disputed on a number of grounds [discussed in some detail by Ginsburg (118) and by Foley and Tilley (95)]. Nevertheless, there is a significant body of evidence consistent with Pgh-1 having some involvement in the resistance of P. falciparum parasites to chloroquine (95, 270), as well as to a number of other antimalarial agents (51, 74a, 246, 255, 348). A recent paper in which Pgh-1 expressing a number of different mutations was transfected into both chloroquine-sensitive and chloroquine-resistant parasites provides direct evidence that Pgh-1 can influence the susceptibility of P. falciparum to a range of antimalarial agents (261). For some drugs (chloroquine and mefloquine) and some parasite strains at least, changes in the primary structure of Pgh-1 induced changes in the level of drug accumulation within the parasitized erythrocyte, although the mechanism by which this occurs is not yet known.
Figure 10B shows an alternative role for Pgh-1-mediated chloroquine transport. If Pgh-1 serves to transport chloroquine into rather than out of the food vacuole, chloroquine resistance might arise from impaired function of Pgh-1, leading to reduced chloroquine accumulation (126a, 277a). It is not clear, however, how this model might account for the ability of verapamil and other "reversal agents" to increase drug accumulation by chloroquine-resistant parasites (126a).
In the model represented in Figure 10C, decreased
chloroquine accumulation is secondary to an increased vacuolar pH,
arising from a weakened vacuolar H+ pump
(131), increased H+ leakage
(131), or perhaps from an impaired Cl
conductance in the vacuolar membrane imposing a limitation on the
electrogenic flux of H+ into the vacuole
(335). However, there is no direct evidence that
chloroquine-resistant parasites have a raised vacuolar pH, and a recent
report has suggested that the opposite may actually be the case
(76a, 89b). Furthermore, molecular
characterization of two of the eight subunits of the V-type
H+-ATPase of chloroquine-sensitive and
chloroquine-resistant strains have revealed no mutations that might
account for the resistance (170, 171).
Martiney et al. (214) postulated that decreased vacuolar levels of chloroquine in chloroquine-resistant parasites are a consequence of a reduction of the pH in the parasite cytoplasm (perhaps occurring as a result of altered anion transport across the PPM), causing a decrease in the relative concentration of the (membrane-permeant) neutral unprotonated form of the drug in this compartment. It was argued that this will result in a reduced entry of chloroquine into the food vacuole. If, however, chloroquine crosses the relevant membranes by simple diffusion of the neutral unprotonated species, the concentration of this form of the molecule in all of the subcellular compartments will be the same, irrespective of the relative proportions of protonated and unprotonated species in each. In any case, this model is at odds with the recent reports from several labs (215, 356), although not all (33), that chloroquine-resistant parasites actually have a higher cytoplasmic pH than chloroquine-sensitive parasites.
Lanzer and colleagues (278) have proposed that the influx of chloroquine across the PPM is mediated by the Na+/H+ exchanger proposed to be in the PPM (sect. IXJ3; Fig. 10D) (278). They have furthermore postulated that 1) the Na+/H+ exchanger in chloroquine-sensitive parasites differs from that in chloroquine-resistant parasites with respect to its ability to mediate the accumulative uptake of the drug into the parasite cytosol, with the result that the concentration of chloroquine in the cytosol (and hence in the food vacuole) of the chloroquine-sensitive strains is higher than that in the chloroquine-resistant strains (356), and 2) the plasmodial Na+/H+ exchanger is encoded by a gene (cg2; Ref. 305) that has been linked to chloroquine resistance (277).
Both hypotheses have been disputed. Bray and co-workers (31, 33) have presented evidence that Na+/H+ exchanger inhibitors inhibit the uptake of chloroquine into parasitized erythrocytes by interfering with the binding of chloroquine to heme, rather than by an effect on transport across the PPM. They have also demonstrated that the uptake of chloroquine by isolated parasites (and the inhibition of this process by amiloride) is unaffected by the removal of Na+ from the extracellular medium, under which conditions Na+/H+ exchange is prevented.
Wellems et al. (345) have addressed the question of whether the gene cg2 encodes a Na+/H+ exchanger and have advanced a number of arguments as to why this is unlikely to be the case. The cg2 protein has few, if any, predicted membrane-spanning domains and is not localized to the PPM. In any case, recent studies have cast doubt on the role of cg2 in chloroquine resistance (89a). However, there is now good evidence that another gene, pfcrt, located close to the cg2 gene, does play a central role in chloroquine resistance (89b). The corresponding protein, Pfcrt, has 10 putative membrane-spanning domains and is postulated to be a transporter or channel. It localizes primarily to the parasite food vacuole, and it reportedly influences the pH of the food vacuole pH, with the "resistant" form of the protein being associated with a reduction in vacuolar pH (89b).
In contrast to the very substantial literature on the accumulation of chloroquine by malaria-infected erythrocytes, there have been very few studies of the transport of other antimalarial drugs. Several recent studies have highlighted the potential of transport pathways in the malaria-infected erythrocyte as drug-targeting routes (2, 36, 108, 199, 274), although in general the pathways involved in the transport of drugs in the malaria-infected erythrocyte are not well understood.
| |
X. CONCLUSIONS |
|---|
|
|
|---|
P. falciparum, the most deadly of the four strains of malaria parasite infective to humans, has demonstrated the ability to become resistant to most, if not all, of the antimalarial agents presently available. It is quite possible that within the next decade there will be parts of the world in which malaria is an untreatable disease, and it is likely that unless new treatments are developed the number of fatalities from this disease, already large, will increase dramatically. There is an urgent need for the identification of new chemotherapeutic targets and the development of new antimalarial strategies.
To those familiar with the advances over the last decade in our understanding of the physiology of other cell types, it will be apparent that our present understanding of the physiology of the malaria parasite is relatively primitive. It is not yet properly understood, even in the most general terms, how the parasite undertakes such basic housekeeping functions as maintaining its ionic composition, taking up nutrients or eliminating metabolic waste products, let alone what are the detailed molecular characteristics of the pathways involved. Some of the physiological features of the parasite described to date are characteristic of higher eukaryote (animal) cells, whereas others are characteristic of lower eukaryotes (plants, yeast). There is increasing molecular and biochemical evidence that the intracellular parasite has at its surface a range of different transport pathways, at least some of which (e.g., ATP/ADP exchanger, V-type H+-ATPase, H+-PPase) are, in other systems, found typically on the membranes of intracellular organelles. Further work will establish the full extent to which this is true.
In the context of antimalarial chemotherapy, membrane transport pathways such as those discussed here do hold considerable potential. They may serve not only as drug targets in their own right but as routes for the targeting of cytotoxic agents into the intracellular parasite. A great deal more work is necessary, however, before we will be in a position to design such strategies on a rational basis.
| |
ACKNOWLEDGMENTS |
|---|
I am greatly indebted to Barry Elford, who first introduced me to the complexities of membrane transport in the malaria-infected erythrocyte and whose generous support enabled me to start work in this field. I am grateful to Clive Ellory and Chris Newbold for their interest and support, and I wish to thank those members of my own lab, past and present, who have contributed to this work, particularly Heather Horner, Julie Kirk, and Henry Staines at the University of Oxford and Richard Allen, Lisa Alleva, Jemma Elliott, Rhys Hayward, Pauline Junankar, Rowena Martin, and Kevin Saliba at the Australian National University. Finally, I am grateful to Kevin Saliba and Arieh Lew for helpful comments on the manuscript.
Research in this area in my laboratory has been supported by the Australian National Health and Medical Research Council, the Australian Research Council, the Ramaciotti Foundations, the Wellcome Trust, and the Lister Institute of Preventive Medicine.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: K. Kirk, Div. of Biochemistry and Molecular Biology, Faculty of Science, Australian National University, Canberra, ACT 0200, Australia (E-mail: kiaran.kirk{at}anu.edu.au).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adovelande J, Bastide B, Deleze J, and Schrevel J. Cytosolic free calcium in Plasmodium falciparum-infected erythrocytes and the effect of verapamil: a cytofluorimetric study. Exp Parasitol 76: 247-258, 1993[Web of Science][Medline]. |
| 2. | Akompong T, VanWye J, Ghori N, and Haldar K. Artemisinin and its derivatives are transported by a vacuolar-network of Plasmodium falciparum and their anti-malarial activities are additive with toxic sphingolipid analogs that block the network. Mol Biochem Parasitol 101: 71-79, 1999[Web of Science][Medline]. |
| 3. | Amtmann A, and Sanders D. Mechanisms of Na+ uptake by plant cells. Adv Botan Res 29: 75-112, 1998. |
| 4. | Ancelin ML, Parant M, Thuet MJ, Philippot JR, and Vial HJ. Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection. Biochem J 273: 701-709, 1991. |
| 5. |
Ancelin ML, and Vial HJ.
Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport.
Antimicrob Agents Chemother
29: 814-820, 1986 |
| 6. | Ancelin ML, and Vial HJ. Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes. Biochim Biophys Acta 1001: 82-89, 1989[Medline]. |
| 7. | Ancelin ML, Vial HJ, and Philippot JR. Inhibitors of choline transport into Plasmodium-infected erythrocytes are effective antiplasmodial compounds in vitro. Biochem Pharmacol 34: 4068-4071, 1985[Web of Science][Medline]. |
| 8. | Ansorge I, Benting J, Bhakdi S, and Lingelbach K. Protein sorting in Plasmodium falciparum-infected red blood cells permeabilized with the pore-forming protein streptolysin O. Biochem J 315: 307-314, 1996. |
| 9. | Ansorge I, Paprotka K, Bhakdi S, and Lingelbach K. Permeabilization of the erythrocyte membrane with streptolysin O allows access to the vacuolar membrane of Plasmodium falciparum and a molecular analysis of membrane topology. Mol Biochem Parasitol 84: 259-261, 1997[Web of Science][Medline]. |
| 10. | Atamna H, and Ginsburg H. The malaria parasite supplies glutathione to its host cell: investigation of glutathione metabolism in human erythrocytes infected with Plasmodium falciparum. Eur J Biochem 250: 670-679, 1997[Web of Science][Medline]. |
| 11. | Atkinson CT, Aikawa M, Perry G, Fujino T, Bennett V, Davidson EA, and Howard RJ. Ultrastructural localization of erythrocyte cytoskeletal and integral membrane proteins in Plasmodium falciparum-infected erythrocytes. Eur J Cell Biol 45: 192-199, 1987[Web of Science]. |
| 12. | Ayi K, Cappadoro M, Branca M, Turrini F, and Arese P. Plasmodium falciparum glutathione metabolism and growth are independent of glutathione system of host erythrocyte. FEBS Lett 424: 257-261, 1998[Web of Science][Medline]. |
| 13. |
Bakker-Grunwald T.
Ion transport in parasitic protozoa.
J Exp Biol
172: 311-322, 1992 |
| 14. | Barker RH Jr, Metelev V, Coakley A, and Zamecnik P. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro. Exp Parasitol 88: 51-59, 1998[Web of Science][Medline]. |
| 15. |
Barker RH,
Metelev V,
Rapaport E, and Zamecnik P.
Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides.
Proc Natl Acad Sci USA
93: 514-518, 1996 |
| 16. | Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, Taraschi TF, and Howard RJ. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82: 77-87, 1995[Web of Science][Medline]. |
| 17. | Baumeister S, Burgwedel A, Maier U, and Lingelbach K. Reconstitution of protein transport across the vacuolar membrane in Plasmodium falciparum-infected permeabilized cells. In: Transport and Trafficking in the Malaria-Infected Erythrocyte. Chichester, UK: Wiley, 1999, p. 145-153. (Novartis Found Symp No. 226) |
| 18. | Benchimol M, De Souza W, Vanderheyden N, Zhong L, Lu HG, Moreno SN, and Docampo R. Functional expression of a vacuolar-type H+-ATPase in the plasma membrane and intracellular vacuoles of Trypanosoma cruzi. Biochem J 332: 695-702, 1998. |
| 19. |
Bernhardt I,
Hall AC, and Ellory JC.
Effects of low ionic strength media on passive human red cell monovalent cation transport.
J Physiol (Lond)
434: 489-506, 1991 |
| 20. | Bhaduri McIntosh S, and Vaidya AB. Molecular characterization of a Plasmodium falciparum gene encoding the mitochondrial phosphate carrier. Mol Biochem Parasitol 78: 297-301, 1996[Web of Science][Medline]. |
| 21. | Bhaduri McIntosh S, and Vaidya AB. Plasmodium falciparum: import of a phosphate carrier protein into heterologous mitochondria. Exp Parasitol 88: 252-254, 1998[Web of Science][Medline]. |
| 22. | Bhakdi S, Weller U, Walev I, Martin E, Jonas D, and Palmer M. A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med Microbiol Immunol Berl 182: 167-175, 1993[Medline]. |
| 23. | Blackman MJ. Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. Methods Cell Biol 45: 213-220, 1994[Web of Science][Medline]. |
| 24. | Bodammer JE, and Bahr GF. The initiation of a "metabolic window" in the surface of host erythrocytes by Plasmodium berghei NYU-2. Lab Invest 28: 708-718, 1973[Web of Science][Medline]. |
| 25. | Bond TD, Higgins CF, and Valverde MA. P-glycoprotein and swelling-activated chloride channels. Methods Enzymol 292: 359-370, 1998[Web of Science][Medline]. |
| 25a. |
Bonday ZQ,
Dhanasekaran S,
Rangarajan PN, and Padmanaban G.
Import of host -aminolevulinate dehydratase into the malarial parasite: identification of a new drug target.
Nature Med.
6: 898-903, 2000[Web of Science][Medline].
|
| 26. | Bookchin RM, Lew VL, Nagel RL, and Raventos C. Increase in potassium and calcium transport in human red cells infected with Plasmodium falciparum in vitro (Abstract). J Physiol (Lond) 312: 65P, 1980. |
| 27. | Bosia A, Ghigo D, Turrini F, Nissani E, Pescarmona GP, and Ginsburg H. Kinetic characterization of Na+/H+ antiport of Plasmodium falciparum membrane. J Cell Physiol 154: 527-534, 1993[Web of Science][Medline]. |
| 28. | Bowman S, Lawson D, Basham D, Brown D, Chillingworth T, Churcher CM, Craig A, Davies RM, Devlin K, Feltwell T, Gentles S, Gwilliam R, Hamlin N, Harris D, Holroyd S, Hornsby T, Horrocks P, Jagels K, Jassal B, Kyes S, McLean J, Moule S, Mungall K, Murphy L, Oliver K, Quail M-A, Rajandream MA, Rutter S, Skelton J, Squares R, Squares S, Sulston JE, Whitehead S, Woodward JR, Newbold CI, and Barrell BG. The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum. Nature 400: 532-538, 1999[Medline]. |
| 29. | Bozdech Z, Delling U, Volkman SK, Cowman AF, and Schurr E. Cloning and sequence analysis of a novel member of the ATP-binding cassette (ABC) protein gene family from Plasmodium falciparum. Mol Biochem Parasitol 81: 41-51, 1996[Web of Science][Medline]. |
| 30. | Bozdech Z, VanWye J, Haldar K, and Schurr E. The human malaria parasite Plasmodium falciparum exports the ATP-binding cassette protein PFGCN20 to membrane structures in the host red blood cell. Mol Biochem Parasitol 97: 81-95, 1998[Web of Science][Medline]. |
| 31. |
Bray PG,
Janneh O,
Raynes KJ,
Mungthin M,
Ginsburg H, and Ward SA.
Cellular uptake of Chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.
J Cell Biol
145: 363-376, 1999 |
| 32. | Bray PG, and Ward SA. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum. Pharmacol Ther 77: 1-28, 1998[Web of Science][Medline]. |
| 33. | Bray PG, Ward SA, and Ginsburg H. Na+/H+ antiporter, chloroquine uptake and drug resistance: inconsistencies in a newly proposed model. Parasitol Today 15: 360-363, 1999[Web of Science][Medline]. |
| 34. | Breuer WV, Kutner S, Sylphen J, Ginsburg H, and Cabantchik ZI. Covalent modification of the permeability pathways induced in the human erythrocyte membrane by the malarial parasite Plasmodium falciparum. J Cell Physiol 133: 55-63, 1987[Web of Science][Medline]. |
| 35. |
Brohn FH, and Trager W.
Coenzyme A requirement of malaria parasites: enzymes of coenzyme A biosynthesis in normal duck erythrocytes and erythrocytes infected with Plasmodium lophurae.
Proc Natl Acad Sci USA
72: 2456-2458, 1975 |
| 36. | Brown DM, Netting AG, Chun BK, Choi Y, Chu CK, and Gero AM. L-Nucleoside analogues as potential antimalarials that selectively target Plasmodium falciparum adenosine deaminase. Nucleosides Nucleotides 18: 2521-2532, 1999[Web of Science][Medline]. |
| 37. | Bursell JDH. Swelling-Activated Membrane Transport Systems in Vertebrate and Protozoan Cells: a Comparative Study (DPhil thesis). Oxford, UK: Univ. of Oxford, 1996. |
| 38. |
Buyse G,
Voets T,
Tytgat J,
De Greef C,
Droogmans G,
Nilius B, and Eggermont J.
Expression of human pICln and ClC-6 in Xenopus oocytes induces an identical endogenous chloride conductance.
J Biol Chem
272: 3615-3621, 1997 |
| 39. |
Cabantchik ZI.
Altered membrane transport of malaria-infected erythrocytes: a possible pharmacologic target.
Blood
74: 1464-1471, 1989 |
| 40. | Cabantchik ZI. Properties of permeation pathways induced in the human red cell membrane by malaria parasites. Blood Cells 16: 421-432, 1990[Web of Science][Medline]. |
| 41. | Cabantchik ZI, Silfen J, and Glickstein H. Discrete sites of permeation induced in the human red cell membrane by malaria parasites. In: Cellular and Molecular Biology of Normal and Abnormal Erythroid Membranes, edited by Cohen CM, and Palek J. New York: Liss, 1990, p. 267-281. |
| 42. |
Cantiello HF,
Jackson GR Jr,
Grosman CF,
Prat AG,
Borkan SC,
Wang Y,
Reisin IL,
O'Riordan CR, and Ausiello DA.
Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulator.
Am J Physiol Cell Physiol
274: C799-C809, 1998 |
| 43. | Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem 56: 395-433, 1987[Web of Science][Medline]. |
| 44. |
Carter NS,
Ben Mamoun C,
Liu W,
Silva EO,
Landfear SM,
Goldberg DE, and Ullman B.
Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum.
J Biol Chem
275: 10683-10691, 2000 |
| 45. | Cheng Q, Cloonan N, Fischer K, Thompson J, Waine G, Lanzer M, and Saul A. stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. Mol Biochem Parasitol 97: 161-176, 1998[Web of Science][Medline]. |
| 46. | Choi I, and Mego JL. Intravacuolar proteolysis in Plasmodium falciparum digestive vacuoles is similar to intralysosomal proteolysis in mammalian cells. Biochim Biophys Acta 926: 170-176, 1987[Medline]. |
| 47. | Choi I, and Mikkelsen RB. Plasmodium falciparum: ATP/ADP transport across the parasitophorous vacuolar and plasma membranes. Exp Parasitol 71: 452-462, 1990[Web of Science][Medline]. |
| 48. | Chou AC, and Fitch CD. Mechanism of hemolysis induced by ferriprotoporphyrin IX. J Clin Invest 68: 672-677, 1981. |
| 49. | Clark DL, Chrisey LA, Campbell JR, and Davidson EA. Non-sequence-specific antimalarial activity of oligodeoxynucleotides. Mol Biochem Parasitol 63: 129-134, 1994[Web of Science][Medline]. |
| 50. | Colombini M, Blachly-Dyson E, and Forte M. VDAC, a channel in the outer mitochondrial membrane. Ion Channels 4: 169-202, 1996[Medline]. |
| 51. |
Cowman AF,
Galatis D, and Thompson JK.
Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine.
Proc Natl Acad Sci USA
91: 1143-1147, 1994 |
| 52. |
Cowman AF,
Karcz S,
Galatis D, and Culvenor JG.
A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole.
J Cell Biol
113: 1033-1042, 1991 |
| 53. | Crabb BS, Cooke BM, Reeder JC, Waller RF, Caruana SR, Davern KM, Wickham ME, Brown GV, Coppel RL, and Cowman AF. Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress. Cell 89: 287-296, 1997[Web of Science][Medline]. |
| 54. | Crandall I, and Sherman IW. Plasmodium falciparum (human malaria)-induced modifications in human erythrocyte band 3 protein. Parasitology 3: 335-340, 1991. |
| 55. | Crandall I, and Sherman IW. Cytoadherence-related neoantigens on Plasmodium falciparum (human malaria)-infected human erythrocytes result from the exposure of normally cryptic regions of the band 3 protein. Parasitology 108: 257-267, 1994. |
| 56. |
Cranmer SL,
Conant AR,
Gutteridge WE, and Halestrap AP.
Characterization of the enhanced transport of L- and D-lactate into human red blood cells infected with Plasmodium falciparum suggests the presence of a novel saturable lactate proton cotransporter.
J Biol Chem
270: 15045-15052, 1995 |
| 57. |
Dagher G, and Lew VL.
Maximal calcium extrusion capacity and stoichiometry of the human red cell calcium pump.
J Physiol (Lond)
407: 569-586, 1988 |
| 58. | Dame JB, Arnot DE, Bourke PF, Chakrabarti D, Christodoulou Z, Coppel RL, Cowman AF, Craig AG, Fischer K, Foster J, Goodman N, Hinterberg K, Holder AA, Holt DC, Kemp DJ, Lanzer M, Lim A, Newbold CI, Ravetch JV, Reddy GR, Rubio J, Schuster SM, Su XZ, Thompson JK, Vital F, Wellems TE, and Werner EB. Current status of the Plasmodium falciparum genome project. Mol Biochem Parasitol 79: 1-12, 1996[Web of Science][Medline]. |
| 59. | Dawson PA, Cochran DA, Emmerson BT, and Gordon RB. Inhibition of Plasmodium falciparum hypoxanthine-guanine phosphoribosyltransferase mRNA by antisense oligodeoxynucleotide sequence. Mol Biochem Parasitol 60: 153-156, 1993[Web of Science][Medline]. |
| 60. | Deitsch KW, and Wellems TE. Membrane modifications in erythrocytes parasitized by Plasmodium falciparum. Mol Biochem Parasitol 76: 1-10, 1996[Web of Science][Medline]. |
| 61. | De Koning HP, and Jarvis SM. Purine nucleobase transport in bloodstream forms of Trypanosoma brucei is mediated by two novel transporters. Mol Biochem Parasitol 89: 245-258, 1997[Web of Science][Medline]. |
| 62. | De Koning HP, and Jarvis SM. Hypoxanthine uptake through a purine-selective nucleobase transporter in Trypanosoma brucei brucei procyclic cells is driven by protonmotive force. Eur J Biochem 247: 1102-1110, 1997[Web of Science][Medline]. |
| 62a. | Desai SA, Bezrukov SM, and Zimmerberg J. A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature 406: 1001-1005, 2000[Medline]. |
| 63. | Desai SA, Krogstad DJ, and McCleskey EW. A nutrient-permeable channel on the intraerythrocytic malaria parasite. Nature 362: 643-646, 1993[Medline]. |
| 64. | Desai SA, McCleskey EW, Schlesinger PH, and Krogstad DJ. A novel pathway for Ca2+ entry into Plasmodium falciparum-infected blood cells. Am J Trop Med Hyg 54: 464-470, 1996. |
| 65. |
Desai SA, and Rosenberg RL.
Pore size of the malaria parasite's nutrient channel.
Proc Natl Acad Sci USA
94: 2045-2049, 1997 |
| 66. |
Desai SA,
Schlesinger PH, and Krogstad DJ.
Physiologic rate of carrier-mediated Ca2+ entry matches active extrusion in human erythrocytes.
J Gen Physiol
98: 349-364, 1991 |
| 67. | Desai SA, and Zimmerberg J. A voltage-dependent anion channel on Plasmodium falciparum-infected human rbcs absent from normal rbcs (Abstract). Am J Trop Med Hyg 61: 312-313, 1999. |
| 68. | Deuticke B, Beyer E, and Forst B. Discrimination of three parallel pathways of lactate transport in the human erythrocyte membrane by inhibitors and kinetic properties. Biochim Biophys Acta 684: 96-110, 1982[Medline]. |
| 69. | Divo AA, Geary TG, Davis NL, and Jensen JB. Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J Protozool 32: 59-64, 1985[Medline]. |
| 70. |
Dluzewski AR,
Fryer PR,
Griffiths S,
Wilson RJ, and Gratzer WB.
Red cell membrane protein distribution during malarial invasion.
J Cell Sci
92: 691-699, 1989 |
| 71. |
Dluzewski AR,
Mitchell GH,
Fryer PR,
Griffiths S,
Wilson RJ, and Gratzer WB.
Origins of the parasitophorous vacuole membrane of the malaria parasite, Plasmodium falciparum, in human red blood cells.
J Cell Sci
102: 527-532, 1992 |
| 72. | Docampo R, and Moreno SNJ. Acidocalcisome: a novel Ca2+ storage compartment in trypanosomatids and apicomplexan parasites. Parasitol Today 15: 443-448, 1999[Web of Science][Medline]. |
| 73. | Dorn A, Stoffel R, Matile H, Bubendorf A, and Ridley RG. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature 374: 269-271, 1995[Medline]. |
| 74. | Dunn MJ. Alterations of red blood cell sodium transport during malarial infection. J Clin Invest 48: 674-684, 1969. |
| 74a. | Duraisinhgh MT, Jones P, Sambou I, von Seidlein L, Pinder M, and Warhurst DC. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 108: 13-23, 2000[Web of Science][Medline]. |
| 75. | Dyer M, Jackson M, McWhinney C, Zhao G, and Mikkelsen R. Analysis of a cation-transporting ATPase of Plasmodium falciparum. Mol Biochem Parasitol 78: 1-12, 1996[Web of Science][Medline]. |
| 76. | Dyer M, Wong IH, Jackson M, Huynh P, and Mikkelsen R. Isolation and sequence analysis of a cDNA encoding an adenine nucleotide translocator from Plasmodium falciparum. Biochim Biophys Acta 1186: 133-136, 1994[Medline]. |
| 76a. | Dzekunov SM, Ursos LMB, and Roepe PD. Digestive vacuole pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol 110: 107-124, 2000[Web of Science][Medline]. |
| 77. | Egan TJ, Ross DC, and Adams PA. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett 352: 54-57, 1994[Web of Science][Medline]. |
| 78. | Elford BC. L-Glutamine influx in malaria-infected erythrocytes: a target for antimalarials. Parasitol Today 2: 310-312, 1986. |
| 79. | Elford BC. Generating viable extra-erythrocytic forms of P. falciparum. TDR News (WHO Bull) 41: 11, 1993. |
| 80. | Elford BC, Cowan GM, and Ferguson DJP. Parasite-regulated membrane transport processes and metabolic control in malaria-infected erythrocytes. Biochem J 308: 361-374, 1995. |
| 81. | Elford BC, Haynes JD, Chulay JD, and Wilson RJ. Selective stage-specific changes in the permeability to small hydrophilic solutes of human erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 16: 43-60, 1985[Web of Science][Medline]. |
| 82. | Elford BC, Pinches RA, Newbold CI, and Ellory JC. Heterogeneous and substrate-specific membrane transport pathways induced in malaria-infected erythrocytes. Blood Cells 16: 433-436, 1990[Web of Science][Medline]. |
| 83. | Elford BC, Pinches RA, Newbold CI, and Ellory JC. Quinine inhibits cation-selective membrane transport in Plasmodium falciparum-infected human red cells (Abstract). J Physiol (Lond) 426: 100P, 1990. |
| 84. |
Elias PM,
Goerke J, and Friend DS.
Freeze-fracture identification of sterol-digitonin complexes in cell and liposome membranes.
J Cell Biol
78: 577-593, 1978 |
| 84a. | Elliott JL, Saliba KJ, and Kirk K. Transport of lactate and pyruvate in the intraerythrocytic malaria parasite, Plasmodium falciparum. Biochem J. In press. |
| 85. | Ellory JC, and Hall AC. Temperature effects on red cell membrane transport processes. Symp Soc Exp Biol 41: 53-66, 1987[Medline]. |
| 86. |
Ellory JC,
Jones SE, and Young JD.
Glycine transport in human erythrocytes.
J Physiol (Lond)
320: 403-422, 1981 |
| 87. | Elmendorf HG, and Haldar K. Secretory transport in Plasmodium. Parasitol Today 9: 98-102, 1993[Web of Science][Medline]. |
| 88. |
Elmendorf HG, and Haldar K.
Plasmodium falciparum exports the Golgi marker sphingomyelin synthase into a tubovesicular network in the cytoplasm of mature erythrocytes.
J Cell Biol
124: 449-462, 1994 |
| 89. | Ferguson DJP, and Elford BC. Electron dense tracers fail to identify a "parasitophorous duct" in Plasmodium falciparum infected red blood cells. In: Electron Microscopy, edited by Jouffrey B, and Colliex C. France: Les Ulis, 1994, p. 1415-1416. |
| 89a. | Fidock DA, Nomura T, Cooper RA, Su X, Talley AK, and Wellems TE. Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum. Mol Biochem Parasitol 110: 1-10, 2000[Web of Science][Medline]. |
| 89b. | Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LMB, bir Singh Sidhu A, Naudé B, Deitsch KW, Su X, Wootton JC, Roepe PD, and Wellems TE. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871, 2000[Web of Science][Medline]. |
| 90. | Fievet B, Gabillat N, Borgese F, and Motais R. Expression of band 3 anion exchanger induces chloride current and taurine transport: structure-function analysis. EMBO J 14: 5158-5169, 1995[Web of Science][Medline]. |
| 91. | Fincham DA, Wolowyk MW, and Young JD. Volume-sensitive taurine transport in fish erythrocytes. J Membr Biol 96: 45-56, 1987[Web of Science][Medline]. |
| 92. | Flatman PW. Mechanisms of magnesium transport. Annu Rev Physiol 53: 259-271, 1991[Web of Science][Medline]. |
| 93. |
Flores MV,
Atkins D,
Wade D,
O'Sullivan WJ, and Stewart TS.
Inhibition of Plasmodium falciparum proliferation in vitro by ribozymes.
J Biol Chem
272: 16940-16945, 1997 |
| 94. | Foley M, and Tilley L. Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol 27: 231-240, 1997[Web of Science][Medline]. |
| 95. | Foley M, and Tilley L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 79: 55-87, 1998[Web of Science][Medline]. |
| 96. | Foote SJ, Thompson JK, Cowman AF, and Kemp DJ. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57: 921-930, 1989[Web of Science][Medline]. |
| 97. | Francis SE, Gluzman IY, Oksman A, Knickerbocker A, Mueller R, Bryant ML, Sherman DR, Russell DG, and Goldberg DE. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J 13: 306-317, 1994[Web of Science][Medline]. |
| 98. | Frommer WB, and Ninnemann O. Heterologous expression of genes in bacterial, fungal, animal and plant cells. Annu Rev Plant Physiol Plant Mol Biol 46: 419-444, 1995[Web of Science]. |
| 99. | Fujioka H, and Aikawa M. Morphological changes of clefts in Plasmodium-infected erythrocytes under adverse conditions. Exp Parasitol 76: 302-307, 1993[Web of Science][Medline]. |
| 100. | Fujioka H, and Akaiwa M. There is no ducking the duct: reply. Parasitol Today 10: 223-225, 1994. |
| 101. | Garcia CRS. Calcium homeostasis and signaling in the blood-stage malaria parasite. Parasitol Today 15: 488-491, 1999[Web of Science][Medline]. |
| 102. | Garcia CRS, Dluzewski AR, Catalani LH, Burting R, Hoyland J, and Mason WT. Calcium homeostasis in intraerythrocytic malaria parasites. Eur J Cell Biol 71: 409-413, 1996[Web of Science][Medline]. |
| 103. |
Garcia Romeu F,
Cossins AR, and Motais R.
Cell volume regulation by trout erythrocytes: characteristics of the transport systems activated by hypotonic swelling.
J Physiol (Lond)
440: 547-567, 1991 |
| 104. |
Gardner MJ,
Tettelin H,
Carucci DJ,
Cummings LM,
Aravind L,
Koonin EV,
Shallom S,
Mason T,
Yu K,
Fujii C,
Pederson J,
Shen K,
Jing J,
Aston C,
Lai Z,
Schwartz DC,
Pertea M,
Salzberg S,
Zhou L,
Sutton GC,
Clayton R,
White O,
Smith HO,
Fraser CM,
Adams MD,
Venter JC, and Hoffman SL.
Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum.
Science
282: 1126-1132, 1998 |
| 105. | Gati WP, Lin AN, Wang TI, Young JD, and Paterson ARP. Parasite-induced processes for adenosine permeation in mouse eythrocytes infected with the malaria parasite Plasmodium yoelii. Biochem J 272: 277-280, 1990[Web of Science][Medline]. |
| 106. | Gero AM, Brown GV, and O'Sullivan WJ. Pyrimidine de novo synthesis during the life cycle of the intraerythrocytic stage of Plasmodium falciparum. J Parasitol 70: 536-541, 1984[Medline]. |
| 107. | Gero AM, Bugledich EM, Paterson AR, and Jamieson GP. Stage-specific alteration of nucleoside membrane permeability and nitrobenzylthioinosine insensitivity in Plasmodium falciparum infected erythrocytes. Mol Biochem Parasitol 27: 159-170, 1988[Web of Science][Medline]. |
| 108. | Gero AM, and Hall ST. Plasmodium falciparum: transport of entantiomers of nucleosides into Sendai-treated trophozoites. Exp Parasitol 86: 228-231, 1997[Web of Science][Medline]. |
| 109. | Gero AM, and Kirk K. Nutrient transport pathways in Plasmodium-infected erythrocytes: what and where are they? Parasitol Today 10: 395-399, 1994. |
| 110. | Gero AM, and O'Sullivan W. Purines and pyrimidines in malarial parasites. Blood Cells 16: 467-484, 1990[Web of Science][Medline]. |
| 111. | Gero AM, Scott HV, O'Sullivan WJ, and Christopherson RI. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites. Mol Biochem Parasitol 34: 87-97, 1989[Web of Science][Medline]. |
| 112. | Gero AM, and Upston JM. Altered membrane permeability: a new approach to malaria chemotherapy. Parasitol Today 8: 283-286, 1992. |
| 113. | Gero AM, Wood AM, Hogue DL, and Upston JM. Effect of diamide on nucleoside and glucose transport in Plasmodium falciparum and Babesia bovis infected erythrocytes. Mol Biochem Parasitol 44: 195-206, 1991[Web of Science][Medline]. |
| 114. |
Ghosh JK,
Shaool D,
Guillaud P,
Ciceron L,
Mazier D,
Kustanovich I,
Shai Y, and Mor A.
Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis.
J Biol Chem
272: 31609-31616, 1997 |
| 115. | Gill DR, Hyde SC, Higgins CF, Valverde MA, Mintenig GM, and Sepulveda FV. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71: 23-32, 1992[Web of Science][Medline]. |
| 116. | Ginsburg H. Alterations caused by the intraerythrocytic malaria parasite in the permeability of its host cell membrane. Comp Biochem Physiol 95: 31-39, 1990. |
| 117. | Ginsburg H. Some reflections concerning host erythrocyte-malarial parasite interrelationships. Blood Cells 16: 225-235, 1990[Web of Science][Medline]. |
| 118. | Ginsburg H. Is the multidrug resistant protein of the malaria parasite involved in drug resistance? In: Biochemical Protozoology, edited by Coombs G, and North M. London: Taylor and Francis, 1991, p. 424-435. |
| 119. | Ginsburg H. How Plasmodium secures nutrients: new targets for drugs. Parasitol Today 10: 102-103, 1994. |
| 120. | Ginsburg H. Transport pathways in the malaria-infected erythrocyte. Their characterization and their use as potential targets for chemotherapy. Biochem Pharmacol 48: 1847-1856, 1994[Web of Science][Medline]. |
| 121. | Ginsburg H. The permeability properties of the parasite cell membrane. In: Transport and Trafficking in the Malaria-Infected Erythrocyte. Chichester, UK: Wiley, 1999, p. 99-106. (Novartis Found Symp No. 226) |
| 122. | Ginsburg H, Famin O, Zhang J, and Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 56: 1305-1313, 1998[Web of Science][Medline]. |
| 123. | Ginsburg H, and Geary TG. Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials. Biochem Pharmacol 36: 1567-1576, 1987[Web of Science][Medline]. |
| 124. | Ginsburg H, Handeli S, Friedman S, Gorodetsky R, and Krugliak M. Effects of red blood cell potassium and hypertonicity on the growth of Plasmodium falciparum in culture. Z Parasitenkd 72: 185-199, 1986[Medline]. |
| 125. | Ginsburg H, and Kirk K. Membrane transport in the malaria-infected erythrocyte. In: Malaria: Parasite Biology, Pathogenesis, and Protection, edited by Sherman IW. Washington, DC: Am Soc Microbiol, 1998, p. 219-232. |
| 126. | Ginsburg H, and Krugliak M. Uptake of L-tryptophan by erythrocytes infected with malaria parasites (Plasmodium falciparum). Biochim Biophys Acta 729: 97-103, 1983[Medline]. |
| 126a. |
Ginsburg H, and Krugliak M.
Chloroquine some open questions on its antimalarial mode of action and resistance.
Drug Resistance Updates
2: 180-187, 1999[Web of Science][Medline].
|
| 127. | Ginsburg H, Krugliak M, Eidelman O, and Cabantchik ZI. New permeability pathways induced in membranes of Plasmodium falciparum infected erythrocytes. Mol Biochem Parasitol 8: 177-190, 1983[Web of Science][Medline]. |
| 128. | Ginsburg H, Kutner S, Krugliak M, and Cabantchik ZI. Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum infected red blood cells. Mol Biochem Parasitol 14: 313-322, 1985[Web of Science][Medline]. |
| 129. | Ginsburg H, Nissani E, and Krugliak M. Alkalinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity. Biochem Pharmacol 38: 2645-2654, 1989[Web of Science][Medline]. |
| 130. | Ginsburg H, and Stein WD. Biophysical analysis of novel transport pathways induced in red blood cell membranes. J Membr Biol 96: 1-10, 1987[Web of Science][Medline]. |
| 131. | Ginsburg H, and Stein WD. Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Assessment of the factors that may determine drug resistance. Biochem Pharmacol 41: 1463-1470, 1991[Web of Science][Medline]. |
| 132. | Ginsburg H, Ward SA, and Bray PG. An integrated model of chloroquine action. Parasitol Today 15: 357-360, 1999[Web of Science][Medline]. |
| 133. | Glaser TA, Utz GL, and Mukkada AJ. The plasma membrane electrical gradient (membrane potential) in Leishmania donovani promastigotes and amastigotes. Mol Biochem Parasitol 51: 9-15, 1992[Web of Science][Medline]. |
| 134. |
Goldstein L, and Brill SR.
Volume-activated taurine efflux from skate erythrocytes: possible band 3 involvement.
Am J Physiol Regulatory Integrative Comp Physiol
260: R1014-R1020, 1991 |
| 135. |
Goldstein L, and Davis EM.
Taurine, betaine, and inositol share a volume-sensitive transporter in skate erythrocyte cell membrane.
Am J Physiol Regulatory Integrative Comp Physiol
267: R426-R431, 1994 |
| 136. | Goldstein L, Davis Amaral EM, and Musch MW. Organic osmolyte channels: transport characteristics and regulation. Kidney Int 49: 1690-1694, 1996[Web of Science][Medline]. |
| 137. | Goodyer ID, Hayes DJ, and Eisenthal R. Efflux of 6-deoxy-D-glucose from Plasmodium falciparum-infected erythrocytes via two saturable carriers. Mol Biochem Parasitol 84: 229-239, 1997[Web of Science][Medline]. |
| 138. | Goodyer ID, Pouvelle B, Schneider TG, Trelka DP, and Taraschi TF. Characterization of macromolecular transport pathways in malaria-infected erythrocytes. Mol Biochem Parasitol 87: 13-28, 1997[Web of Science][Medline]. |
| 139. |
Grellier P,
Rigomier D,
Clavey V,
Fruchart JC, and Schrevel J.
Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells.
J Cell Biol
112: 267-277, 1991 |
| 140. | Gschwentner M, Susanna A, Schmarda A, Laich A, Nagl UO, Ellemunter H, Deetjen P, Frick J, and Paulmichl M. ICln: a chloride channel paramount for cell volume regulation. J Allergy Clin Immunol 98: S98-S101, 1996[Web of Science][Medline]. |
| 141. |
Haldar K,
de Amorim AF, and Cross GA.
Transport of fluorescent phospholipid analogues from the erythrocyte membrane to the parasite in Plasmodium falciparum-infected cells.
J Cell Biol
108: 2183-2192, 1989 |
| 142. | Haldar K, Elmendorf HG, Das A, Li WL, Ferguson DJ, and Elford BC. In vitro secretory assays with erythrocyte-free malaria parasites. Methods Cell Biol 45: 221-246, 1994[Web of Science][Medline]. |
| 143. | Haldar K, and Uyetake L. The movement of fluorescent endocytotic tracers in Plasmodium falciparum infected erythrocytes. Mol Biochem Parasitol 50: 161-178, 1992[Web of Science][Medline]. |
| 144. | Halestrap AP, and Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343: 281-299, 1999. |
| 145. | Hall AC, and Ellory JC. Evidence for the presence of volume-sensitive KCl transport in "young" human red cells. Biochim Biophys Acta 26: 317-320, 1986. |
| 146. | Hall S, and Gero AM. Plasmodium falciparum: transport of entantiomers of nucleosides into Sendai-treated trophozoites. Exp Parasitol 86: 228-231, 1997. |
| 147. | Hand M, Morrison R, and Strange K. Characterization of volume-sensitive organic osmolyte efflux and anion current in Xenopus oocytes. J Membr Biol 157: 9-16, 1997[Web of Science][Medline]. |
| 148. | Hardy SP, Goodfellow HR, Valverde MA, Gill DR, Sepulveda V, and Higgins CF. Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J 14: 68-75, 1995[Web of Science][Medline]. |
| 149. | Hatin I, Jambou R, Ginsburg H, and Jaureguiberry G. Single or multiple localization of ADP/ATP transporter in human malarial Plasmodium falciparum. Biochem Pharmacol 43: 71-75, 1992[Web of Science][Medline]. |
| 150. | Hatin I, and Jaureguiberry G. Molecular characterisation of the ADP/ATP-transporter cDNA from the human malaria parasite Plasmodium falciparum. Eur J Biochem 228: 86-91, 1995[Web of Science][Medline]. |
| 150a. |
Hayashi M,
Yamada H,
Mitamura T,
Horii T,
Yamamoto A, and Moriyama Y.
Vacuolar H+-ATPase localized in plasma membranes of malaria parasite cells, Plasmodium falciparum, is involved in regional acidification of parasitized erythrocytes.
J Biol Chem
275: 34353-34358, 2000 |
| 151. |
Haynes JK, and Goldstein L.
Volume-regulatory amino acid transport in erythrocytes of the little skate, Raja erinacea.
Am J Physiol Regulatory Integrative Comp Physiol
265: R173-R179, 1993 |
| 152. | Helmby H, Cavelier L, Pettersson U, and Wahlgren M. Rosetting Plasmodium falciparum-infected erythrocytes express unique strain-specific antigens on their surface. Infect Immun 61: 284-288, 1993. |
| 153. |
Hibbs AR,
Stenzel DJ, and Saul A.
Macromolecular transport in malaria does the duct exist?
Eur J Cell Biol
72: 182-188, 1997[Web of Science][Medline].
|
| 154. | Higgins CF. The ABC of channel regulation. Cell 82: 693-696, 1995[Web of Science][Medline]. |
| 155. | Hille B. Ionic Channels of Excitable Membranes. Sunderland, MA: Sinauer, 1992. |
| 156. | Hodge T, and Colombini M. Regulation of metabolite flux through voltage-gating of VDAC channels. J Membr Biol 157: 271-279, 1997[Web of Science][Medline]. |
| 157. | Holz GG Jr. Lipids and the malarial parasite. Bull WHO 55: 237-248, 1977[Web of Science][Medline]. |
| 158. | Hoppe HC, Coetzee J, and Louw AI. Plasmodium falciparum: isolation of intact and erythrocyte-free trophozoites from sorbitol lysates. Parasitology 104: 379-385, 1992. |
| 158a. | Hotta CT, Gazarini ML, Beraldo FH, Varotti FP, Lopes C, Marjus RP, Pozzan T, and Garcia CRS. Calcium-dependent modulation by melatonin of the circadian rhythm in malarial parasites. Nature Cell Biol. 2: 466-468, 2000[Web of Science][Medline]. |
| 159. | Hsiao LL, Howard RJ, Aikawa M, and Taraschi TF. Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum. Biochem J 274: 121-132, 1991. |
| 160. | Huang CC, Basavappa S, and Ellory JC. Volume-activated taurine permeability in cells of the human erythroleukemic cell line K562. J Cell Physiol 167: 354-358, 1996[Web of Science][Medline]. |
| 161. | Izumo A, Tanabe K, Kato M, Doi S, Maekawa K, and Takada S. Transport processes of 2-deoxy-D-glucose in erythrocytes infected with Plasmodium yoelii, a rodent malaria parasite. Parasitology 98: 371-379, 1989. |
| 162. | Jia ZP, McCullough N, Martel R, Hemmingsen S, and Young PG. Gene amplification at a locus encoding a putative Na+/H+ antiporter confers sodium and lithium tolerance in fission yeast. EMBO J 11: 1631-1640, 1992[Web of Science][Medline]. |
| 163. | Jiang S, Anderson SA, Winget GD, and Mukkada AJ. Plasma membrane K+/H+-ATPase from Leishmania donovani. J Cell Physiol 159: 60-66, 1994[Web of Science][Medline]. |
| 164. |
Joyner SE, and Kirk K.
Two pathways for choline transport in eel erythrocytes: a saturable carrier and a volume-activated channel.
Am J Physiol Regulatory Integrative Comp Physiol
267: R773-R779, 1994 |
| 165. | Kamchonwongpaisan S, Samoff E, and Meshnick SR. Identification of hemoglobin degradation products in Plasmodium falciparum. Mol Biochem Parasitol 86: 179-186, 1997[Web of Science][Medline]. |
| 166. | Kanaani J, and Ginsburg H. Compartment analysis of ATP in malaria-infected erythrocytes. Biochem Int 17: 451-459, 1988[Web of Science][Medline]. |
| 167. |
Kanaani J, and Ginsburg H.
Metabolic interconnection between the human malarial parasite Plasmodium falciparum and its host erythrocyte. Regulation of ATP levels by means of an adenylate translocator and adenylate kinase.
J Biol Chem
264: 3194-3199, 1989 |
| 168. | Kanaani J, and Ginsburg H. Transport of lactate in Plasmodium falciparum-infected human erythrocytes. J Cell Physiol 149: 469-476, 1991[Web of Science][Medline]. |
| 169. |
Kara UA,
Stenzel DJ,
Ingram LT,
Bushell GR,
Lopez JA, and Kidson C.
Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane.
Infect Immun
56: 903-909, 1988 |
| 170. | Karcz SR, Herrmann VR, and Cowman AF. Cloning and characterization of a vacuolar ATPase A subunit homologue from Plasmodium falciparum. Mol Biochem Parasitol 58: 333-344, 1993[Web of Science][Medline]. |
| 171. | Karcz SR, Herrmann VR, Trottein F, and Cowman AF. Cloning and characterization of the vacuolar ATPase B subunit from Plasmodium falciparum. Mol Biochem Parasitol 65: 123-133, 1994[Web of Science][Medline]. |
| 172. | Kimura M, Yamaguchi Y, Takada S, and Tanabe K. Cloning of a Ca(2+)-ATPase gene of Plasmodium falciparum and comparison with vertebrate Ca(2+)-ATPases. J Cell Sci 104: 1129-1136, 1993[Abstract]. |
| 173. | King GF, York MJ, Chapman BE, and Kuchel PW. Proton NMR spectroscopic studies of dipeptidase in human erythrocytes. Biochem Biophys Res Commun 110: 305-312, 1983[Web of Science][Medline]. |
| 174. | Kirk K. Swelling-activated organic osmolyte channels. J Membr Biol 158: 1-16, 1997[Web of Science][Medline]. |
| 175. | Kirk K, Ashworth KJ, Elford BC, Pinches RA, and Ellory JC. Characteristics of 86Rb+ transport in human erythrocytes infected with Plasmodium falciparum. Biochim Biophys Acta 1061: 305-308, 1991[Medline]. |
| 176. |
Kirk K,
Ellory JC, and Young JD.
Transport of organic substrates via a volume-activated channel.
J Biol Chem
267: 23475-23478, 1992 |
| 177. | Kirk K, and Horner HA. In search of a selective inhibitor of the induced transport of small solutes in Plasmodium falciparum-infected erythrocytes: effects of arylaminobenzoates. Biochem J 311: 761-768, 1995. |
| 178. |
Kirk K, and Horner HA.
Novel anion dependence of induced cation transport in malaria-infected erythrocytes.
J Biol Chem
270: 24270-24275, 1995 |
| 179. |
Kirk K,
Horner HA,
Elford BC,
Ellory JC, and Newbold CI.
Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional characteristics of a chloride channel.
J Biol Chem
269: 3339-3347, 1994 |
| 180. | Kirk K, Horner HA, and Kirk J. Glucose uptake in Plasmodium falciparum-infected erythrocytes is an equilibrative not an active process. Mol Biochem Parasitol 82: 195-205, 1996[Web of Science][Medline]. |
| 181. | Kirk K, Horner HA, Spillett DJ, and Elford BC. Glibenclamide and meglitinide block the transport of low molecular weight solutes into malaria-infected erythrocytes. FEBS Lett 323: 123-128, 1993[Web of Science][Medline]. |
| 182. | Kirk K, Poli de Figueiredo CE, Elford BC, and Ellory JC. Effect of cell age on erythrocyte choline transport: implications for the increased choline permeability of malaria-infected erythrocytes. Biochem J 283: 617-619, 1992. |
| 183. | Kirk K, Staines HM, Martin RE, and Saliba KJ. Transport properties of the host cell membrane. In: Transport and Trafficking in the Malaria-Infected Erythrocyte. Chichester, UK: Wiley, 1999, p. 55-73. (Novartis Found Symp No. 226) |
| 184. | Kirk K, Wong HY, Elford BC, Newbold CI, and Ellory JC. Enhanced choline and Rb+ transport in human erythrocytes infected with the malaria parasite Plasmodium falciparum. Biochem J 278: 521-525, 1991. |
| 185. |
Kohler S,
Delwiche CF,
Denny PW,
Tilney LG,
Webster P,
Wilson RJ,
Palmer JD, and Roos DS.
A plastid of probable green algal origin in Apicomplexan parasites.
Science
275: 1485-1489, 1997 |
| 186. | Kolakovich KA, Gluzman IY, Duffin KL, and Goldberg DE. Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production. Mol Biochem Parasitol 87: 123-135, 1997[Web of Science][Medline]. |
| 187. | Kramer R, and Ginsburg H. Calcium transport and compartment analysis of free and exchangeable calcium in Plasmodium falciparum-infected red blood cells. J Protozool 38: 594-601, 1991[Medline]. |
| 188. |
Krishna S,
Cowan G,
Meade JC,
Wells RA,
Stringer JR, and Robson KJ.
A family of cation ATPase-like molecules from Plasmodium falciparum.
J Cell Biol
120: 385-398, 1993 |
| 189. | Krishna S, Cowan GM, Robson KJ, and Meade JC. Plasmodium falciparum: further characterization of putative cation ATPases. Exp Parasitol 78: 113-117, 1994[Web of Science][Medline]. |
| 190. | Krishna S, and Woodrow CJ. Expression of parasite transporters in Xenopus oocytes. In: Transport and Trafficking in the Malaria-Infected Erythrocyte. Chichester, UK: Wiley, 1999, p. 126-139. (Novartis Found Symp No. 226) |
| 190a. | Krishna S, Woodrow CJ, Burchmore RJS, Saliba KJ, and Kirk K. Hexose transport in asexual stages of Plasmodium falciparum and Kinetoplastidae. Parasitol Today 16: 516-521, 2000[Web of Science][Medline]. |
| 190b. | Krishna S, Woodrow CJ, Webb R, Penny J, Takeyasu K, Kimura M, and East JM. Expression and functional characterization of a Plasmodium falciparumn Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. J Biol Chem. In press. |
| 190c. | Krishna S, Woodrow CJ, Webb R, Takeyasu K, and Kimura M. P-type ATPase of malaria parasites. In: Na/K ATPases and Related ATPases, edited by Taniguchi K, and Kaya S. Amsterdam, Netherlands: Elsevier, 2000, p. 759-762. |
| 191. |
Krogstad DJ,
Gluzman IY,
Kyle DE,
Oduola AM,
Martin SK,
Milhous WK, and Schlesinger PH.
Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.
Science
238: 1283-1285, 1987 |
| 192. |
Krogstad DJ,
Schlesinger PH, and Gluzman IY.
Antimalarials increase vesicle pH in Plasmodium falciparum.
J Cell Biol
101: 2302-2309, 1985 |
| 193. | Kutner S, Breuer WV, Ginsburg H, Aley SB, and Cabantchik ZI. Characterization of permeation pathways in the plasma membrane of human erythrocytes infected with early stages of Plasmodium falciparum: association with parasite development. J Cell Physiol 125: 521-527, 1985[Web of Science][Medline]. |
| 194. | Kutner S, Breuer WV, Ginsburg H, and Cabantchik ZI. On the mode of action of phlorizin as an antimalarial agent in in vitro cultures of Plasmodium falciparum. Biochem Pharmacol 36: 123-129, 1987[Web of Science][Medline]. |
| 195. | Kutner S, Ginsburg H, and Cabantchik ZI. Permselectivity changes in malaria (Plasmodium falciparum) infected human red blood cell membranes. J Cell Physiol 114: 245-251, 1983[Web of Science][Medline]. |
| 196. |
Kyes SA,
Rowe JA,
Kriek N, and Newbold CI.
Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum.
Proc Natl Acad Sci USA
96: 9333-9338, 1999 |
| 197. |
Labotka RJ,
Lundberg P, and Kuchel PW.
Ammonia permeability of erythrocyte membrane studied by 14N and 15N saturation transfer NMR spectroscopy.
Am J Physiol Cell Physiol
268: C686-C699, 1995 |
| 198. | Lambros C, and Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418-420, 1979[Medline]. |
| 199. |
Lauer SA,
Rathod PK,
Ghori N, and Haldar K.
A membrane network for nutrient import in red cells infected with the malaria parasite.
Science
276: 1122-1125, 1997 |
| 199a. | Lauer S, VanWye J, Harrison T, McManus H, Samuel BU, Hiller NL, Mohandas N, and Haldar K. Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection. EMBO J 19: 3556-3564, 2000[Web of Science][Medline]. |
| 200. | Lee P, Ye Z, Van Dyke K, and Kirk RG. X-ray microanalysis of Plasmodium falciparum and infected red blood cells: effects of qinghaosu and chloroquine on potassium, sodium, and phosphorus composition. Am J Trop Med Hyg 39: 157-165, 1988. |
| 201. | Leida MN, Mahoney JR, and Eaton JW. Intraerythrocytic plasmodial calcium metabolism. Biochem Biophys Res Commun 103: 402-406, 1981[Web of Science][Medline]. |
| 202. | Lew VL, Tsien RY, Miner C, and Bookchin RM. Physiological [Ca2+]i level and pump-leak turnover in intact red cells measured using an incorporated Ca chelator. Nature 298: 478-481, 1982[Medline]. |
| 203. | Lewis RA, Bursell JDH, and Kirk K. Anion-selectivity of the swelling-activated osmolyte channel in eel erythrocytes. J Membr Biol 149: 103-111, 1996[Web of Science][Medline]. |
| 204. | Lingelbach K, and Joiner KA. The parasitophorous vacuole membrane surrounding Plasmodium and Toxoplasma: an unusual compartment in infected cells. J Cell Sci 111: 1467-1475, 1998[Abstract]. |
| 205. |
Linsdell P, and Hanrahan JW.
Adenosine triphosphate-dependent asymmetry of anion permeation in the cystic fibrosis transmembrane conductance regulator chloride channel.
J Gen Physiol
111: 601-614, 1998 |
| 206. |
Linsdell P, and Hanrahan JW.
Glutathione permeability of CFTR.
Am J Physiol Cell Physiol
275: C323-C326, 1998 |
| 207. |
Linsdell P,
Tabcharani JA,
Rommens JM,
Hou YX,
Chang XB,
Tsui LC,
Riordan JR, and Hanrahan JW.
Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions.
J Gen Physiol
110: 355-364, 1997 |
| 208. | Loyevsky M, and Cabantchik ZI. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites. Mol Pharmacol 45: 446-452, 1994[Abstract]. |
| 209. | Loyevsky M, Lytton SD, Mester B, Libman J, Shanzer A, and Cabantchik ZI. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J Clin Invest 91: 218-224, 1993. |
| 210. | Luo S, Marchesini N, Moreno SN, and Docampo R. A plant-like vacuolar H(+)-pyrophosphatase in Plasmodium falciparum. FEBS Lett 460: 217-220, 1999[Web of Science][Medline]. |
| 211. | Maguire PA, Prudhomme J, and Sherman IW. Alterations in erythrocyte membrane phospholipid organization due to the intracellular growth of the human malaria parasite, Plasmodium falciparum. Parasitology 102: 179-186, 1991. |
| 212. | Marchesini N, Luo S, Rodrigues CO, Moreno SN, and Docampo R. Acidocalcisomes and a vacuolar H+-pyrophosphatase in malaria parasites. Biochem J 347: 243-253, 2000. |
| 213. |
Martin SK,
Oduola AM, and Milhous WK.
Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.
Science
235: 899-901, 1987 |
| 214. |
Martiney JA,
Cerami A, and Slater AF.
Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect.
J Biol Chem
270: 22393-22398, 1995 |
| 215. | Martiney JA, Ferrer AS, Cerami A, Dzekunov S, and Roepe P. Chloroquine uptake, altered partitioning and the basis of drug resistance: evidence for chloride-dependent ionic regulation. In: Transport and Trafficking in the Malaria-Infected Erythrocyte. Chichester, UK: Wiley, 1999, p. 265-276. (Novartis Found Symp No. 226) |
| 216. | Maurois P, Delcourt P, Slomianny C, Gueux E, and Rayssiguier Y. Effect of dietary magnesium on the susceptibility of mice to infection by protozoan parasites of the Apicomplexa and Mastigophora phyla. Magnes Res 8: 159-167, 1995[Medline]. |
| 217. | Maurois P, Gueux E, and Rayssiguier Y. Protective effect of severe magnesium deficiency on Plasmodium chabaudi infection. Magnesium Res 2: 183-187, 1989. |
| 218. | McAlister RO, and Mishra GC. Putative inhibitors of erythrocyte transmembrane Ca2+ kill Plasmodium falciparum in vitro. J Parasitol 69: 777-778, 1983[Medline]. |
| 219. | McFadden GI, Reith ME, Mulholland J, and Lang-Unnasch N. Plastid in human parasites. Nature 381: 482, 1996[Medline]. |
| 220. | McFadden GI, and Waller RF. Plastids in parasites of humans. Bioessays 19: 1033-1040, 1997[Web of Science][Medline]. |
| 221. | McIntosh MT, Smith T, Drozdowicz Y, Rea P, and Vaidya AB. The Plasmodium falciparum homologue of the H+ pumping vacuolar pyrophosphatase of plants (Abstract). Am J Trop Med Hyg 61: 200, 1999. |
| 222. |
McNamara MK, and Wiley JS.
Passive permeability of human red blood cells to calcium.
Am J Physiol Cell Physiol
250: C26-C31, 1986 |
| 223. | Menting JG, Tilley L, Deady LW, Ng K, Simpson RJ, Cowman AF, and Foley M. The antimalarial drug, chloroquine, interacts with lactate dehydrogenase from Plasmodium falciparum. Mol Biochem Parasitol 88: 215-224, 1997[Web of Science][Medline]. |
| 224. |
Mikkelsen RB,
Tanabe K, and Wallach DF.
Membrane potential of Plasmodium-infected erythrocytes.
J Cell Biol
93: 685-689, 1982 |
| 225. | Mikkelsen RB, Wallach DF, Van Doren E, and Nillni EA. Membrane potential of erythrocytic stages of Plasmodium chabaudi free of the host cell membrane. Mol Biochem Parasitol 21: 83-92, 1986[Web of Science][Medline]. |
| 226. | Mons B. Preferential invasion of malaria merozoites into young red blood cells. Blood Cells 16: 299-312, 1990[Web of Science][Medline]. |
| 227. | Moreno SN, Zhong L, Lu HG, Souza WD, and Benchimol M. Vacuolar-type H+-ATPase regulates cytoplasmic pH in Toxoplasma gondii tachyzoites. Biochem J 330: 853-860, 1998. |
| 228. | Motais R, Fievet B, Borgese F, and Garcia Romeu F. Association of the band 3 protein with a volume-activated, anion and amino acid channel: a molecular approach. J Exp Biol 200: 361-367, 1997[Abstract]. |
| 229. | Motais R, Guizouarn H, and Garcia Romeu F. Red cell volume regulation: the pivotal role of ionic strength in controlling swelling-dependent transport systems. Biochim Biophys Acta 1075: 169-180, 1991[Medline]. |
| 230. | Moulder JW. The Biochemistry of Intracellular Parasitism. Chicago, IL: Univ. of Chicago Press, 1962. |
| 231. | Moulder JW. The cell as an extreme environment. Proc R Soc Lond B Biol Sci 204: 199-210, 1979[Medline]. |
| 232. |
Musch MW,
Leffingwell TR, and Goldstein L.
Band 3 modulation and hypotonic-stimulated taurine efflux in skate erythrocytes.
Am J Physiol Regulatory Integrative Comp Physiol
266: R65-R74, 1994 |
| 233. |
Neefjes JJ,
Momburg F, and Hammerling GJ.
Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter.
Science
261: 769-771, 1993 |
| 234. |
Nelson N, and Harvey WR.
Vacuolar and plasma membrane proton-adenosinetriphosphatases.
Physiol Rev
79: 361-385, 1999 |
| 235. | Nicolas E, Goodyer ID, and Taraschi TF. An additional mechanism of ribosome-inactivating protein cytotoxicity: degradation of extrachromosomal DNA. Biochem J 327: 413-417, 1997. |
| 236. | Nilius B, Eggermont J, Voets T, Buyse G, Manolopoulos V, and Droogmans G. Properties of volume-regulated anion channels in mammalian cells. Prog Biophys Mol Biol 68: 69-119, 1997[Web of Science][Medline]. |
| 237. | Nillni EA, Schmidt Ullrich R, Mikkelsen RB, and Wallach DF. Extracellular development of Plasmodium knowlesi erythrocytic stages in an artificial intracellular medium. Mol Biochem Parasitol 17: 219-237, 1985[Web of Science][Medline]. |
| 238. | Odoom JE, Campbell ID, Ellory JC, and King GF. Characterisation of peptide fluxes into human erythrocytes: a proton NMR study. Biochem J 267: 141-147, 1990[Web of Science][Medline]. |
| 239. |
Okada Y.
Volume expansion-sensing outward-rectifier Cl channel: fresh start to the molecular identity and volume sensor.
Am J Physiol Cell Physiol
273: C755-C789, 1997 |
| 240. |
Orjih AU,
Banyal HS,
Chevli R, and Fitch CD.
Hemin lyses malaria parasites.
Science
214: 667-669, 1981 |
| 241. | Overman RR. Reversible cellular permeability alterations in disease. In vivo studies on sodium, potassium and chloride concentrations in erythrocytes of the malarious monkey. Am J Physiol 152: 113-121, 1948[Web of Science][Medline]. |
| 241a. |
Pagola S,
Stephens PW,
Bohle DS,
Kosar AD, and Madsen SK.
The structure of malaria pigment -haematin.
Nature
404: 307-310, 2000[Medline].
|
| 241b. | Parker MD, Hyde RJ, Yao SYM, McRobert L, Cass CE, Young JD, McConkey GA, and Baldwin SA. Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for antimalarial chemotherapy. Biochem J 349: 67-75, 2000[Web of Science][Medline]. |
| 242. | Passos AP, and Garcia CR. Characterization of Ca2+ transport activity associated with a non-mitochondrial calcium pool in the rodent malaria parasite P. chabaudi. Biochem Mol Biol Int 42: 919-925, 1997[Web of Science][Medline]. |
| 243. | Passos AP, and Garcia CR. Inositol 1,4,5-trisphosphate induced Ca2+ release from chloroquine-sensitive and -insensitive intracellular stores in the intraerythrocytic stage of the malaria parasite P. chabaudi. Biochem Biophys Res Commun 245: 155-160, 1998[Web of Science][Medline]. |
| 244. | Pasvol G, Wilson RJ, Smalley ME, and Brown J. Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann Trop Med Parasitol 72: 87-88, 1978[Web of Science][Medline]. |
| 245. |
Payne JA,
Lytle C, and McManus TJ.
Foreign anion substitution for chloride in human red blood cells: effect on ionic and osmotic equilibria.
Am J Physiol Cell Physiol
259: C819-C827, 1990 |
| 246. | Peel SA, Merritt SC, Handy J, and Baric RS. Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. Am J Trop Med Hyg 48: 385-397, 1993. |
| 247. | Penny JI, Hall ST, Woodrow CJ, Cowan GM, Gero AM, and Krishna S. Expression of substrate-specific transporters encoded by Plasmodium falciparum in Xenopus laevis oocytes. Mol Biochem Parasitol 93: 81-89, 1998[Web of Science][Medline]. |
| 248. | Pfaller MA, Krogstad DJ, Parquette AR, and Nguyen Dinh P. Plasmodium falciparum: stage-specific lactate production in synchronized cultures. Exp Parasitol 54: 391-396, 1982[Web of Science][Medline]. |
| 249. | Pohlmeyer K, Soll J, Grimm R, Hill K, and Wagner R. A high-conductance solute channel in the chloroplastic outer envelope from pea. Plant Cell 10: 1297-1216, 1998. |
| 250. |
Poole RC, and Halestrap AP.
Transport of lactate and other monocarboxylates across mammalian plasma membranes.
Am J Physiol Cell Physiol
264: C761-C782, 1993 |
| 251. | Pouvelle B, Gormley JA, and Taraschi TF. Characterization of trafficking pathways and membrane genesis in malaria-infected erythrocytes. Mol Biochem Parasitol 66: 83-96, 1994[Web of Science][Medline]. |
| 252. | Pouvelle B, and Gysin J. Presence of the parasitophorous duct in Plasmodium falciparum and P. vivax parasitized Saimiri monkey red blood cells. Parasitol Today 13: 357-361, 1997[Web of Science][Medline]. |
| 253. | Pouvelle B, Spiegel R, Hsiao L, Howard RJ, Morris RL, Thomas AP, and Taraschi TF. Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature 353: 73-75, 1991[Medline]. |
| 254. |
Prat AG,
Reisin IL,
Ausiello DA, and Cantiello HF.
Cellular ATP release by the cystic fibrosis transmembrane conductance regulator.
Am J Physiol Cell Physiol
270: C538-C545, 1996 |
| 255. |
Price RN,
Cassar C,
Brockman A,
Duraisingh M,
van Vugt M,
White NJ,
Nosten F, and Krishna S.
The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.
Antimicrob Agents Chemother
43: 2943-2949, 1999 |
| 256. | Ramasamy R, Kanagaratnam R, Misiura K, Rebowski G, Amerakoon R, and Stec WJ. Anti-sense oligodeoxynucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites. Biochem Biophys Res Commun 218: 930-933, 1996[Web of Science][Medline]. |
| 257. |
Rapaport E,
Misiura K,
Agrawal S, and Zamecnik P.
Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum.
Proc Natl Acad Sci USA
89: 8577-8580, 1992 |
| 258. | Raventos-Suarez C, Bookchin RM, Lew DL, Nagel RL, and Lew VL. Ca2+ is required for reinfection of red cells by Plasmodium falciparum. Federation Proc 41: 1121, 1982. |
| 259. | Raynes K, Foley M, Tilley L, and Deady L. Novel bisquinoline antimalarials: synthesis, antimalarial activity and inhibition of haem polymerisation. Biochem Pharmacol 52: 551-559, 1996[Web of Science][Medline]. |
| 260. | Razakantoanina V, and Jaureguiberry G. Localisation and role of ADP-ATP transporter in cytoplasmic membrane of Plasmodium falciparum (Abstract). Am J Trop Med Hyg 61: 297, 1999. |
| 261. | Reed MB, Saliba KJ, Caruana SR, Kirk K, and Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403: 906-909, 2000[Medline]. |
| 262. |
Reisin IL,
Prat AG,
Abraham EH,
Amara JF,
Gregory RJ,
Ausiello DA, and Cantiello HF.
The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel.
J Biol Chem
269: 20584-20591, 1994 |
| 263. | Ridley RG, Dorn A, Vippagunta SR, and Vennerstrom JL. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ann Trop Med Parasitol 91: 559-566, 1997[Web of Science][Medline]. |
| 264. | Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, Marsh K, and Newbold CI. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357: 689-692, 1992[Medline]. |
| 265. | Roos DS, Crawford MJ, Donald RG, Kissinger JC, Klimczak LJ, and Striepen B. Origin, targeting, and function of the apicomplexan plastid. Curr Opin Microbiol 2: 426-432, 1999[Web of Science][Medline]. |
| 266. | Rosenthal PJ, and Meshnick SR. Hemoglobin processing and the metabolism of amino acids, heme and iron. In: Malaria: Parasite Biology, Pathogenesis, and Protection, edited by Sherman IW. Washington, DC: Am Soc Microbiol, 1998, p. 145-158. |
| 267. | Roth E. Plasmodium falciparum carbohydrate metabolism: a connection between host cell and parasite. Blood Cells 16: 453-460, 1990[Web of Science][Medline]. |
| 268. | Rowe JA, Moulds JM, Newbold CI, and Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388: 292-295, 1997[Medline]. |
| 269. | Rubio JP, and Cowman AF. Plasmodium falciparum: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite. Exp Parasitol 79: 137-147, 1994[Web of Science][Medline]. |
| 270. | Rubio JP, and Cowman AF. The ATP-binding cassette (ABC) gene family of Plasmodium falciparum. Parasitol Today 12: 135-140, 1996[Web of Science][Medline]. |
| 271. |
Ruetz S,
Delling U,
Brault M,
Schurr E, and Gros P.
The pfmdr1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells.
Proc Natl Acad Sci USA
93: 9942-9947, 1996 |
| 272. | Saliba KJ, Folb PI, and Smith PJ. Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem Pharmacol 56: 313-320, 1998[Web of Science][Medline]. |
| 273. |
Saliba KJ,
Horner HA, and Kirk K.
Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum.
J Biol Chem
273: 10190-10195, 1998 |
| 274. | Saliba KJ, and Kirk K. Uptake of an antiplasmodial protease inhibitor into Plasmodium falciparum-infected human erythrocytes via a parasite-induced pathway. Mol Biochem Parasitol 94: 297-301, 1998[Web of Science][Medline]. |
| 275. | Saliba KJ, and Kirk K. pH regulation in the intracellular malaria parasite, Plasmodium falciparum: H+ extrusion via a V-type H+-ATPase. J Biol Chem 47: 33213-33219, 1999. |
| 276. | Saliba KJ, Martin R, Staines HM, and Kirk K. A novel "anion channel" in the malaria-infected erythrocyte: opportunities for antimalarial chemotherapy. In: Chloride Channels, edited by Kozlowski RZ. Oxford, UK: Isis Medical Media, 1999, p. 137-148. |
| 276a. | Salmon BL, Oksman A, and Golberg DE. Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc Natl Acad Sci USA 13: 271-276, 2001. |
| 277. | Sanchez CP, Horrocks P, and Lanzer M. Is the putative chloroquine resistance mediator CG2 the Na+/H+ exchanger of Plasmodium falciparum? Cell 92: 601-602, 1998[Web of Science][Medline]. |
| 277a. | Sanchez CP, and Lanzer M. Changing ideas on chloroquine in Plasmodium falciparum. Curr Opin Infect Dis 13: 653-658, 2000[Web of Science][Medline]. |
| 278. |
Sanchez CP,
Wunsch S, and Lanzer M.
Identification of a chloroquine importer in Plasmodium falciparum. Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype.
J Biol Chem
272: 2652-2658, 1997 |
| 279. |
Scheibel LW,
Colombani PM,
Hess AD,
Aikawa M,
Atkinson CT, and Milhous WK.
Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design.
Proc Natl Acad Sci USA
84: 7310-7314, 1987 |
| 280. |
Schwab JC,
Beckers CJ, and Joiner KA.
The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve.
Proc Natl Acad Sci USA
91: 509-513, 1994 |
| 281. |
Schwartz RS,
Olson JA,
Raventos Suarez C,
Yee M,
Heath RH,
Lubin B, and Nagel RL.
Altered plasma membrane phospholipid organization in Plasmodium falciparum-infected human erythrocytes.
Blood
69: 401-407, 1987 |
| 282. |
Schwiebert EM.
ABC transporter-facilitated ATP conductive transport.
Am J Physiol Cell Physiol
276: C1-C8, 1999 |
| 283. | Scott MD, Ranz A, Kuypers FA, Lubin BH, and Meshnick SR. Parasite uptake of desferroxamine: a prerequisite for antimalarial activity. Br J Haematol 75: 598-602, 1990[Web of Science][Medline]. |
| 284. |
Seeman P.
Transient holes in the erythrocyte membrane during hypotonic hemolysis and stable holes in the membrane after lysis by saponin and lysolecithin.
J Cell Biol
32: 55-70, 1967 |
| 285. |
Seeman P,
Cheng D, and Iles GH.
Structure of membrane holes in osmotic and saponin lysis.
J Cell Biol
56: 519-527, 1973 |
| 286. |
Sheppard DN, and Welsh MJ.
Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents.
J Gen Physiol
100: 573-591, 1992 |
| 287. | Sherman IW. Transport of amino acids and nucleic acid precursors in malarial parasites. Bull WHO 55: 211-225, 1977[Web of Science][Medline]. |
| 288. | Sherman IW. Mechanisms of molecular trafficking in malaria. Parasitology 96: S57-S81, 1988. |
| 289. | Sherman IW, and Tanigoshi L. Glucose transport in the malarial (Plasmodium lophurae) infected erythrocyte. J Protozool 21: 603-607, 1974[Medline]. |
| 290. | Sherman IW, and Winograd E. Antigens on the Plasmodium falciparum infected erythrocyte surface are not parasite derived. Parasitol Today 6: 317-320, 1990. |
| 291. | Sherman IW, and Zidovetski R. A parasitophorous duct in Plasmodium-infected red blood cells. Parasitol Today 8: 2-3, 1992. |
| 292. | Shimbo K, Brassard DL, Lamb RA, and Pinto LH. Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes. Biophys J 69: 1819-1829, 1995[Web of Science][Medline]. |
| 293. | Silfen J, Yanai P, and Cabantchik ZI. Bioflavonoid effects on in vitro cultures of Plasmodium falciparum. Inhibition of permeation pathways induced in the host cell membrane by the intraerythrocytic parasite. Biochem Pharmacol 37: 4269-4276, 1988[Web of Science][Medline]. |
| 294. | Simoes AP, Moll G, Beaumelle H, Vial H, Roelofsen B, and Op den Kamp JA. Plasmodium knowlesi induces alterations in phosphatidylcholine and phosphatidylethanolamine molecular species composition of parasitized monkey erythrocytes. Biochim Biophys Acta 1022: 135-145, 1990[Medline]. |
| 295. |
Singh S,
Puri SK,
Singh SK,
Srivastava R,
Gupta RC, and Pandey VC.
Characterization of simian malarial parasite (Plasmodium knowlesi)-induced putrescine transport in rhesus monkey erythrocytes. A novel putrescine conjugate arrests in vitro growth of simian malarial parasite (Plasmodium knowlesi) and cures multidrug resistant murine malaria (Plasmodium yoelii) infection in vivo.
J Biol Chem
272: 13506-13511, 1997 |
| 296. | Slater AF, and Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355: 167-169, 1992[Medline]. |
| 297. | Sleep J, Wilson D, Simmons R, and Gratzer W. Elasticity of the red cell membrane and its relation to hemolytic disorders: an optical tweezers study. Biophys J 77: 3085-3095, 1999[Web of Science][Medline]. |
| 298. | Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Petersen DS, Pinches R, Newbold CI, and Miller LH. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82: 101-110, 1995[Web of Science][Medline]. |
| 299. |
Sprague RS,
Ellsworth ML,
Stephenson AH,
Kleinhenz ME, and Lonigro AJ.
Deformation-induced ATP release from red blood cells requires CFTR activity.
Am J Physiol Heart Circ Physiol
275: H1726-H1732, 1998 |
| 300. | Staines HM. Cation Transport in the Malaria-Infected Erythrocyte (DPhil thesis). Oxford, UK: Univ. of Oxford, 1998. |
| 301. | Staines HM, Chang W, Ellory JC, Tiffert T, Kirk K, and Lew VL. Passive Ca2+ transport and Ca2+-dependent K+ transport in Plasmodium falciparum-infected red cells. J Membr Biol 172: 13-24, 1999[Web of Science][Medline]. |
| 301a. | Staines HM, Ellory JC, and Kirk K. Perturbation of the Na+/K+ pump-leak balance in malaria-infected erythrocytes. Am J Physiol Cell Physiol. In press. |
| 302. | Staines HM, and Kirk K. Increased choline transport in erythrocytes from mice infected with the malaria parasite Plasmodium vinckei vinckei. Biochem J 334: 525-530, 1998. |
| 303. | Staines HM, Rae C, and Kirk K. Increased permeability of the malaria-infected erythrocyte to organic cations. Biochim Biophys Acta 1463: 88-98, 2000[Medline]. |
| 304. |
Strange K,
Emma F, and Jackson PS.
Cellular and molecular physiology of volume-sensitive anion channels.
Am J Physiol Cell Physiol
270: C711-C730, 1996 |
| 305. | Su X, Kirkman LA, Fujioka H, and Wellems TE. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91: 593-603, 1997[Web of Science][Medline]. |
| 306. | Su X, and Wellems TE. Genome discovery and malaria research: current status and promise. In: Malaria: Parasite Biology, Pathogenesis, and Protection, edited by Sherman IW. Washington, DC: Am Soc Microbiol, 1998, p. 253-266. |
| 307. | Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS, Ravetch JA, and Wellems TE. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82: 89-100, 1995[Web of Science][Medline]. |
| 308. | Tanabe K. Glucose transport in malaria-infected erythrocytes. Parasitol Today 6: 225-229, 1990. |
| 309. | Tanabe K, Izumo A, Kato M, Miki A, and Doi S. Stage-dependent inhibition of Plasmodium falciparum by potent Ca2+ and calmodulin modulators. J Protozool 36: 139-143, 1989[Medline]. |
| 310. |
Tanabe K,
Mikkelsen RB, and Wallach DF.
Calcium transport of Plasmodium chabaudi-infected erythrocytes.
J Cell Biol
93: 680-684, 1982 |
| 311. | Tang X, Halleck MS, Schlegel RA, and Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 272: 1495-1497, 1996[Abstract]. |
| 312. | Taraschi TF. Macromolecular transport in malaria-infected erythrocytes. In: Transport and Trafficking in the Malaria-Infected Erythrocyte. Chichester, UK: Wiley, 1999, p. 114-120. (Novartis Found Symp No. 226) |
| 313. | Taraschi TF, and Pouvelle B. There is no ducking the duct. Parasitol Today 10: 212-213, 1994. |
| 314. | Taraschi TF, and Pouvelle B. There is no ducking the duct: reply. Parasitol Today 10: 224-225, 1994[Web of Science]. |
| 315. | Tiffert T, Garcia-Sancho J, and Lew VL. Irreversible ATP depletion caused by low concentrations of formaldehyde and of calcium-chelator esters in intact human red cells. Biochim Biophys Acta 773: 143-156, 1984[Medline]. |
| 316. |
Tiffert T,
Staines HM,
Ellory JC, and Lew VL.
Functional state of the plasma membrane Ca2+ pump in Plasmodium falciparum-infected human red blood cells.
J Physiol (Lond)
525: 125-134, 2000 |
| 317. | Tilley L, Foley M, Anders RF, Dluzewski AR, Gratzer WB, Jones GL, and Sawyer WH. Rotational dynamics of the integral membrane protein, band 3, as a probe of the membrane events associated with Plasmodium falciparum infections of human erythrocytes. Biochim Biophys Acta 1025: 135-142, 1990[Medline]. |
| 318. |
Tosteson DC, and Hoffman JF.
Regulation of cell volume by active cation transport in high and low potassium sheep red cells.
J Gen Physiol
44: 169-194, 1960 |
| 319. | Trager W. Parasitophorous duct? Still more questions than answers. Parasitol Today 11: 69, 1995. |
| 320. |
Trager W, and Jensen JB.
Human malaria parasites in continuous culture.
Science
193: 673-675, 1976 |
| 321. | Trager W, and Jensen JB. Continuous culture of Plasmodium falciparum: its impact on malaria research. Int J Parasitol 27: 989-1006, 1997[Web of Science][Medline]. |
| 322. |
Trager W,
Zung J, and Tershakovec M.
Initial extracellular development in vitro of erythrocytic stages of malaria parasites (Plasmodium falciparum).
Proc Natl Acad Sci USA
87: 5618-5622, 1990 |
| 323. | Trigg PI, and Kondrachine AV. The current global malaria situation. In: Malaria: Parasite Biology, Pathogenesis, and Protection, edited by Sherman IW. Washington, DC: Am Soc Microbiol, 1998, p. 11-22. |
| 324. | Trottein F, and Cowman AF. Molecular cloning and sequence of two novel P-type adenosinetriphosphatases from Plasmodium falciparum. Eur J Biochem 227: 214-225, 1995[Web of Science][Medline]. |
| 325. | Trottein F, Thompson J, and Cowman AF. Cloning of a new cation ATPase from Plasmodium falciparum: conservation of critical amino acids involved in calcium binding in mammalian organellar Ca(2+)-ATPases. Gene 158: 133-137, 1995[Web of Science][Medline]. |
| 326. | Tzounopoulos T, Maylie J, and Adelman JP. Induction of endogenous channels by high levels of heterologous membrane proteins in Xenopus oocytes. Biophys J 69: 904-908, 1995[Web of Science][Medline]. |
| 327. | Upston JM, and Gero AM. Parasite-induced permeation of nucleosides in Plasmodium falciparum malaria. Biochim Biophys Acta 1236: 249-258, 1995[Medline]. |
| 328. |
Uyemura SA,
Luo S,
Moreno SN, and Docampo R.
Oxidative phosphorylation, Ca(2+) transport, and fatty acid-induced uncoupling in malaria parasites mitochondria.
J Biol Chem
275: 9709-9715, 2000 |
| 329. | Vaidya AB. Mitochondrial physiology as a target for atovaquone and other antimalarials. In: Malaria: Parasite Biology, Pathogenesis and Protection, edited by Sherman IW. Washington, DC: Am Soc Microbiol, 1998. |
| 330. | Valverde MA, Diaz M, Sepulveda FV, Gill DR, Hyde SC, and Higgins CF. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355: 830-833, 1992[Medline]. |
| 331. | Vanderheyden N, Benaim G, and Docampo R. The role of a H(+)-ATPase in the regulation of cytoplasmic pH in Trypanosoma cruzi epimastigotes. Biochem J 318: 103-109, 1996. |
| 332. | Vander Jagt DL, Hunsaker LA, and Campos NM. Characterization of a hemoglobin-degrading, low molecular weight protease from Plasmodium falciparum. Mol Biochem Parasitol 18: 389-400, 1986[Web of Science][Medline]. |
| 333. | Vander Jagt DL, Hunsaker LA, Campos NM, and Baack BR. D-Lactate production in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 42: 277-284, 1990[Web of Science][Medline]. |
| 334. |
van Dijk MR,
Waters AP, and Janse CJ.
Stable transfection of malaria parasite blood stages.
Science
268: 1358-1362, 1995 |
| 335. | Van Es HH, Renkema H, Aerts H, and Schurr E. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene. Mol Biochem Parasitol 68: 209-219, 1994[Web of Science][Medline]. |
| 336. | Vial HJ, and Ancelin ML. Malaria lipids. In: Malaria: Parasite Biology, Pathogenesis, and Protection, edited by Sherman IW. Washington, DC: Am Soc Microbiol, 1998, p. 159-175. |
| 337. | Vial HJ, Eldin P, Martin D, Gannoun L, Calas M, and Ancelin ML. Transport of phospholipid synthesis precursors and lipid trafficking into malaria-infected erythrocytes. In: Transport and Trafficking in the Malaria-Infected Erythrocyte. Chichester, UK: Wiley, 1999, p. 74-83. (Novartis Found Symp No. 226) |
| 338. |
Vieira L,
Slotki I, and Cabantchik ZI.
Chloride conductive pathways which support electrogenic H+ pumping by Leishmania major promastigotes.
J Biol Chem
270: 5299-5304, 1995 |
| 339. |
Voets T,
Buyse G,
Tytgat J,
Droogmans G,
Eggermont J, and Nilius B.
The chloride current induced by expression of the protein pICln in Xenopus oocytes differs from the endogenous volume-sensitive chloride current.
J Physiol (Lond)
495: 441-447, 1996 |
| 340. |
Volkman SK,
Cowman AF, and Wirth DF.
Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum.
Proc Natl Acad Sci USA
92: 8921-8925, 1995 |
| 341. |
Waller RF,
Keeling PJ,
Donald RGK,
Striepen B,
Handman E,
Lang-Unnasch N,
Cowman AF,
Besra GS,
Roos DS, and McFadden GI.
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum.
Proc Natl Acad Sci USA
95: 12352-12357, 1998 |
| 342. | Ward GE, Miller LH, and Dvorak JA. The origin of parasitophorous vacuole membrane lipids in malaria-infected erythrocytes. J Cell Sci 106: 237-248, 1993[Abstract]. |
| 343. | Wasserman M, Alarcon C, and Mendoza PM. Effects of Ca2+ depletion on the asexual cell cycle of Plasmodium falciparum. Am J Trop Med Hyg 31: 711-717, 1982. |
| 344. | Waters AP, Thomas AW, van Dijk MR, and Janse CJ. Transfection of malaria parasites. Methods 13: 134-147, 1997[Web of Science][Medline]. |
| 345. | Wellems TE, Wootton JC, Fujioka H, Su X, Cooper R, Baruch D, and Fidock DA. P. falciparum CG2, linked to chloroquine resistance, does not resemble Na+/H+ exchangers. Cell 94: 285-286, 1998[Web of Science][Medline]. |
| 346. |
Wieczorek H,
Putzenlechner M,
Zeiske W, and Klein U.
A vacuolar-type proton pump energizes K+/H+ antiport in an animal plasma membrane.
J Biol Chem
266: 15340-15347, 1991 |
| 347. |
Wilson CM,
Serrano AE,
Wasley A,
Bogenschutz MP,
Shankar AH, and Wirth DF.
Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum.
Science
244: 1184-1186, 1989 |
| 348. | Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DE, Milhous WK, and Wirth DF. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 57: 151-160, 1993[Web of Science][Medline]. |
| 349. | Wohlhueter RM, and Plagemann PG. Measurement of transport versus metabolism in cultured cells. Methods Enzymol 173: 714-732, 1989[Web of Science][Medline]. |
| 349a. |
Woodrow CJ,
Burchmore RJ, and Krishna S.
Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
Proc Natl Acad Sci USA
97: 9931-9936, 2000 |
| 350. |
Woodrow CJ,
Penny JI, and Krishna S.
Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
J Biol Chem
274: 7272-7277, 1999 |
| 351. | Wright EM and Diamond JM. Anion selectivity in biological systems. Physiol Rev 57: 1977. |
| 352. |
Wu Y,
Sifri CD,
Lei HH,
Su XZ, and Wellems TE.
Transfection of Plasmodium falciparum within human red blood cells.
Proc Natl Acad Sci USA
92: 973-977, 1995 |
| 353. | Wunderlich F, Fiebig S, Vial H, and Kleinig H. Distinct lipid compositions of parasite and host cell plasma membranes from Plasmodium chabaudi-infected erythrocytes. Mol Biochem Parasitol 44: 271-277, 1991[Web of Science][Medline]. |
| 354. | Wunsch S, Horrocks P, Gekle M, and Lanzer M. Single-cell in vivo measurements of ion concentrations within the intracellular parasite Plasmodium falciparum. Parasitol Today 15: 198-200, 1999[Web of Science][Medline]. |
| 355. | Wunsch S, Sanchez C, Gekle M, Kersting U, Fischer K, Horrocks P, and Lanzer M. A method to measure the cytoplasmic pH of single, living Plasmodium falciparum parasites. Behring Inst Mitt 99: 44-50, 1997. |
| 356. |
Wunsch S,
Sanchez CP,
Gekle M,
Grosse Wortmann L,
Wiesner J, and Lanzer M.
Differential stimulation of the Na+/H+ exchanger determines chloroquine uptake in Plasmodium falciparum.
J Cell Biol
140: 335-345, 1998 |
| 357. | Yayon A, Cabantchik ZI, and Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J 3: 2695-2700, 1984[Web of Science][Medline]. |
| 358. |
Yayon A,
Cabantchik ZI, and Ginsburg H.
Susceptibility of human malaria parasites to chloroquine is pH dependent.
Proc Natl Acad Sci USA
82: 2784-2788, 1985 |
| 359. | Yayon A, Timberg R, Friedman S, and Ginsburg H. Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J Protozool 31: 367-372, 1984[Medline]. |
| 360. | Young JD, Wolowyk MW, Fincham DA, Cheeseman CI, Rabenstein DL, and Ellory JC. Conflicting evidence regarding the transport of alpha-glutamyl-dipeptides by human erythrocytes. Biochem J 242: 309-311, 1987[Web of Science][Medline]. |
| 361. | Zalis MG, Wilson CM, Zhang Y, and Wirth DF. Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol Biochem Parasitol 62: 83-92, 1993[Web of Science][Medline]. |
| 362. | Zanner MA, Galey WR, Scaletti JV, Brahm J, and Vander Jagt DL. Water and urea transport in human erythrocytes infected with the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 40: 269-278, 1990[Web of Science][Medline]. |
| 363. | Zarchin S, Krugliak M, and Ginsburg H. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials. Biochem Pharmacol 35: 2435-2442, 1986[Web of Science][Medline]. |
| 364. | Zhang Y, Merali S, and Meshnick SR. p-Aminobenzoic acid transport by normal and Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol 52: 185-194, 1992[Web of Science][Medline]. |
| 365. | Zilberstein D, and Dwyer DM. Identification of a surface membrane proton-translocating ATPase in promastigotes of the parasitic protozoan Leishmania donovani. Biochem J 256: 13-21, 1988[Web of Science][Medline]. |
This article has been cited by other articles:
![]() |
J.C Ellory, H Guizouarn, F Borgese, L.J Bruce, R.J Wilkins, and G.W Stewart Leaky Cl--HCO3- exchangers: cation fluxes via modified AE1 Phil Trans R Soc B, January 27, 2009; 364(1514): 189 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Witola, K. El Bissati, G. Pessi, C. Xie, P. D. Roepe, and C. B. Mamoun Disruption of the Plasmodium falciparum PfPMT Gene Results in a Complete Loss of Phosphatidylcholine Biosynthesis via the Serine-Decarboxylase-Phosphoethanolamine-Methyltransferase Pathway and Severe Growth and Survival Defects J. Biol. Chem., October 10, 2008; 283(41): 27636 - 27643. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Azim-Zadeh, A. Hillebrecht, U. Linne, M. A. Marahiel, G. Klebe, K. Lingelbach, and J. Nyalwidhe Use of Biotin Derivatives to Probe Conformational Changes in Proteins J. Biol. Chem., July 27, 2007; 282(30): 21609 - 21617. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bouyer, S. Egee, and S. L. Y. Thomas Toward a unifying model of malaria-induced channel activity PNAS, June 26, 2007; 104(26): 11044 - 11049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Rozier, V. J. Zata, and M. L. Ellsworth Lactate interferes with ATP release from red blood cells Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3038 - H3042. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Hines, H. J. Fromm, and R. B. Honzatko Structures of Activated Fructose-1,6-bisphosphatase from Escherichia coli: COORDINATE REGULATION OF BACTERIAL METABOLISM AND THE CONSERVATION OF THE R-STATE J. Biol. Chem., April 20, 2007; 282(16): 11696 - 11704. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Staines, S. Ashmore, H. Felgate, J. Moore, T. Powell, and J. C. Ellory Solute transport via the new permeability pathways in Plasmodium falciparum-infected human red blood cells is not consistent with a simple single-channel model Blood, November 1, 2006; 108(9): 3187 - 3194. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. El Bissati, R. Zufferey, W. H. Witola, N. S. Carter, B. Ullman, and C. Ben Mamoun The plasma membrane permease PfNT1 is essential for purine salvage in the human malaria parasite Plasmodium falciparum PNAS, June 13, 2006; 103(24): 9286 - 9291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guergnon, F. Dessauge, V. Dominguez, J. Viallet, S. Bonnefoy, V. J. Yuste, O. Mercereau-Puijalon, X. Cayla, A. Rebollo, S. A. Susin, et al. Use of Penetrating Peptides Interacting with PP1/PP2A Proteins As a General Approach for a Drug Phosphatase Technology Mol. Pharmacol., April 1, 2006; 69(4): 1115 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gengenbacher, T. B. Fitzpatrick, T. Raschle, K. Flicker, I. Sinning, S. Muller, P. Macheroux, I. Tews, and B. Kappes Vitamin B6 Biosynthesis by the Malaria Parasite Plasmodium falciparum: BIOCHEMICAL AND STRUCTURAL INSIGHTS J. Biol. Chem., February 10, 2006; 281(6): 3633 - 3641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Gardiner, K. R. Trenholme, T. S. Skinner-Adams, C. M. Stack, and J. P. Dalton Overexpression of Leucyl Aminopeptidase in Plasmodium falciparum Parasites: TARGET FOR THE ANTIMALARIAL ACTIVITY OF BESTATIN J. Biol. Chem., January 20, 2006; 281(3): 1741 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pessi, J.-Y. Choi, J. M. Reynolds, D. R. Voelker, and C. B. Mamoun In Vivo Evidence for the Specificity of Plasmodium falciparum Phosphoethanolamine Methyltransferase and Its Coupling to the Kennedy Pathway J. Biol. Chem., April 1, 2005; 280(13): 12461 - 12466. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Vaidya Malaria parasites deck the holes in erythrocytes Blood, December 15, 2004; 104(13): 3844 - 3844. [Full Text] [PDF] |
||||
![]() |
G. A. Biagini, E. M. Pasini, R. Hughes, H. P. De Koning, H. J. Vial, P. M. O'Neill, S. A. Ward, and P. G. Bray Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs Blood, November 15, 2004; 104(10): 3372 - 3377. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Ziegler, H. S. Hansen, D. Staerk, S. B. Christensen, H. Hagerstrand, and J. W. Jaroszewski The Antiparasitic Compound Licochalcone A Is a Potent Echinocytogenic Agent That Modifies the Erythrocyte Membrane in the Concentration Range Where Antiplasmodial Activity Is Observed Antimicrob. Agents Chemother., October 1, 2004; 48(10): 4067 - 4071. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Huber, C. Duranton, G. Henke, C. van de Sand, V. Heussler, E. Shumilina, C. D. Sandu, V. Tanneur, V. Brand, R. S. Kasinathan, et al. Plasmodium Induces Swelling-activated ClC-2 Anion Channels in the Host Erythrocyte J. Biol. Chem., October 1, 2004; 279(40): 41444 - 41452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Go, M. Liu, P. Wilairat, P. J. Rosenthal, K. J. Saliba, and K. Kirk Antiplasmodial Chalcones Inhibit Sorbitol-Induced Hemolysis of Plasmodium falciparum-Infected Erythrocytes Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3241 - 3245. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pessi, G. Kociubinski, and C. B. Mamoun A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation PNAS, April 20, 2004; 101(16): 6206 - 6211. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Duranton, S. M. Huber, V. Tanneur, V. B. Brand, C. Akkaya, E. V. Shumilina, C. D. Sandu, and F. Lang Organic Osmolyte Permeabilities of the Malaria-induced Anion Conductances in Human Erythrocytes J. Gen. Physiol., March 29, 2004; 123(4): 417 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Verloo, C. H. M. Kocken, A. Van der Wel, B. C. Tilly, B. M. Hogema, M. Sinaasappel, A. W. Thomas, and H. R. De Jonge Plasmodium falciparum-activated Chloride Channels Are Defective in Erythrocytes from Cystic Fibrosis Patients J. Biol. Chem., March 12, 2004; 279(11): 10316 - 10322. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Locher, P. C. Ruben, J. Gut, and P. J. Rosenthal 5HT1A Serotonin Receptor Agonists Inhibit Plasmodium falciparum by Blocking a Membrane Channel Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3806 - 3809. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Rosenthal Antimalarial drug discovery: old and new approaches J. Exp. Biol., November 1, 2003; 206(21): 3735 - 3744. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M Staines, T. Powell, J Clive Ellory, S. Egee, F. Lapaix, G. Decherf, S. L Y Thomas, C. Duranton, F. Lang, and S. M Huber Modulation of Whole-Cell Currents in Plasmodium Falciparum-Infected Human Red Blood Cells by Holding Potential and Serum J. Physiol., October 1, 2003; 552(1): 177 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Biagini, E. Richier, P. G. Bray, M. Calas, H. Vial, and S. A. Ward Heme Binding Contributes to Antimalarial Activity of Bis-Quaternary Ammoniums Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2584 - 2589. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Joet, U. Eckstein-Ludwig, C. Morin, and S. Krishna Validation of the hexose transporter of Plasmodium falciparum as a novel drug target PNAS, June 24, 2003; 100(13): 7476 - 7479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirono, M. Ojika, H. Mimura, Y. Nakanishi, and M. Maeshima Acylspermidine Derivatives Isolated from a Soft Coral, Sinularia sp., Inhibit Plant Vacuolar H+-Pyrophosphatase J. Biochem., June 1, 2003; 133(6): 811 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Lew, T. Tiffert, and H. Ginsburg Excess hemoglobin digestion and the osmotic stability of Plasmodium falciparum-infected red blood cells Blood, May 15, 2003; 101(10): 4189 - 4194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gazarini, A. P. Thomas, T. Pozzan, and C. R.S. Garcia Calcium signaling in a low calcium environment: how the intracellular malaria parasite solves the problem J. Cell Biol., April 14, 2003; 161(1): 103 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nyalwidhe, S. Baumeister, A. R. Hibbs, S. Tawill, J. Papakrivos, U. Volker, and K. Lingelbach A Nonpermeant Biotin Derivative Gains Access to the Parasitophorous Vacuole in Plasmodium falciparum-infected Erythrocytes Permeabilized with Streptolysin O J. Biol. Chem., October 11, 2002; 277(42): 40005 - 40011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Egee, F. Lapaix, G. Decherf, H. M Staines, J C. Ellory, C. Doerig, and S. L Y Thomas A stretch-activated anion channel is up-regulated by the malaria parasite plasmodium falciparum J. Physiol., August 1, 2002; 542(3): 795 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wengelnik, V. Vidal, M. L. Ancelin, A.-M. Cathiard, J. L. Morgat, C. H. Kocken, M. Calas, S. Herrera, A. W. Thomas, and H. J. Vial A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes Science, February 15, 2002; 295(5558): 1311 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Staines, J. C. Ellory, and K. Kirk Perturbation of the pump-leak balance for Na+ and K+ in malaria-infected erythrocytes Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1576 - C1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rager, C. B. Mamoun, N. S. Carter, D. E. Goldberg, and B. Ullman Localization of the Plasmodium falciparum PfNT1 Nucleoside Transporter to the Parasite Plasma Membrane J. Biol. Chem., October 26, 2001; 276(44): 41095 - 41099. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |